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STABILIZATION OF HYPOXIA INDUCIBLE FACTOR BY COBALT CHLORIDE 
CAN ALTER RENAL TRANSEPITHELIAL TRANSPORT 
SUBHRA SANKAR NAG 
ABSTRACT 
Kidney cyst expansion, stagnant fluid accumulation, and insufficient vascular 
supply can result in localized chronic ischemia-hypoxia in kidney cysts, as well as in 
normal renal epithelia adjacent to a cyst. We hypothesize that in normal epithelia near a 
cyst, the stabilization of Hypoxia Inducible Factor 1α (HIF1α), a major regulator of cellular 
response to hypoxia, can cause altered paracellular and transcellular transport, 
transforming a normal absorptive phenotype to a secretory and paracellularly leaky 
phenotype, leading to cyst expansion. 
Using 100 µmol/L cobalt chloride (CoCl2), HIF1α was stabilized in cellular nucleus 
of a mouse cortical collecting duct cell line (mCCD 1296 (d)), which resulted in an 
increased level of erythropoietin, an effector and reporter molecule of HIF1α. The mCCD 
monolayers have a high transepithelial resistance (TER) value (̴ 3000 Ω-cm2) and around 
95% amiloride-sensitive voltage value. Equivalent current was calculated to compare 
active ion transport. Our results showed that TER values decreased significantly after 48 
and 72 hours of HIF-stabilization. The decrease of TER value was consistent with the 
increase in the permeability of 70 kDa FITC-dextran molecules, supporting the hypothesis 
that HIF-stabilization altered paracellular transport. Stabilization of HIF caused a 
significant decrease in the protein level of zonula occludin 1 (ZO1), which controls 
paracellular transport through tight junctions. Decrease in the ZO1 protein level was 
ix 
 
consistent with the decreased TER value and the increased paracellular permeability. 
Similarly, HIF-stabilization was found to increase paracellular permeability in Mardin-
Darby Canine Kidney (MDCK) epithelial monolayers. In mCCD monolayers, HIF-
stabilization for 48 hours caused loss of active sodium ion (Na+) transport, and very 
interestingly, 72 hours of HIF-stabilization caused a switch in the direction of net active 
ion transport. HIF-stabilization caused a significant decrease of protein level of sodium-
potassium-ATPase (Na+/ K+-ATPase) α1 subunit, the catalytic subunit of the enzyme 
responsible for active Na+ transport, consistent with the loss of active transport of Na+.  
Our results indicate that HIF-stabilization can transform a normal absorptive 
epithelium to a paracellularly leaky and cyst-like secretory epithelium by reversing net Na+ 
transport and increasing monolayer permeability due to alterations of tight junctions, and 
thereby HIF-stabilization may contribute to cyst expansion. 
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CHAPTER I 
INTRODUCTION 
1.1  General Introduction  
The function of a kidney is to maintain electrolyte (ion) and pH balance in our body. 
Excess ions are removed from the blood in the form of urine and thereby the kidney helps 
in controlling blood pressure.  A kidney is made of around a million of filtering units, called 
nephrons (Pitts 1968). As shown in figure 1, kidney tubules are lined with epithelial cells 
having primary cilia. A renal cilium senses fluid flow and helps in maintaining normal 
function and physiology of the kidney. Thus, cilia, fluid flow, and epithelial cells are 
related to each other to maintain kidney anatomy and physiology, and thereby kidney 
homeostasis.  
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Figure 1: Kidney physiology maintained by epithelial cells containing primary cilia 
which sense fluid flow. The diagram A shows fluid flow through a cylindrical kidney 
tubule lined with epithelial cells having primary cilia. The diagram B shows an 
immunocytochemistry of renal epithelial cell and red protruding structure shows a primary 
cilium. 
Around 600,000 people in the United States alone have polycystic kidney disease 
(PKD), which is characterized by the formation of fluid-filled pouch like structures called 
cysts, as shown in figure 2. The cysts expand over the years and finally causes kidney 
failure. Kidney cysts can compress onto blood vessels and can create kidney localized 
ischemic-hypoxic condition (Bernhardt, Wiesener et al. 2007). Kidney cystic epithelium 
was shown to have altered epithelial physiology and kidney localized hypoxia may affect 
the normal epithelia near a cyst (Yu, Kanzawa et al. 2008; Wilson 2011).  
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Figure 2: Polycystic kidney disease and epithelial physiology. Kidney cysts have altered 
epithelial physiology and kidney cysts may affect physiology of normal non-cystic 
epithelia.  
As shown in figure 3, kidney cysts can block fluid flow. Renal cilia sense fluid flow 
and are believed to play an important role in maintaining normal kidney function. Blockage 
of kidney fluid flow can affect the cilia. Kidney localized ischemic-hypoxic condition can 
affect normal epithelial physiology. Kidney localized hypoxia can affect renal cilia.  
Hypoxia can affect renal ciliary length and ciliary biomechanics and thereby may affect 
ciliary flow-sensing (Verghese, Zhuang et al. 2011; Resnick 2016). Alterations of renal 
cilia can affect normal renal epithelial physiology. Ciliary length and fluid flow were found 
to control active transport of sodium ions (Resnick and Hopfer 2007; Resnick 2011). 
Hypoxia can affect renal epithelial transport (Husted, Lu et al. 2010). Thus, cyst and cyst 
induced hypoxia may affect normal renal fluid flow and cilia, thereby affecting ion 
transport and physiology of normal epithelial cells.  The different aspects are discussed in 
detail in this section of introduction.  
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Figure 3: Effect of kidney cysts and cyst-induced localized hypoxia on normal renal 
epithelial physiology.  
1.2  Overview of Kidney Anatomy and Function 
1.2.1  Kidney Anatomy 
A kidney, which is a compound organ made of tubules, can be divided into three 
major sections: 1) outer medulla, 2) inner medulla, and 3) cortex. Inner and outer medulla 
together is called the medulla (Layton 2012). Functional and structural identical units of a 
kidney are called nephrons (Pitts 1968). A kidney is composed of around one million to 
one and one fourth of a million nephrons in humans and around 38,000 nephrons in rats 
(Pitts 1968; Layton 2012).  As shown in figure 4, a nephron is composed of a renal 
corpuscle consisting of glomerulus and Bowman’s capsule, a proximal convoluted tubule, 
a loop of Henle and  the distal convoluted tubule (Pitts 1968). Inside the glomerulus, blood 
plasma first goes through endothelial fenestrations and fluid enters Bowman’s capsule, 
followed by the fluid traveling through the nephron (figure 4). During this fluid flow 
through nephrons, water and solutes are actively and passively transported across epithelial 
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cell layers with the help of transporters and ions channels. Many nephrons put their    
contents into a multibranched collecting duct. Numerous collecting ducts combine and pass 
their contents through a duct of Bellini, finally disposing into a renal calyx (Pitts 1968). 
The collecting duct is considered as the terminal part of the nephron and acts as an osmotic 
exchanger to control hypertonicity of urine (Pitts 1968).  
 
Figure 4: Structure of a nephron. Figure credit: Pearson Education. 
1.2.2  Function of Kidney 
A kidney performs various essential regulatory functions in our body. The most 
well-known function is to remove metabolic wastes and toxins from our blood and excrete 
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them in the form of urine.  The kidney also helps in maintaining homeostasis in our body 
by regulating water, electrolytes, and acid-base balance.  The kidney is also known to be 
responsible for  synthesis or activation of hormones  that  are associated with     
erythropoiesis,  metabolism of calcium, and control of pressure and flow of blood (Layton 
2012). 
1.2.3  Mechanisms Involved in Urine Production 
Three separate mechanisms result in the production of urine: 1) glomerular 
ultrafiltration 2) tubular reabsorption 3) tubular secretion. 
1) Glomerular ultrafiltration removes or filters colloidal matters such as, proteins and 
lipids and other particulates. However, this process cannot prevent molecules with 
small dimensions such as crystalloidal solutes (Pitts 1968).  
2) In tubular reabsorption, glucose is completely reabsorbed in this process while 
traveling through the first half of the proximal tubule (Walker and Hudson 1936). 
Sodium ions are thought to be actively reabsorbed, whereas chloride ions are 
thought be passively reabsorbed in the proximal tubule. The tubule is known to be 
freely permeable to water. Reabsorption of ions creates an osmotic gradient which 
drives the reabsorption of water to maintain the osmotic balance(Pitts 1968). In the 
distal tubule, ions are reabsorbed faster than water, thereby urine is diluted. Thus, 
without proportionally high loss of ions, water is removed in the distal tubule (Pitts 
1968).  
3) Reabsorption of water does not account for increased concentration of certain 
molecules in the urine (Pitts 1968). For example, the increased concentration of 
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urea in the urine can be caused by the process of tubular secretion (Marshall Jr and 
Crane 1924; Pitts 1968).  
1.2.4  Urine Concentrating Mechanism 
The actual mechanism by which a mammalian kidney is able to concentrate urine 
when deprived of consumption of water still remains an unsolved mystery and have 
hypothetical predictions even after many decades of research attempts (Sands and Layton 
2000; Layton 2012). The urine concentrating mechanism is known in the outer medulla of 
the kidney where counter-current multiplication can concentrate urine by absorbing salt in 
between parallel and opposing flows in descending and ascending tubes which stay in 
direct contact with each other. However, the urine concentrating mechanism in the kidney 
inner medulla, which is known to be the site for main urine concentrating function in 
mammals, is still vaguely understood (Layton, Layton et al. 2009; Layton 2012).  Normal 
blood plasma osmolality is around 300 mOsm/kg H2O. The capability of the kidney to 
concentrate urine during deprivation of water consumption varies among different animal 
species. For example, humans can concentrate urine up to a maximum at around 3.8 times 
higher osmolality than blood plasma and normal mice and rats around 9-10 times; whereas 
the Australian hopping mouse, which lives in the desert, can concentrate urine at around 
30 times higher osmolality than blood plasma (Beuchat 1996; Layton 2012). For this 
reason, the sea water should be avoided for human consumption to quench thirst since sea 
water is known to have osmolality around  2,000 to 2,400 mOsm/kg H2O (Layton 2012).  
1.3  Fluid Flow in the Kidney 
Hydrodynamic pressure gradients are known to drive fluid flow through kidney 
tubules (Layton 2012). Fluid flow in the kidney may be quantified as volumetric flow rates 
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in terms of single nephron glomerular filtration rate (SNGFR), or flow can also be 
expressed as wall shear stress (Nag and Resnick 2017).  Micropuncture studies reported 
SNGFR rates in kidney proximal tubule around 25-45 nl/ min in rats and 60-85 nl/ min in 
dogs and around 125 nl/min in humans (Gottschalk and Mylle 1959; Nag and Resnick 
2017). Similarly, using fluorescence markers, SNGFR was measured to be around 32 nl/ 
min in rats(Kang, Toma et al. 2006). A rise in the blood pressure within the glomerulus 
can result in the increased SNGFR and can cause increased fluid flow rate throughout the 
tubule(Layton 2012). Fluid flow through kidney is not a steady flow, rather it has time-
dependent oscillatory or pulsatile flow pattern (Layton 2012; Nag and Resnick 2017).  In 
the glomerulus, endothelial fenestrations and podocyte slit diaphragm can absorb high 
frequency pressure oscillations. Rhythmic contractions of pelvicalyceal wall around the 
inner medulla creates unsteady fluid flow pattern within the nephron (Young and Marsh 
1981; Sakai, Craig et al. 1986; Holstein-Rathlou and Marsh 1989; Pruitt, Knepper et al. 
2006; Nag and Resnick 2017). Pressure, flow, and solute concentrations in the proximal 
tubule show oscillatory patterns with frequencies in the range of 0.015-0.2 Hz (Young and 
Marsh 1981; Sakai, Craig et al. 1986; Holstein-Rathlou and Marsh 1989; Pruitt, Knepper 
et al. 2006; Nag and Resnick 2017). Tubular flow was found to show oscillatory pattern 
with oscillations of 0.1 to 0.02 Hz (Kang, Toma et al. 2006; Rosivall, Mirzahosseini et al. 
2006).  In mouse kidney, green fluorescent protein (GFP) expressing cilia in the proximal 
tubule region showed ciliary oscillation having frequency of 4.8 Hz (O’Connor, Malarkey 
et al. 2013; Nag and Resnick 2017). Thus, oscillatory fluid flow in the kidney tubule can 
cause oscillatory motion of renal cilia (Nag and Resnick 2017). 
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Fluid flow was found to decrease active sodium transport in cultured epithelial 
monolayers derived from kidney cortical collecting duct as compared to no flow. The cell 
cultures under dynamic or variable fluid flow culture conditions showed dedifferentiated 
pro-growth like phenotype, whereas cells under stable flow conditions maintained 
differentiated cellular phenotype (Resnick 2011). Therefore, fluid flow seems to be 
important in maintaining the normal functional phenotype of renal epithelial cells. 
Normal function of kidney is maintained by a narrow range of fluid flow through 
glomerulus and nephron.  The tubular fluid flow rate is important in maintaining the 
balance of water and sodium in our body and gets adjusted according to the body’s 
requirements. The flow rate in the tubules is mainly controlled by glomerular filtration rate 
which includes tubuloglomerular feedback (TGF) and myogenic mechanism (Layton 
2012). 
1.3.1  Tubuloglomerular Feedback 
The TGF mechanism plays a crucial role in the regulation of glomerular filtration 
rate. The TGF system is controlled by the chloride concentration in the macula densa, a 
bundle made of specialized cells located in the thick ascending limb of the Henle’s loop, 
named the “Juxtaglomerular apparatus” (Layton 2012). When the chloride concentration 
in the macula densa is very low, this feedback mechanism induces vasodilation (i.e., 
widening of blood vessels) of afferent arterioles leading to a rise in the pressure of 
glomerular filtration. A rise in blood pressure in the glomerulus increases the rate of fluid 
flow in the kidney tubule. Increased flow results in decreased tubular transport period and 
allows less absorption of sodium chloride (NaCl). Similarly, when chloride concentration 
in the macula densa is very high, then vasoconstriction of afferent arteriole is induced, and 
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followed by decreased flow rate and increased NaCl absorption (Layton 2012). This TGF 
mechanism can cause a continuous oscillation of around 30 mHz in nephron fluid flow 
(Leyssac and Baumbach 1983).  
1.3.2  Myogenic Effect 
 Vascular smooth muscle in the afferent arteriole in the glomerulus develops active 
forces and compensatory vasoconstriction to adjust to the increased stretch generated by 
transmural pressure. This intrinsic feature or response of vascular smooth muscle to be able 
to constrict when intraluminal pressure increases is known as the myogenic effect. This 
myogenic response is known to be important in the autoregulation of blood flow and 
capillary blood pressure (Layton 2012). The renal afferent arteriole is known to have 
rhythmic activity, also referred as vasomotion as seen in other arterioles and small arteries. 
This vascular oscillation is independent of heart beat or respiration. This oscillatory pattern 
is believed to be controlled by resident cells in the arterial wall. Myogenic responses are 
known to be blocked by membrane channel blockers, such Ca2+ and K+ channel blocker 
(Layton 2012). Mathematical models to study myogenic response predict that voltage-
gated channels and voltage-calcium-gated channels control Ca2+ and K+ fluxes 
respectively, these two ion fluxes interact and a rhythmic transport pattern of these two 
ions result (Chen, Sgouralis et al. 2010; Sgouralis and Layton 2012). Ion flux interactions 
and rhythmic transport process can lead to periodic variation in the cytoplasmic calcium 
concentration and can cause myosin light chain phosphorylation, and finally result in the 
development of muscle stress. Therefore, rhythmic oscillations in cytosolic calcium 
concentration can cause sudden vasomotion in the afferent arteriole, and the findings of the 
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mathematical models were reported to be consistent with the experimental results 
(Steinhausen, Endlich et al. 1997; Layton 2012). 
1.3.3  Fluid Flow Related Forces Acting on Kidney Tubule  
Fluid flow through elastic kidney tubules can generate three different forces, two 
forces (normal and shear stress) acting on tubular walls lined with epithelial cells and the 
third force (hydrodynamic drag) acts on protruding renal primary cilia (Nag and Resnick 
2017). Hydrodynamic drag acts only on a primary cilium whose distal end is free to move, 
and cilia can bend in response to fluid flow. This ciliary bending mechanism is believed to 
be responsible for ciliary mediated intracellular calcium influx and cellular signaling (Nag 
and Resnick 2017).  
1.4  Overview of Primary Cilia Anatomy and Function 
Epithelial cells in the kidney control transport of solutes and water using ion 
channels and transporters. Primary non-motile cilia are found on epithelial cells in renal 
duct and renal tubule and these protruding or antenna-like structures are made of 
microtubules. Renal cilia act as the cellular fluid flow sensor and also regulate cellular 
differentiation (Praetorius and Spring 2003; Zhang, Taulman et al. 2004). Ciliary defects 
can lead to dysregulation of proliferation and differentiation of epithelial cells and 
polycystic kidney disease (Calvet 2002; Deane and Ricardo 2007).   
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Figure 5: Structural components of a primary cilium. Figure credit (Smith and 
Rohatgi 2011) 
1.4.1  Major Structural Components of a Primary Cilium 
The microtubule-based cytoskeleton in the inner core of a cilium is called the 
axoneme, which remains covered by a lipid bilayer membrane continuous with the cellular 
plasma membrane. Ciliary membrane is known to contain a different subset of receptors 
and cell signaling molecules as compared to cellular plasma membrane (Veland, Awan et 
al. 2009). The basal body of a cilium helps in keeping the cilium connected to a cell as well 
as provide the platform for 9-fold symmetry formation of the ciliary axoneme. As shown 
in figure 5, the ciliary ‘necklace’ is a structure which keeps the ciliary and plasma 
membrane compartment separated (Gilula and Satir 1972; Veland, Awan et al. 2009). 
Transition fibers connect the ciliary necklace to the transition zone of the basal body of a 
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cilium.  These fibers are believed to form ‘ciliary pore complex’, which selectively allows 
proteins to get inside the ciliary compartment (Rosenbaum and Witman 2002). A renal 
cilium is non-motile and is designated as (9+0) as compared to designation of (9+2) for a 
motile cilium, where ‘9’ shows the number of outer doublet microtubules in the axoneme 
and ‘0’ or ‘2’ shows the number of central microtubules that are present (Veland, Awan et 
al. 2009). Central microtubule pair and structures, such as dynein arm and radical spokes 
which are responsible for motility, are absent in a non-motile renal cilium (Veland, Awan 
et al. 2009). Intraflagellar transport (IFT) is a very conserved mechanism in a cilium and 
involves bidirectional passage of IFT particles (i.e., protein complexes) within the axoneme 
of the cilium (figure 5). Anterograde (base to tip of a cilium) movement is driven by motors 
of kinesin-2 and retrograde movement is guided by cytoplasmic dynein 2 (KozMINSKI, 
Johnson et al. 1993; Scholey 2008; Veland, Awan et al. 2009). Mutations of IFTs, such as 
ift88, in mice showed formation of kidney cysts along with a number of developmental 
defects (Lehman, Michaud et al. 2008).  
1.4.2  Mechanosensory Functions of a Cilium 
  1.4.2.1  Ciliary Flow Sensing and Calcium Influx 
The mechanical links connecting bending of a cilium to increased levels of 
intracellular Ca2+ influx is not clearly understood. Bending of the cilia by fluid flow is 
known to increase cytosolic levels of calcium, a second messenger, and lead to calcium 
induced calcium release (Praetorius and Spring 2001; Praetorius, Frokiaer et al. 2003; 
Praetorius and Spring 2003). Increase in the cilioplasmic Ca2+ concentration results in the 
increase in cAMP and cytosolic concentration of Ca2+, causing activation of protein kinase 
A (PKA) and initiate downstream signalling pathways (Jin, Mohieldin et al. 2014; Nag and 
Resnick 2017). Loss of renal cilia was found to cause uncontrolled influx of intracellular 
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Ca2+ (Siroky, Ferguson et al. 2006). A study, contradicting the existing ciliary calcium 
influx model, reported that the application of fluid flow increases cytoplasmic Ca2+ 
concentration rather than cilioplasmic Ca2+ concentration and non-ciliary site was the initial 
site for increased levels of Ca2+ in response to fluid flow (Delling, Indzhykulian et al. 
2016).  Previous studies did not specifically isolate and study the effect of hydrodynamic 
drag force which acts on protruding cilia and is responsible for ciliary bending. In 
experimental set up involving fluid flow, the shear and stretch act on renal epithelial cells 
and initiate cell signalling responses which can mask the ciliary flow sensing response 
(Nag and Resnick 2017). 
Major suspects responsible for ciliary mechanosensation are believed to be the 
polycystin and polycystin-like proteins encoded by PKD1/PKD2 and PKD1L1/PKD2L2 
genes respectively.  Polycystin 2 (PC2) proteins form the calcium channel (Luo, Vassilev 
et al. 2003) and Polycystin 1 (PC1) has been suggested to be a G-protein coupled receptor 
(GPCR) and acts as a sensor (Patel and Honoré 2010; Trudel, Yao et al. 2016). Renal cilia 
are known to contain several transient receptor potential (TRP) proteins acting as ion 
channels, such as TRP melastatin-4 (TRPM4),  TRP vanilloid 4 (TRPV4), and TRPP2 
(polycystin) (PKD2) (Flannery, Kleene et al. 2015; Phua, Lin et al. 2015; Pablo, DeCaen 
et al. 2016; Nag and Resnick 2017). Fluid flow sensing occurs by opening of divalent cation 
channel PKD2 along with opening of the TRPV4 (Lee, Guevarra et al. 2015).   
  1.4.2.2  Effect of Cilia on Active Sodium Transport 
In kidney cortical collecting duct cells, application of fluid flow using an orbital 
shaker was found to enhance movement of angiotensin receptor type 1 to the apical surface 
and suggested that ciliary mechanosensation play some role in regulating flow dependent 
reabsorption of sodium (Na+) ions and water in kidney proximal tubule (Kolb, Woost et al. 
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2004; Resnick and Hopfer 2007). The presence of an intact cilium was found to be crucial 
in the active Na+ ion transport through epithelial Na channels (ENaC), since the removal 
of cilia caused cellular monolayer to become non-responsive to fluid flow induced changes 
of ENaC current (Resnick and Hopfer 2007). Presence of fluid flow in renal epithelial 
monolayers caused around 60% drop in the sodium current and around 30% decrease in 
the length of the cilium (Resnick and Hopfer 2007). Thus, the active sodium transport in 
renal epithelial cells is believed to be regulated by functional renal cilia.  The proteins -
PC1 and PC2 encoded by PKD1 and PKD2 genes respectively (Nauli, Alenghat et al. 
2003), Polaris encoded by Tg737 (Taulman, Haycraft et al. 2001), and cystin encoded by 
cpk gene (Hou, Mrug et al. 2002) are all found to be localized in the cilia (Yoder, Hou et 
al. 2002), and mutations of these genes cause an absorptive epithelia to transform into a 
secretory cystic epithelia as seen in polycystic kidney disease (Brown and Murcia 2003; 
Nauli, Alenghat et al. 2003). 
1.4.3  Renal Ciliary Length Alterations  
Cell signaling molecules were found to affect the length of cilia. Activation of PKA 
by cyclic AMP (cAMP) was shown to increase ciliary length and inhibition of PKA caused 
decrease in ciliary length (Besschetnova, Kolpakova-Hart et al. 2010). In contrast, ciliary 
length altered inversely with intracellular calcium concentration (Besschetnova, 
Kolpakova-Hart et al. 2010; Nag and Resnick 2017). Renal ciliary length was found to 
increase in response to injury in mouse models (Verghese, Weidenfeld et al. 2007; Wang, 
Weidenfeld et al. 2008) and human kidney transplant with acute form of tubular necrosis 
(Verghese, Weidenfeld et al. 2007). The absence of fluid flow in renal epithelial cell culture 
caused elongation of renal cilia (Resnick and Hopfer 2007). Stabilization of hypoxia 
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inducible factor (HIF) by cobalt chloride was shown to increase the lengths of the cilia 
(Verghese, Zhuang et al. 2011). Another study with similar experimental approach showed 
that HIF-stabilization decreased the effective bending modulus of a cilium and hence the 
cilium became more flexible (Resnick 2016). A mouse model of polycystic kidney disease, 
orpk/Tg737 showed formation of much shorter cilia (Cano, Murcia et al. 2004; Liu, Murcia 
et al. 2005).   
The change in cilia lengths could be assumed as a cellular mechanism to adapt to 
adverse physiological conditions, such as lack of fluid flow or hypoxia. Therefore, it is 
tempting to speculate that the ciliary length alterations can reflect altered ciliary 
biomechanical properties, such as bending modulus, and can lead to altered ciliary flow 
sensing and calcium signaling. 
1.5  Renal Epithelial Transport 
1.5.1  Epithelial Cells 
 An epithelial cell separates complimentary transport proteins in apical and 
basolateral membranes, maintaining cell polarity. An epithelial tissue has the ability to 
transport electrolytes and non-electrolytes in a specific direction (vectorial), since this 
tissue is composed of polarized cells and cellular tight junctions. Epithelial cells can 
perform selective transport (absorption or secretion) of electrolytes and non-electrolytes 
against their electrochemical gradient (Lewis 1996).  
1.5.2  Overview of Cellular Transport 
Transport of ions and molecules across cellular layers is crucial to maintain tissue 
function and homeostasis. From a thermodynamic point of view, transport of molecules 
and ions can be divided into two categories: active transport and passive transport 
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(Srivastava 2005). If the transport process is driven by cellular environment, the transport 
is called passive transport, which does not utilize any cellular energy. On the other hand, 
if the transport process uses energy generated by cellular metabolism, the transport is then 
called active transport (Srivastava 2005). Chloride ions having a smaller size, with 
diameter of 0.3 to 0.4 nm, can easily diffuse through the pores on a cellular membrane 
having diameter of 0.5 to 0.8 nm (Srivastava 2005). Na+ ions in an aqueous solution 
maintain hydrated form with diameter of 0.51 nm, whereas hydrated form of  K+ ions 
maintain diameter of 0.39 nm (Srivastava 2005). Therefore, hydrated K+ ions diffuse easily 
through cellular membrane pores as compared to Na+ ions. Moreover, the interior of pores 
contains positively charged ions such as Ca2+, therefore anions such Cl- can pass through 
the pores easily, whereas the passage of positively charged cations such as Na+ and K+ is 
prevented (Srivastava 2005). Active transport can occur even if there is no electric-
potential gradient and can also occur against the electrochemical gradient (Srivastava 
2005).  
Active transport can be divided into two categories: 1) Primary active transport 2) 
secondary active transport.  In the primary active transport, normally hydrolysis of ATP by 
the transporter, e.g., ion pump or ATPase, generates the energy required to drive the 
transport process. All epithelia are known to have one or more ATPases, such as Na+/ K+-
ATPase and H+-ATPase (Reuss, Wills et al. 1996). On the other hand, secondary active 
transport uses the energy formed by the electrochemical gradient created due to transport 
one substance to drive the transport of other substance or substances. Normally the 
secondary active transport is coupled to active Na+ transport. The electrochemical gradient 
created by Na+ pump acts as the energy source to transport of Na+ and other substances 
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(Reuss, Wills et al. 1996). The sodium-coupled secondary active transport is called 
cotransport, when Na+ ion and the other substance both move along the same direction of 
electrochemical gradient of Na+, and the transport proteins are referred to as the 
cotransporters or symporters. For example, in the kidney proximal tubule, sodium/ glucose 
cotransporter (SLGT1) transports 2 Na+ ions along with 1 glucose molecule into the cell. 
When the transport of a substance occurs in the opposite direction of Na+ electrochemical 
gradient, then the secondary active transport is called counter-transport, and the transport 
proteins are referred to as the exchangers or antiporters. For example, Na+/Ca2+ exchanger 
(NCX) 1, which is found in kidney distal tubule, is known to move 3 Na+ ions inside the 
cell in exchange for moving 1 Ca2+ ion out of the cell (Magyar, White et al. 2002).  
1.5.3  Epithelial Transport Pathways 
The epithelial transport pathway can be divided into two categories: 
1) Intercellular or paracellular pathway: This process involves transport across 
cellular tight junction and then movement along the intercellular spaces in between 
two adjacent cells. 
2) Transcellular pathway transport: This mode of transport begins by the entrance of 
ions or molecules through apical membrane and existing through basolateral 
membrane of a cell (Reuss, Wills et al. 1996).  
1.5.4  Properties of Epithelial Cells 
The basic building block of an epithelium consists of 1) epithelial cells 2) tight 
junctions 3) Basement membrane. The basement membrane provides structural support 
and acts as the site for cellular attachment. Tight junctions help in keeping cells bound 
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together and can also restrict passage of substances among epithelial cells. Tight junctions 
keep the apical membrane separated from the basolateral membrane (Lewis 1996).  
  1.5.4.1  Epithelial Junctional Complex 
Other than tight junction, the junctional structure consists of 1) gap junction 2) 
desmosomes, and 3) zona adherens (Lewis 1996). Cell to cell communication occurs via 
gap junctions. Spot junctions, also known as desmosomes, provide integrity of cellular 
structures. The cellular actin filaments from lateral membrane bind to the site in the 
junctional region, called zona adherens. The space that exists between cells is referred as 
the lateral intercellular space. The lateral intercellular space can be very small, around 10 
nanometers (nm), and can be as large as 1-3 micrometers (µm) depending on the specific 
type of epithelia. The transport through paracellular space is determined by the tight 
junctions and lateral intercellular space (Lewis 1996).  
The junctional complex has three major functions: 
1) The tight junction in the junctional complex separates the apical membrane and the 
basolateral membrane. The junctional complex creates a barrier that prevents migration 
of apical membrane protein to basolateral side and basolateral membrane protein to 
apical side. Thus, the junctional complex helps in maintaining the cell membrane 
polarity (Lewis 1996). 
2) The junctional complex provides epithelial structural integrity by keeping epithelial 
cells bound together. 
3) The junctional complex controls paracellular route of transport of electrolytes and non-
electrolytes.  Hydrophilic substances can move transcellularly using ion channels and 
membrane proteins on apical and basolateral membranes. The junctional complex 
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selectively allows passage of hydrophilic substances on the basis of charge and size 
(Lewis 1996).  
Leaky and Tight Epithelia 
Electrical resistance is the inverse of electrical conductance. An epithelium belongs 
to one out of the two categories based on the electrical resistance by tight junctions. An 
epithelium having low tight junction resistance (less than 100 Ω-cm2) is called a leaky 
epithelium, whereas an epithelium having high tight junction resistance (more than 500 Ω-
cm2) is termed as the tight epithelium (Fromter and Diamond 1972).  
A leaky epithelium has low transepithelial (combined transcellular and paracellular) 
voltage for two possible reasons: 
1) Voltage generated by active ion transport can be leaked through the low resistance 
epithelial junctions. 
2) A leaky epithelium can actively transport ions in an electroneutral process. For 
example, cotransport of a cation and anion together or absorption of a cation 
causing secretion of another cation does not develop any electrical current (Lewis 
1996). 
A leaky epithelium cannot maintain an ion concentration gradient for two possible reasons: 
1) Epithelial junctions have high permeability for ions since the junctional electrical 
resistance is low. Ions can freely move from high concentration gradient to low 
concentration gradient by the process of diffusion, resulting in the loss of ion 
concentration gradient (Lewis 1996).  
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2) A leaky epithelium cannot maintain an ion concentration gradient because water 
molecules easily pass through the epithelial layer through osmosis (Fromter and 
Diamond 1972).  
A tight epithelium due to high junctional resistance can maintain high voltage. The 
tight epithelium’s junction is very less permeable to solutes and the passive transport does 
not have any significant effect on the ion concentration gradient created by the active 
transport. Due to low water permeability and low junctional solute permeability, a tight 
epithelium can create and maintain ionic gradients. A leaky epithelium can transport large 
amounts of electrolytes, non-electrolytes, and water as compared to a tight epithelium, 
whereas a tight epithelium can maintain high concentration gradients of electrolytes and 
non-electrolytes. The transport process across a  tight epithelium is known to be hormone 
regulated but not in case of a leaky epithelium (Lewis 1996). 
In a tight epithelium, such as kidney cortical collecting duct, Na+ ions are known 
to be transported actively and Cl- is known to be transported passively. In this tight 
epithelium, Na+ ions enter the cells through apical epithelial Na channels (ENaC). With the 
help of Na+/ K+-ATPase 3 Na+ go to the basolateral side and 2K+ ions enter cells. This 
transport is a transcellular or active transport process (figure 6). There are low conductance 
K+ channels, which help in removing intracellular K+ build up. Movement of Na+ ions 
actively produce negative value of equivalent (short circuit) current. Using sodium channel 
blocker 95% of current can be blocked (Resnick and Hopfer 2007; Resnick 2011). By 
active sodium transport sodium ions are reabsorbed from urine back to blood. Active Na+ 
transport creates electrochemical gradient which drives passive transport of negatively 
charged Cl- ions through tight junctions as shown in figure 6. In some epithelia, such as 
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frog skin epithelia or sweat gland, Cl- can pass transcellularly since those epithelial apical 
and basolateral membrane have chloride conductance (Lewis 1996). 
 
Figure 6: Epithelial transport in a tight epithelium (e.g., kidney cortical collecting 
duct).  Na+ ions are known to be transported through transcellular route using epithelial 
sodium channels (ENaC) and Na+/ K+-ATPase. Cl- ions are known to be transported 
paracellularly.  
  1.5.4.2  Epithelial Na+ and K+ Transport 
In almost all types of epithelial cells, Na+/ K+-ATPase is found to be present in the 
basolateral membrane (Lewis 1996). As discussed previously, the Na+/ K+-ATPase 
transports 3 Na+ ions from cellular cytoplasm to the serosal solution, and during this 
process 2 K+ ions are transported from serosal solution to the cellular cytoplasm. The 
process is called electrogenic, since during one cycle one positive charge moves out of the 
cell. In this process, one ATP molecule is utilized in each cycle. This process is called 
primary active transport since Na+ and K+ ions are transported against their concentration 
gradient. The basolateral membrane is known to maintain a negative voltage between -30 
and -80 mV. The concentration of K+ ions inside the cells is higher as compared to the 
extracellular fluid. For example, cellular K+ concentration is > 100 mmol/L and 
extracellular K+ concentration is 5 mmol/L in mammals (Lewis 1996). The concentration 
of Na+ is known to be lower inside the cell as compared to the extracellular fluid. Cellular 
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concentration of Na+ is around 10-20 mmol/L and extracellular fluid concentration of Na+ 
is around 135-145 mmol/L in humans (Lewis 1996; Wills, Reuss et al. 2012; Staruschenko, 
Ilatovskaya et al. 2016). Each kidney glomeruli can filter 25,000 mEq of Na+ ions per day 
(Staruschenko, Ilatovskaya et al. 2016). The glomerulus freely allows Na+ ions to pass 
through, and the epithelial cells of different segments of nephron reabsorb the majority of 
Na+ during the fluid flow and urine formation (Staruschenko, Ilatovskaya et al. 2016).  
1.5.5  Epithelial Transport Mechanisms 
A hydrophobic or lipid soluble substance can pass through lipid bilayer by a process 
known as solubility-diffusion, a passive transport process. A hydrophilic solute can be 
transported by primary or secondary active transport or passive transport process (Reuss, 
Wills et al. 1996).  
1.5.5.1  Passive Transport 
Passive transport can occur in two ways: 1) through lipid layer of cell membrane 
2) using transport proteins such as channels and carrier proteins.  Passive transport is 
driven by an already existent electrochemical gradient and result in the transport of a 
single substrate.  
The driving force for the passive transport is the electrochemical potential 
difference (Δµj) which is denoted as: 
Δµj = zj VmF +  RT ln (
𝐶j 
𝑖
𝐶j𝑜
) 
Where zj = valency of ion j, Vm = membrane voltage= Vi – V0 ,   i= inside of membrane, 
o= outside of membrane, F= Faraday’s constant, R= Gas constant, T= temperature, Cj 0 = 
concentration of ion j outside of the membrane, and Cj 
i = concentration of ion inside of the 
membrane (Reuss, Wills et al. 1996).  
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  1.5.5.2  Epithelial Transporters 
The transporters onto epithelial cellular membrane can be categorized into three types: 
1) Ion pumps 2) Carriers 3) Channels. 
1) Ion Pumps 
The ion pumps include ATPase which is known to use the energy produced due to 
hydrolysis of ATP and transport ions against the electrochemical gradient. Thus, ion pumps 
drive active ion transport. The ion pumps can transport around 100-200 molecules per 
second, referred to as the turnover number. ATP hydrolysis causes conformational change 
of the subunit of ATPase and dissociation of substrate which was previously associated 
(Läuger 1991; Reuss, Wills et al. 1996). In this section, among the different ion pumps, 
primary emphasis will be given on Na+/ K+-ATPase.  
Major Epithelial Ion Pumps 
a) H+ pumps:  H+-ATPases are expressed in the kidney proximal tubule and distal nephron 
and helps in maintaining acid-base homeostasis (Gluck, Underhill et al. 1996). This 
pump causes K+ reabsorption and H+ secretion and is known to be present in the 
intercalated cells from cortical collecting duct and distal regions of nephrons. The 
activity of H+,K+-ATPase acts independent of Na+, is stimulated by K+,  and can be 
blocked by vanadate (Reuss, Wills et al. 1996).  
b) Ca2+-ATPase: This ATPase drives the active transport of Ca2+ from cellular cytoplasm 
to the interstitial fluid and this pump is found in renal tubule cells.  Each transport cycle 
with Ca2+-ATPase pump causes removal of 2 Ca2+ ions. This ATPase pump is known 
to be inhibited by vanadate (Carafoli 1994).  
c) Na+/ K+-ATPase: This ion pump helps in maintaining high concentration of K+ and low 
concentration of Na+ inside the cells. The Na+/ K+-ATPase maintains the membrane 
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potential and osmotic balance of cells (Blanco and Mercer 1998).  In the kidney, Na+/ 
K+-ATPase helps in the reabsorption of Na+ ions and water and thus this enzyme is 
crucial in maintaining homeostasis of water and electrolytes in our body (Glynn 1985; 
Jørgensen 1990). The turnover number for Na+, K+-ATPase is around 100-200/ second. 
Ouabain is known to block the pump activity and aldosterone, a hormone, is known to 
increase the pump density (Lingrel, Van Huysse et al. 1994).  
  Table I: Intracellular and extracellular Na+ and K+ concentrations.  
Subunits of Na+/ K+-ATPase 
The Na+/ K+-ATPase pump is an oligomer and is made of two subunits, α and β in 
a 1:1 stoichiometric ratio (Reuss, Wills et al. 1996). Another subunit γ of Na+/ K+-ATPase 
has been identified whose function is controversial and not clearly understood (Blanco and 
Mercer 1998). The three isoforms of α: α1, α2, and α3 have molecular mass of around 120 
kDa and two isoforms of β: β1 and β2 have molecular mass around 50 kDa (Reuss, Wills 
et al. 1996). The α and β isoforms show tissue specific expression patterns (Blanco and 
Mercer 1998). The expression of α1 isoform along with β1 isoform is normally seen in all 
tissue (Lingrel 1992; Levenson 1994). In the kidney α1β1 is the major isozyme (Jørgensen 
1990; Blanco and Mercer 1998). The presence of other isoforms of Na+/ K+-ATPase such 
as α2 and α3 and their functional contributions have been debatable (Farman, Corthesy-
Theulaz et al. 1991; Ahn, Madsen et al. 1993; Blanco and Mercer 1998). The mRNA and 
protein level detection of α2 and α3 isoforms suggested that they are equivalent to 0.01% 
Intracellular 
[Na+] 
Extracellular [Na+] Intracellular [K+] Extracellular 
[K+] 
10-20 mmol/L 135-145 mmol/L > 100 mmol/L 5 mmol/L 
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of α1β1 enzyme in the kidney tissue (Lucking, Nielsen et al. 1996).  The α subunit is the 
catalytic subunit and is mainly responsible for ATPase activity and transport of ions 
(Lingrel, Van Huysse et al. 1994; Reuss, Wills et al. 1996; Wills, Reuss et al. 2012).  The 
α subunit is known to contain the site to bind cations, ATP, inhibitor, and ouabain (Mercer 
1993; Pressley 1996; Blanco and Mercer 1998).  The β subunit is needed to assemble and 
target the pump to be delivered onto the basolateral membrane of epithelial cells (Lingrel, 
Van Huysse et al. 1994; Reuss, Wills et al. 1996; Wills, Reuss et al. 2012).  The β subunit 
is crucial in the function of Na+/ K+-ATPase and it regulates the affinity of the enzyme for 
Na+ and K+ (Eakle, Kabalin et al. 1994; Eakle, Lyu et al. 1995; Blanco and Mercer 1998). 
The β subunit acts as a chaperone and guides correct folding of the α subunit to be correctly 
directed to the basolateral membrane (McDonough, Geering et al. 1990).   
Regulation of Na+/ K+-ATPase 
Different isoforms of Na+/ K+-ATPase have different affinities for Na+, K+, and 
ATP (Blanco and Mercer 1998). Intracellular Na+ concentration, a rate limiting step, 
controls Na+/ K+-ATPase function. Intracellular Ca2+ and endogenous ouabain may control 
sodium pump activity for a short period (Blaustein 1993; Blanco and Mercer 1998). 
Intracellular cAMP and exogeneous derivatives of cAMP can inhibit this pump (Bertorello 
and Katz 1993; Blanco and Mercer 1998). Phosphorylation/ dephosphorylation process can 
regulate activity of this pump.  Protein kinase A (PKA) mediated phosphorylation of serine 
residue at the position of 943 of α subunit causes inhibition of this pump’s activity (Fisone, 
Cheng et al. 1994). Activation of protein kinase C (PKC) causes phosphorylation of serine 
residue at the position 16 of α subunit and can result in the inhibition of the pump activity 
(Beguin, Beggah et al. 1994). In the kidney, protein kinase G (PKG) and cGMP shows an 
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inhibitory effect on the active sodium pumping (McKee, Scavone et al. 1994); (Scavone, 
Scanlon et al. 1995). Thus, activation of PKA, PKC, and PKG can regulate the function of 
Na+/K+ pump isozymes. Digoxin and ouabain obtained from plants are known block 
activity of Na/K-ATPase by binding to an extracellular region of the α subunit of this pump 
(Lingrel, Van Huysse et al. 1994). Ouabain was found to cause endocytosis of Na+/ K+-
ATPase in porcine renal epithelial cells (Liu, Kesiry et al. 2004). Different isoforms of α 
of Na+/ K+-ATPase have different affinity for ouabain. The α3β1 and α3β2 isozymes show 
high level, α2β1 and α2β2 isozymes show intermediate level,  and α1β1 isozymes show 
low level of reactivity or sensitivity for ouabain (Obrien, Lingrel et al. 1994; Bamberg and 
Schoner 2012).  
2) Carriers 
The carriers are known to cause secondary active transport or passive transport. The 
carrier which transports one substance is called uniporter. The carriers can also transport 
multiple substances. Electrochemical gradient created by transport of one substance can 
drive the transport of another substance or substances. The carrier can be either symporters 
(cotransporters) i.e., the movement of two substances in the same direction, or exchangers 
(countertransporters) i.e., the movement of two substances in the opposite direction. The 
turn over numbers of carriers are around 102-104 molecules per second (Stein and Litman 
2014). Normally carriers act in conjunction with a pump. Carriers and/ or channels act in 
series or in parallel with a pump. For example, Na+- glucose cotransporter or amiloride-
sensitive sodium channel acts in series with the Na+/ K+-ATPase located in the basolateral 
membrane of an epithelium which absorbs Na+ (Reuss, Wills et al. 1996). 
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Major Renal Epithelial Carriers 
a) Sodium-glucose cotransporter: These apical cotransporters belonging to SGLT 
gene family are used in the absorption of salt and water in the kidney proximal 
tubule (Reuss, Wills et al. 1996). Outward passage of glucose through basolateral 
membrane occurs using glucose uniporters belonging to GLUT gene family 
(Thorens 1993). 
b) Sodium-chloride cotransporter: This cotransporter (NCC) is normally present in the 
apical membrane distal convoluted tubule (DCT) and is known to reabsorb 5-10% 
of Na+ and Cl-  (Reilly and Ellison 2000). In the DCT, this cotransporter is known 
to interact and regulate epithelial Na+ channels (Mistry, Wynne et al. 2016). 
c) Other Na+ organic solute transporters: Na+ electrochemical gradient generated by 
Na+, K+ pump drives secondary active transport i.e., intracellular uptake of 
vitamins, bile salts, and anions (Reuss, Wills et al. 1996).  
d) Na+/H+ exchanger: This NHE is the carrier which causes exchange of a Na+ for a 
H+. This is an electroneutral process. The NHE has two functions: 1) apical NHE 
causes Na+ absorption and H+ secretion 2) basolateral NHE maintains cellular pH 
and volume. The expression of NHE3 is majorly noticed in the kidney proximal 
tubule (Pouysségur 1994; Reuss, Wills et al. 1996).  
e) Na+-K+-Cl- cotransporter: The NKCC cotransporter has important roles in the 
function of chloride transporting epithelia.  This cotransporter performs transport 
of Cl-, Na+, and K+ in a stoichiometric ratio of 2:1:1 in an electroneutral manner. 
The NKCC driven transport can be inhibited by loop diuretics, such as furosemide 
and bumetanide. NKCC is normally found in the Cl- transporting epithelium in the 
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opposite of the membrane in which Cl- channel is expressed (Haas 1994). In the 
thick ascending loop of Henle, NKCC is found in the apical membrane. Cl- ions 
exit the basolateral membrane through Cl- channel and Na+ ions go out using the 
Na+/ K+-ATPase. NKCC2 is seen in the mammalian kidney (Haas 1994). 
f) Anion exchangers: The anion exchangers (AE) cause exchange of Cl- and HCO3- 
in an electroneutral process.  AE1b, a truncated AE1 protein, is found in the 
basolateral membrane of intercalated cells in the kidney collecting duct (Reuss, 
Wills et al. 1996).  
g) Na+-HCO3- cotransporter, Na+ dependent Cl-/ HCO3- exchanger: The Na+-HCO3- 
cotransporter is known to be expressed in the proximal tubule and contribute to 
90% of HCO3
- transport through basolateral membrane of the epithelia (Boron and 
Boulpaep 1989). The Na+ dependent exchange of Cl-/ HCO3
- is an electroneutral 
process and is also seen in the basolateral membrane of cells in the kidney proximal 
tubule. This exchanger contributes to a much less extent in the HCO3
- transport as 
compared to the Na+-HCO3
- cotransporter (Reuss, Wills et al. 1996).  
3) Channels 
Ion-channels are formed by pore-forming proteins and allow the passage of ions 
according to cell’s electrochemical gradient (Nadeau 2017).  The process of the passage of 
ions through channels is a passive transport. The channels are maintained in either one of 
two states: open or closed. The transition in between these two states is called gating 
(Reuss, Wills et al. 1996). Thus, in addition to selectivity, ion channels also show gating 
effect, i.e., these channels open in response to a stimulus. For example, voltage-gated 
channels open in response to transmembrane potential (Nadeau 2017). Channels in open 
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state allows free passage of ions. The typical turnover number for channels is around 106 
to 107 ions per second (Reuss, Wills et al. 1996).  Numerous ion pumps are needed to match 
up with the flow of ions through a channel. It has been suggested that there are around 5000 
to 10000 Na+ pumps per one K+ ion channel present (Hille 2001). In this section, among 
the various epithelial ions channels, a major emphasis will be given on the epithelial 
sodium channel (ENaC).  
Major Epithelial Channels 
a) Sodium channels: The sodium channels can be classified into three categories: 
i. Highly selective Na+ channel: These Na channels have high Na+ selectivity over 
K+ i.e., PNa/ PK≥ 10, low conductance (ca. 5 pS), and the channel open and close 
times are long (0.5 second to 5 second). 
ii. Moderately selective Na+ channel: These Na+ channels have relatively low 
selectivity for Na+ as compared to highly selective Na+ channels, i.e., PNa/ PK= 
3-4; higher conductance (7-15 pS), and very short open or closed times (≤ 50 
ms).  
iii. Non-selective channel: These channels show little selection preference or 
no selection preference for Na+ over K+ i.e., PNa / PK ≤ 1.5; high conductance 
23-28 pS or low conductance ≥ 3 pS (Reuss, Wills et al. 1996).  
All these three types of Na+ channels are amiloride-sensitive (Garty 1994).  The 
channel blockage occurs by a plug-type process. Highly selective Na+ channels are 
expressed in the tight epithelia having high electrical resistance, such as the ENaC present 
in the renal distal tubule and cortical collecting duct (Palmer 1995). The aldosterone-
sensitive and vasopressin-sensitive epithelia showed increase in the open channel 
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probability and numbers of sodium channels in response to hormones. Channel activity is 
known to decrease by intracellular Na+ concentration, which may be due to activation of 
PKC. The moderately selective Na+ channels are known to coexist along with highly 
selective Na+ channels in epithelial cells cultured onto impermeable supports. These 
moderately selective Na+ channels are controlled by G proteins and cellular actin filaments. 
Non-selective Na+ channels were reported to be present in the primary cell cultures of inner 
medullary collecting ducts. The increased level of cGMP is known to cause 
phosphorylation of channels and can decrease the open probability of these non-selective 
Na+ channels (Garty 1994; Palmer 1995; Reuss, Wills et al. 1996). 
Epithelial Na+ Channel (ENaC) 
The final stages of Na+ reabsorption occur in the convoluted and collecting 
tubules and collecting duct using the epithelial Na+ channel (ENaC). Sodium reabsorption 
is known to control extracellular fluid volume and regulate blood pressure (Pratt 2005; 
Rotin and Schild 2008; Hamm, Feng et al. 2010). ENaCs are distinct compared to Na+ 
channels of excitable membrane (Reuss, Wills et al. 1996). The ENaC forms a 
heterotetramer and  consists of two α, one β, and one γ homologous subunits (Canessa, 
Schild et al. 1994; Kellenberger, Hoffmann-Pochon et al. 1999). Each subunit is known 
to have two transmembrane domains: M1 and M2, short intracellular N and C termini of 
9-10 kDa, and large extracellular loops of around 50 kDa with numerous sites for N-
linked glycosylation. The αENaC (78 kDa) subunit helps in forming the Na+ ion selective 
and amiloride sensitive conductive pore. The β and γ subunits are needed in the 
enhancement of channel expression (Garty 1994; Palmer 1995; Reuss, Wills et al. 1996).  
All three, α, β, and γ ENaC subunits on a single channel level show a higher selection for 
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Na+ than K+ and relatively low value of conductance (~5pS) and also exhibit channel 
gating with long channel opening time (Butterworth 2010). Thus, ENaCs act as the 
highly selective Na+ channel.  Half-life of ENaC in the apical side was found to be 
around 20-30 minutes using cell culture studies (Balda and Matter 2000; Hanwell, 
Ishikawa et al. 2002; Butterworth 2010).  
Regulation of ENaC 
ENaC is known to control the Na+ absorption rate in the distal nephron (Bhalla and 
Hallows 2008; Loffing and Korbmacher 2009; Butterworth 2010; Hamm, Feng et al. 2010). 
The ENaC mutations and conditions can result in upregulation and downregulation of 
ENaC activity, such as seen in Liddle syndrome, type I Pseudohypoaldosteronism (PHA-
I), and cystic fibrosis (CF) (Bhalla and Hallows 2008). Glycosylation, cleavage by 
proteolysis, and other post translational modifications are important in the expression and 
activity of ENaC (Bhalla and Hallows 2008). Sodium reabsorption through ENaC can be 
altered by two different mechanisms:  i) the variation of  surface density or number of 
channels on the apical surface and ii) a change in the open probability of channels by gating 
the channel or by proteolytic cleavage of the extracellular loops α and γ (Butterworth 2010).  
i)  Variation of ENaC Surface Density  
The downregulation of apical ENaC involves ubiquitination of ENaC by ubiquitin 
ligase Nedd4-2 and removal from apical surface by the process of endocytosis (Kabra, 
Knight et al. 2008). Endocytosed ENaC can go back to apical surface after removal of 
ubiquitin molecules and recycling or these ubiquitinated ENaC molecules are degraded 
(Butterworth 2010). Aldosterone is known to bring ENaC from intracellular and 
cytoplasmic region to apical surface of principal cells from the distal nephron area. With 
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long term application of aldosterone, ENaC production and protein half-life are increased 
(Niisato, Taruno et al. 2007; Bhalla and Hallows 2008; Frindt, Ergonul et al. 2008; 
Butterworth 2010). Short term application of aldosterone increases numbers of ENaC on 
the surface (Frindt, Ergonul et al. 2008). The cAMP agonist was found to increase channel 
density of ENaC in the apical side of kidney collecting duct epithelial cells (Morris and 
Schafer 2002; Butterworth, Edinger et al. 2005). 
ii)  Change in Channel Open Probability 
Intra and extracellular concentrations of Na+ regulate ENaC activity. A rapid 
change of channel activity, which is seen within seconds due to increased extracellular Na+ 
concentration, is known as Na self-inhibition (Fuchs, Larsen et al. 1977). Noncleaved 
channels maintain low channel opening probability (Po) when extracellular Na
+ 
concentration is high (Sheng, Carattino et al. 2006).  The Na-self inhibition mechanism is 
relieved by proteolytic cleavage of extracellular loops of ENaC α and γ subunits (Bhalla 
and Hallows 2008). 
Feedback inhibition is a slow change in channel activity that occurs after a few 
minutes to hours due to increased intracellular Na+ concentration (MacRobbie and Ussing 
1961). The application of Na+/ K+-ATPase inhibitors does not cause swelling of cells 
(Sheng, Carattino et al. 2006; Bhalla and Hallows 2008) and indicates the importance of 
feedback inhibition.  
Na-self inhibition and feedback inhibition of ENaC are especially important 
specially in high-salt environments or diets (Bhalla and Hallows 2008).  
b) Potassium Channels: Epithelial potassium channels are responsible for three functions:  
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i. High intracellular concentration of K+ ions as compared to extracellular fluid 
concentration of K+, which creates the negative potential and provides the 
electrochemical gradient to move other ions. 
ii. These channels allow transepithelial absorption or secretion of K+ ions.  
iii. During cellular swelling, these K+ channels get activated to control cellular volume 
(Wang, Sackin et al. 1992; Taglialatela and Brown 1994).  
ROMK1 channel: This channel is an inwardly rectifying K+ channel, i.e., it allows 
easier movement of K+ ions into the cells than out of. It is an ATP sensitive K+ channel, 
which is known to have conductance around 39 pS and high sensitivity to K+ than Na+. 
This channel shows increased open probability at membrane potential, which is at a more 
positive value than -60 mV. The ROMK1 expression is seen in the renal cortex and outer 
medulla (Ho, Nichols et al. 1993).  
Other Maxi-K+ channels have been found in the apical membrane in the areas of 
renal proximal tubule and cortical collecting duct (Reuss, Wills et al. 1996).  
c) Chloride Channels: Chloride channels play a crucial role in the epithelia, such secretion 
of Cl-, absorption of NaCl, and regulation of cell volume. Major chloride channels 
include: cystic fibrosis transmembrane conductance regulator (CFTR) and swelling 
activated Cl- channels. CFTR  is an ATP-dependent and cAMP regulated channel and 
can be blocked by 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) and 
glibenclamide (Fong and Jentsch 1995; Reuss, Wills et al. 1996). CFTR is found in the 
apical membrane of most exocrine glands. The intracellular cAMP-controlled opening 
of CFTR channels is diminished in the individuals with cystic fibrosis. In the kidney 
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cysts, CFTR channels are believed to be associated with active chloride secretion (Brill, 
Ross et al. 1996; Hanaoka, Devuyst et al. 1996).  
Swelling activated Cl- channels are found in the culture of cortical collecting 
duct and inner medullary cells. The permeability preference of this channel is PCl> 
PHCO3 > P gluconate > PNa, and these channels can be blocked by the chloride channel 
blocker NPPB (Fong and Jentsch 1995; Reuss, Wills et al. 1996; Wills, Reuss et al. 
2012).  
d) Calcium Channels: The calcium channels play crucial roles in Ca2+ absorption by renal 
epithelial cells, and are thereby important in intracellular signalling. The voltage-
dependent calcium channels get activated due to the depolarization of membrane 
potentials and can be inhibited by Co2+. These channels are similar to L-type Ca2+ 
channels. The role of these Ca2+ channels in the kidney epithelial cellular function is 
unknown (Friedman and Gesek 1993; Reuss, Wills et al. 1996). 
e) Non-selective Cation Channels: These channels have been reported to be present in the 
renal inner medullary collecting duct, renal distal tubule cells, and M-1 cortical 
collecting duct cell line (Reuss, Wills et al. 1996).  
f) Water Channels (Aquaporins): Lipid membranes are known to have high water 
permeability by osmosis and do not actually require water channels or pores. An 
epithelium with high osmotic water permeability, such as a leaky epithelium and 
antidiuretic hormone (ADH) stimulated epithelium, is known to have pores or water 
channels called aquaporins. The aquaporin 1 (AQP) 1 is a tetramer in which each 
subunit is known to act as a pore. The AQP1 has high selectivity for water molecules 
and almost no permeability for electrolytes or non-electrolytes. AQP1 is known to 
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express in the apical and basolateral membranes of the epithelial cells from kidney 
proximal tubule and in the descending thin limb belonging to loop of Henle. Some other 
water channel proteins have also been identified, such as ADH regulated water 
channels: AQP-CD or AQP2 in the apical membrane of the renal collecting duct cells. 
The water channel AQP3 is found in the basolateral membrane of renal collecting 
tubule (Engel, Walz et al. 1994; Sabolic and Brown 1995; Reuss, Wills et al. 1996). 
1.5.6  Overview of Renal Epithelial Na+ Transport  
In the kidney, along with Na+, other ions, such as chloride and bicarbonate ions, 
also get reabsorbed heavily (Staruschenko, Ilatovskaya et al. 2016).  The main mode of 
sodium reabsorption in the kidney is the active transport through transcellular pathways. 
Passive transport is also known to contribute partially in the total Na+ transport in the 
kidney. Sodium reabsorption in known to occur through both active and passive transport 
mechanisms in proximal convoluted tubules (PCT) and the thick ascending limb (TAL) of 
Henle’s loop (Breiderhoff, Himmerkus et al. 2012; Muto, Furuse et al. 2012). Passive 
transport of Na+ ions is majorly seen in the PCT, where the paracellular resistance is low. 
(Staruschenko, Ilatovskaya et al. 2016). Claudin-2 in the tight junction is known to be 
responsible for reabsorption of Na+ (Kiuchi-Saishin, Gotoh et al. 2002).  Around 30% of 
Na+ ions, absorbed from urine to blood by transcellular transport mechanisms, are known 
to go back to the urine in the proximal tubule by paracellular transport process 
(Staruschenko, Ilatovskaya et al. 2016). The electrogenic pump Na+/ K+-ATPase is known 
to be localized in the basolateral membrane of kidney epithelial cells. This pump is found 
in abundance in the TAL of Henle’s loop, distal convoluted tubule (DCT), collecting tubule 
(CT), and principal cells belonging to collecting duct (CD) (Staruschenko, Ilatovskaya et 
37 
 
al. 2016). The kidney segments having high active transport is generally known to have 
increased level of Na+/ K+-ATPase activity (Féraille and Doucet 2001). The absorption of 
Na+ is known to be maximum in the region of kidney proximal tubule and decrease as the 
fluid travels through the distal segments of the kidney tubule. As shown in figure 7, the 
SGLT cotransporter and NHE3 exchanger account for transcellular reabsorption of Na+ ion 
in the proximal tubule and Na+-K+-Cl- cotransporter NKCC2 accounts for the transcellular 
reabsorption of Na+ ions in Henle’s loop. The Na+-Cl- cotransporter NCC drives 
transcellular Na+ reabsorption in the distal convoluted tubule, and ENaC channels in the 
collecting duct allow transcellular entry of Na+ ions for reabsorption. Proximal tubule 
reabsorbs around 60-70% of Na+ ions, and distal convoluted tubule and collecting duct are 
each known to contribute to around 5% of Na+ ion reabsorption and are known to be 
precisely controlled by physiological factors (Féraille and Doucet 2001). 
 
Figure 7: The percentage of Na+ transport involving major ion channels and 
transporters in the different segments of a nephron. Image credit (Staruschenko, 
Ilatovskaya et al. 2016). SGLT= Sodium-glucose cotransporter, NHE= Na+/H+ exchanger, 
NKCC= Na+-K+-Cl- cotransporter, NCC=Na+–Cl- cotransporter, ENaC= Epithelial sodium 
channel. 
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1.5.7  Regulation of Epithelial Permeability by Cellular Tight Junctions 
1.5.7.1  Epithelial Tight Junctions  
In epithelia, tight junctions act as barriers and form morphological and functional 
boundaries between apical and basolateral sides and regulate selective movement of solutes 
through paracellular pathways (Balda and Matter 2000; Cereijido, Shoshani et al. 2000; 
Anderson 2001; Denker and Sabath 2011). Epithelial tight junctional complex is made of 
tight junction, adherens junction, and desmosomes (Farquhar and Palade 1963). The 
paracellular permeability is mainly determined by the unique tight junction composition of 
specific claudin types, which occupy and control the paracellular space (Furuse, Fujita et 
al. 1998). Signalling proteins and pathways are important in maintaining the function of 
tight junctions to regulate permeability.  Zonula occludens 1 (ZO1), a scaffolding protein, 
acts  as a connector which links tight junction protein to each other and to actin 
cytoskeleton, and also to signal transduction molecules (Denker and Sabath 2011). Tight 
junctions can regulate signals for gene expression by transporting DNA binding proteins 
from tight junction to the cellular nucleus (Denker and Sabath 2011). Through tight 
junction signalling process involving ZO1 associated nucleic acid binding proteins, cells 
can estimate cellular density and accordingly initiate cell proliferation (Balda and Matter 
2000; Lima, Parreira et al. 2010). 
  1.5.7.2  Transepithelial Resistance 
Transepithelial resistance (TER), also known as transepithelial electrical resistance 
(TEER), is the inverse of electrical conductance. TER is a combined value of transcellular 
and paracellular resistance arranged in parallel and is therefore calculated as:  1/TER = 
[1/TER transcellular + 1/TER paracellular](Matter and Balda 2003). In epithelia with low TER 
values, the paracellular resistance is much larger than transcellular resistance (Cereijido, 
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Gonzalez-Mariscal et al. 1983; Stefani and Cereijido 1983; Gonzalez-Mariscal, De 
Ramirez et al. 1989). Therefore, the TER values of low resistance epithelia, such as Madin-
Darby Canine Kidney Epithelial Cells II (MDCKII), mostly indicate paracellular resistance 
which is a combination of junctional resistance and resistance by the paracellular space 
(Matter and Balda 2003). Permeability of ions through epithelial cells can be roughly 
estimated by measuring TER values (Matter and Balda 2003). TER of cellular monolayers 
using cell culture media primarily indicates Na+ permeability (Matter and Balda 2003). 
Measurement of TER is a convenient method to test for cellular monolayer formation onto 
permeable support membrane, and TER values indicate integrity of tight junctions. 
Therefore, TER is useful in determining barrier functions of epithelial monolayers (Lea 
2015).  
1.5.7.3  Renal Epithelial Tight Junctions and TER 
Major tight junction proteins of kidney epithelial cells are shown in figure 8A.  
Claudins are the major integral membrane proteins which help in maintaining barrier 
function and allow paracellular transport selectively. Proteins, such as ZO1 and occludin, 
also help in the maintenance of epithelial tight junction barrier. Tissue injury causes 
phosphorylation of tight junction proteins and disruption of epithelial barrier function. As 
shown in figure 8A, tight junction disruption or injury causes loss of selective paracellular 
permeability and increase in TER values. Recovery of tight junction proteins help in 
restoring barrier function by regaining selective paracellular permeability and decrease of 
TER values (Denker and Sabath 2011). 
TER values of different segments of nephron are inversely proportional with 
permeability as shown in figure 8B. In the nephron of a mammalian kidney, the paracellular 
permeability decreases from proximal tubule to the collecting duct as the unique 
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composition of different claudin changes (Kiuchi-Saishin, Gotoh et al. 2002), and higher 
ZO1 and occludin protein levels are expressed in the lower segments of the nephron 
(Gonzalez-Mariscal, Namorado et al. 2000). A major claudin normally found in the 
proximal tubule is claudin-2 which creates high conductance pores for cations, such as 
sodium ion, and therefore proximal tubule shows low electrical resistance (Muto, Hata et 
al. 2010). Proximal tubule is known as the leaky region of the nephron and one third of the 
fluid reabsorption occurs by paracellular pathway. Thus, starting from glomerulus, the 
lower segments of nephrons are less and less permeable and show more selective transport 
and high TER values (figure 8B). The distal region of the nephron, such as collecting duct, 
is considered as a tight epithelium with high resistance and very selective permeability i.e., 
low cation permeability due to the presence of cation barrier forming claudins such as 
claudin-4 and 8 (Denker and Sabath 2011). The permeability difference between proximal 
tubule and collecting duct is around 100 fold (Denker and Sabath 2011). 
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Figure 8: Epithelial tight junctions and TER of a nephron. Image credit (Denker and 
Sabath 2011). (A). Major Tight junction proteins in kidney epithelial cells. (B) Different 
segments of the nephron with major claudins. 
  1.5.7.4  Tight Junction Integrity and Paracellular Transport 
Tight junctions maintain two functions 1) as a fence and 2) as a gate. The junction 
fence prevents the intermixing of lipid molecules in the outer phospholipid layer of the cell 
membrane (Matter and Balda 2003). Fluorescence conjugated lipids such as sphingomyelin 
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or glycolipids are commonly used to label outer leaflet of  plasma membranes in order to 
estimate to “fence function”  (Meer and Simons 1986; Mandel, Bacallao et al. 1993; Balda, 
Whitney et al. 1996). The diffusion of lipids is studied by confocal microscopy in cells or 
fluorometric analysis is performed with cell lysates (Matter and Balda 2003).  
The gate function of tight junctions controls the paracellular transport pathway. 
Paracellular transport is generally considered as passive transport and is driven by electro-
osmotic gradient created due to active transport. Epithelial paracellular transport can occur 
through two separate pathways: 1) through charge and size selective 4 Å sized pores made 
by claudins and 2) large discontinuities in the tight junction which allows large molecules 
to pass through irrespective of charge and size (Anderson and Van Itallie 2009). Several 
orders of magnitude difference of permeability can be seen between a tight and leaky 
epithelium (Anderson and Van Itallie 2009). An epithelium with “tight” tight junctions can 
have high electrochemical gradient due to active  transport of ions or charged species 
(Anderson and Van Itallie 2009). Nearly all leaky epithelia preferentially allow transport 
of sodium ions than chloride ions i.e. the ratio of Permeability of Na+ (PNa)/ Permeability 
of Cl- (PCl) will be around 10 to 1.5 (Anderson and Van Itallie 2009).  
  1.5.7.5  Experimental Measurement of Epithelial Paracellular       
    Permeability 
Epithelial permeability can be measured using hydrophilic tracers such as 
fluorophore labelled dextrans or radiolabelled inulin or mannitol. Variable sized tracer 
molecules can be analysed by labelling dextran molecules with FITC or rhodamine, and 
different fluorophore tags allow analysis of more than one tracer in a single cellular 
monolayer in one experimental set up (Matter and Balda 2003). In simple ion selective 
43 
 
experiments, filters with cellular monolayers are tested in the presence NaCl or LiCl to test 
for Na or Li permeability. Tracers, such as mannitol (radius= 4.2 Å) in radius, inulin 
(radius= 15 Å), and FITC-conjugated dextran molecules (3, 10, 70 kDa, etc), go through 
the non-pore pathway i.e., temporary breaks in the tight junction, rather than  the pathway 
involving claudin pores (Anderson and Van Itallie 2009). Fluorescence of FITC-dextran 
molecules that can permeate through epithelial monolayer can be detected by measuring 
fluorescence values at time intervals and the transepithelial permeability can be quantified 
in terms of the apparent permeability (Papp) values (Nag and Resnick 2017). TER or small 
tracer permeability cannot estimate only paracellular permeability but combined 
transcellular and paracellular permeabilities. Dextran molecules with size around 4 kDa 
can be transported across epithelial monolayer through paracellular pathway as well as 
through fluid-phase transcytosis (Matter and Balda 2003). Fluid-phase transcytosis can be 
estimated by allowing cells to uptake horseradish peroxidase (HRP) and after washing and 
incubating transcytosed HRP can be detected using enzymatic reactions (Miettinen, Matter 
et al. 1992; Balda, Whitney et al. 1996). Application of large sized tracers such 40-400 kDa 
can show only paracellular transport (Matter and Balda 2003). Thus, by choosing a variety 
of tracer molecules, paracellular transport can be estimated.  
1.6  Epithelial Electrophysiology 
Epithelial transport can be characterized by measuring electrical properties, such as 
transepithelial potential difference, transepithelial resistance, short circuit current, and 
capacitance (Lewis 1996). Cellular lipid bilayer is resistant to charged molecules, therefore 
simple diffusion cannot produce an electrical current, rather transport needed to occur 
through ion channels which are pore-forming proteins allowing selective ion-transport, 
44 
 
although some non-selective ion channels can also be present allowing either all cations or 
anions to pass  (Nadeau 2017). Some of the majorly used electrophysiological analysis 
systems are discussed below. 
1.6.1  Transepithelial Electrical Resistance 
Transepithelial resistance (TER), also known as transepithelial electrical resistance 
(TEER), can be measured by passing a current ΔI across the epithelial layer and measuring 
the resultant change in voltage (ΔV) in a current-clamp mode. The TER can also be 
measured in a voltage-clamp mode by passing a voltage (ΔV) and measuring the change in 
current (ΔI) which is needed to maintain at that voltage (Lewis 1996). The resistance is 
determined from Ohm’s law i.e., the resistance is equal to the transepithelial voltage change 
divided by transepithelial current change (Lewis 1996).   
𝑅𝑚𝑒𝑎𝑠. =  
∆𝑉𝑡
∆𝐼𝑡
× 𝐴 
Where, A= area of epithelial layer  
Unit of resistance is expressed in the units of ohm-cm2.  Measured resistance (R 
meas.) is a sum of transepithelial resistance and series resistance of the measuring solution 
(Rs). Actual transepithelial resistance TER can be measured by subtracting measuring 
solution resistance from total measured resistance i.e., TER= Rmeas. – Rs (Lewis 1996). The 
value of the series resistance can be measured by measuring the resistance of an empty cell 
culture insert without any epithelial cells. For epithelia with high resistance, the value of 
Rs accounts for very minor corrections. Transepithelial conductance= Gt = Gtrc + Gp  
Where, Gt= transepithelial conductance, Gtrc= transcellular conductance, and Gp= 
paracellular conductance. Electrical resistance is the inverse value of conductance. 
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 Therefore, transepithelial resistance is calculated as: 
𝐺𝑡 =
1
𝑇𝐸𝑅
=
1
𝑅𝑡𝑟𝑐
+
1
𝑅𝑝
 
 Where, TER= Transepithelial Resistance, Rtrc= Transcellular Resistance, and Rp= 
Paracellular Resistance (Lewis 1996). 
1.6.1.1  Equivalent Electrical Circuit of an Epithelial Monolayer 
The transcellular and paracellular resistances act in parallel. The detailed equivalent 
electrical circuit of an epithelial monolayer is shown in figure 9. Apical membrane and 
basolateral membrane contribute to total resistance separately and they act as series 
resistances.   Transcellular resistance, Rtrc is the sum of apical resistance (Ra) and 
basolateral resistance (Rb). The paracellular resistance (Rp) is the main contributor in the 
total resistance, especially in the beginning of the cellular monolayer barrier formation, 
when tight junctions and adherent junctions are not yet formed in between cells (Bertrand, 
Durand et al. 1998; Benson, Cramer et al. 2013; ávan der Meer, JungáKim et al. 2015). 
Generally, any experimental manipulation causing a change of TER value, indicates the 
change of Rp (Matter and Balda 2003).  This model is applicable to measurement using DC 
currents with frequency of 0 Hz, however AC current with very low frequency can also be 
used in this model (ávan der Meer, JungáKim et al. 2015). Total monolayer resistance can 
be expressed as: 
 
 
Since, Ra and Rb resistances act in series. (Ra+ Rb), Rp, and Rg act all in parallel. 
 
1
𝑅𝑇
=
1
𝑅𝑎 + 𝑅𝑏
+
1
𝑅𝑃
+
1
𝑅𝑔
 
TER = R
T
 + R
f
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Figure 9: Equivalent circuit model for TER of an epithelial monolayer. (A) Different 
resistance components of a confluent epithelial monolayer. Rf= fluid resistance, Ra= apical 
membrane resistance, Rb= basolateral membrane resistance, Rp= paracellular resistance, 
and Rgap= gap resistance which is absent in a confluent monolayer. (B) Resistances 
contributed by epithelial cells of a cellular monolayer. 
 
Rg shows the gap resistance of a partial cell coverage of the cellular monolayer. If 
a cellular layer has 99.6% cell coverage or confluence the measured TER value can be 80% 
lower than the TER value of a culture with 100% cell coverage or confluence (ávan der 
Meer, JungáKim et al. 2015). Thus, a drastic decrease of TER indicates a loss of cellular 
confluence and thereby can help to monitor monolayer health. 
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  1.6.1.2  TER Measurement Methods 
For TER measurement, two electrodes are used (one electrode in the upper 
compartment and second one in the lower compartment), and a cell culture insert with 
cellular monolayer is placed in between. TER can be measured by applying a direct current 
(DC) voltage across a cellular monolayer and by measuring the resulting current and then 
calculated as the ratio of voltage and current following Ohm’s law. Direct current can 
damage electrodes and cells due to charging effects on electrodes and cellular layer. To 
avoid this issue, an alternating current (AC) with low frequency (12.5 Hz) is applied 
(Srinivasan, Kolli et al. 2015). In a current-clamp mode, first the membrane potential is set 
to zero, then an AC current (12.5 Hz)  is applied with one pair of electrodes and deflection 
of voltage is measured with a second pair of electrodes (Matter and Balda 2003; Srinivasan, 
Kolli et al. 2015). TER values are calculated using Ohm’s law R= V/I. A silver-silver 
chloride chopstick electrode (such as, STX2 from World Precision Instrument or Millicell 
STX probe from Millipore) or a small electrode chamber system (such, Endohm chamber 
from World Precision Instrument) connected to an epithelial voltmeter (such as, EVOM 
from World Precision Instrument or Millicell-ERS Voltmeter from Millipore) are used to 
measure the TER values in cell culture inserts (Matter and Balda 2003; ávan der Meer, 
JungáKim et al. 2015). Properly performed, a TER experiment will ensure equal current 
distribution throughout the membrane. Use of cell culture media acting as a conductive 
interphase ensures a close-to-an-equal drop in the potential throughout the whole 
membrane (ávan der Meer, JungáKim et al. 2015).  
1.6.1.3  Factors that Can Affect TER Measurements 
Transfer of filters into a measurement chamber can cause fluctuation in TER value, 
and the fluctuation can be nullified by equilibrating the filter in the measurement chamber 
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for around 15 minutes. The same fluid levels need to be maintained in the inner and outer 
chamber (Matter and Balda 2003). The cultures or cell culture media should be maintained 
at 37°C since temperature strongly affects TER values (Gonzalez-Mariscal, De Ramirez et 
al. 1985). For example, lowering of temperature to ambient temperature causes TER value 
to increase more than three times in MDCK, kidney epithelial cells (Matter and Balda 
2003). Media change or washing right before measure can show a large change in the TER 
values (Matter and Balda 2003).   
1.6.1.4  Other TER Measurement System 
A DC based TER measurement system may have a few drawbacks, such as 
restricted measurement range, possible measurement errors due to electrode surface 
alterations after prolonged usage, and possible adverse effects on cellular health due to 
silver ions released by overused electrodes (ávan der Meer, JungáKim et al. 2015). To 
overcome these limitations, complex-impedance based system has been also used to obtain 
TER values (Benson, Cramer et al. 2013). Currently, AC based systems: cellZscope 
system72 from nanoAnalytics GmbH and the ECIS system from Applied Biophysics are 
commercially available to determine TER in Transwell systems (ávan der Meer, JungáKim 
et al. 2015). 
1.6.2  Impedance Analysis 
Another way of monitoring epithelial transport is the use of impedance analysis 
which measures frequency dependent characteristics of epithelia by measuring voltage by 
applying a small current. Impedance analysis involves modelling of epithelia as an 
electrical model made of capacitors and resistors (Lewis, Clausen et al. 1996). Therefore, 
impedance measures the resistance of an electric circuit which exhibits sinusoidal signal at 
a fixed frequency. Impedance measurements include capacitance i.e., the ability of a 
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biological membrane to store charge and acting as a capacitor (Lewis, Clausen et al. 1996). 
Therefore, understanding capacitance of membrane may help to understand the information 
about membrane area, for example, geometry of epithelial crypts or extracellular structures. 
The drawback of impedance analysis is the complexity of coming up with the actual or 
physiologically relevant equivalent circuit model to extract meaningful data (Lewis, 
Clausen et al. 1996).   
1.6.3. Short Circuit Current  
The amount of transepithelial movement of total charged species can be quantified 
by determining the current that needs to pass through an epithelial layer to reduce the 
potential or transepithelial voltage to zero. This current is referred as the short-circuit 
current (Isc) (Lewis 1996). In simple terms, the current that short-circuits the tissue is the 
Isc. This current can be measured using a voltage-clamp to detect the amount of current 
needed to bring the epithelial voltage to zero millivolts (Lewis 1996).  
In an Ussing chamber, when identical bathing solution is present on both sides of 
epithelial monolayer, and only one specific ion gets actively transported, the Isc is equal to 
the rate of transport of that ion. When more than one ion species is involved in the active 
transport, then Isc will be equal to the algebraic sum of all active ion transport mechanisms 
(Lewis 1996).  In the frog skin model to study Na+ transport from a pond to the blood of a 
frog, the net Na+ transport was found to be equal to the value of Isc (Koefoed‐Johnsen and 
Ussing 1958). 
 The relation between current and ion transport can be expressed as: 
𝐽𝑖 =
𝐼𝑠𝑐
𝑧𝐹
 
 Where, Ji denotes net flux of ion i, Isc is the short circuit current. 
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F= Faraday’s constant and z= valency of the transported species (e.g., Na+ = 1). 
Generally, spontaneous electrical potential can be created across an epithelium due 
to passive transport forces, such as osmotic and electrochemical gradients. An Ussing 
chamber omits the effect of passive transport by clamping the epithelial potential to zero 
by passing an external current across the epithelium and thereby eliminates the possible 
effects of transepithelial diffusive forces (Clarke 2009).  Thus, an Ussing chamber only 
detects the active transport process, and the Isc is known to be equivalent to the algebraic 
sum of active transport of electrogenic ions (Clarke 2009).  
Commercially available electrode systems as used for TER measurement, such as 
Endohm chamber or chopstick electrode connected to EVOM or Millicell voltmeters are 
used to obtain voltage values. The equivalent current (Ieq) or equivalent short circuit current 
(Isceq) can be calculated from voltage and resistance read outs following Ohm’s law i.e., 
I= V/ R (where, I= current, v= voltage, R= resistance) (Resnick and Hopfer 2007; Resnick 
2011; Nag and Resnick 2017).  
Channel Blockers 
Ion channel activity can be isolated by using specific agents that can block the 
channel. Use of channel blockers and measurement of electrical current help to get a clear 
knowledge about a specific ion channel, omitting the possibility of any background noise. 
Tetrodotoxin (TTX) is obtained from puffer fish and acts as a channel blocker for voltage 
gated Na+ channels (Nadeau 2017). Other channel blockers have been developed from 
snakes, spiders, and insects. In case of ligand-gated ion channels, agonists and antagonists 
can be effective in blocking channels. Agonist and antagonists can bind at the same site as 
the ligand or somewhere else, disabling channel activity. Most channel blockers can bind 
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to various channels with varying binding affinity (Nadeau 2017). In a mouse cortical 
collecting duct epithelial cells (Principal cells), application of 10 µmol/L of Na+ channel 
blocker, amiloride, decreased Isc by 95% and suggested 95% of Isc is produced due to active 
Na+ transport (Resnick and Hopfer 2007).  
1.6.4  Other Methods to Study Cellular Electrophysiology 
Cellular electrophysiology can be studied to understand electrical features of cells 
and activity of ion channels using patch-clamping or lipid bilayer recording. In patch-clamp 
technique electrical properties are measured by making direct contact between an electrode 
and a cell (Nadeau 2017). The patch refers to the patch of a cell membrane measured using 
a current or voltage clamp to detect voltage or current of a biological cell. The electrical 
recording of lipid bilayer is similar as the patch-clamp technique, although the physical set 
up is different. In this method, a lipid layer orifice separates two chambers of bath. Ion 
channels can be implanted onto the lipid layer orifice and electrical properties of the 
channel can be evaluated (Nadeau 2017). Measurement of single channel provide better 
understanding of channel activity, whereas whole-cell recordings measure hundreds to 
thousands of channels. Single channel measurements give a clear knowledge about channel 
conductance, and we can understand channel opening and closing modes of action (Nadeau 
2017). Thus, by patch-clamp or lipid bilayer method, single channel or multiple channel 
activity of a single cell can be detected as compared to an Ussing chamber which detects 
all the channel activities of a cellular monolayer. 
1.7  Kidney Pathology and Diseases 
Kidney diseases can be divided into two categories: acute and chronic. Acute 
kidney injury (AKI) does not have an universal definition, rather it is diagnosed on the 
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basis of some physiological parameters such as changes of serum creatinine levels or 
absolute creatinine level (Mehta, Kellum et al. 2007). A kidney disease can be categorized 
as a chronic kidney disease (CKD) when the glomerular filtration rate (GFR) remains 
continuously less than 60 mL/minute/ 1.73 m2 during a period of 3 months or longer 
(Quigley 2012). 
 AKI may occur during clinical procedures, such as kidney transplantation and 
cardiac surgery (Bellomo, Kellum et al. 2012). Diabetes, hypertension, and obesity are 
considered as the leading risk factors for the occurrence of CKD (Coresh, Selvin et al. 
2007).  In this section, among different kidney diseases, a major emphasis will be given on 
polycystic kidney disease.  
1.7.1  Acute Kidney Injury  
AKI, or acute kidney failure (AKF), is a clinical complication characterized by a 
sudden drop (hours to days) of kidney excretory function. AKI or AKF may result in 
decreased urine output and accumulation of metabolic acids and increased levels of 
phosphate and potassium ions. This diseased state causes an accumulation of products 
formed due to nitrogen metabolism, such as creatinine and urea. A small rise of serum 
creatinine level was found to cause patient mortality (Bellomo, Kellum et al. 2012). AKI 
is known to be caused mainly by hypoxia, ischemia or nephrotoxicity (Basile, Anderson et 
al. 2012). AKI has been studied in animal acute ischemic models in which ischemia is 
induced by acutely blocking the renal artery. Animal models of these AKI showed kidney 
localized adverse reactions such as activation of coagulation system, infiltration of 
neutrophils, cytokine release, and damage of the endothelium (Bellomo, Kellum et al. 
2012).  
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1.7.2  Chronic Kidney Disease 
Chronic Kidney Disease (CKD), also known as chronic kidney failure, causes a 
gradual loss of kidney function and finally leads to kidney failure. Earlier stages of CKD 
show some level of kidney damage, as determined by albuminuria, and compromised 
kidney function, detected as GFR by measuring serum creatinine concentration (Levey, 
Eckardt et al. 2005). The end stage symptom of CKD is the kidney failure which requires 
dialysis and kidney transplantation. CKD is also known to increase the risk of 
cardiovascular diseases and can result in other complications (Sarnak, Levey et al. 2003; 
Levey, Eckardt et al. 2005; Coresh, Selvin et al. 2007). In the United States, the number of 
patients with kidney failure related to CKD more than doubled in 2004 as compared to 
1991 (Health 2010). 
1.7.2.1  Hypertension in CKD 
The renin-angiotensin system (RAS) is one of the major control systems that 
regulates the blood pressure as well as fluid balance. Renin is mainly produced and secreted 
from the kidney. Plasma renin concentration is adjusted depending on the blood pressure 
and salt balance (Sparks, Crowley et al. 2014). Renin cleaves angiotensinogen and creates 
angiotensin I.  Angiotensin converting enzyme (ACE) converts angiotensin I to angiotensin 
II, which controls the blood pressure and flow and thereby regulates glomerular filtration 
rate (Sparks, Crowley et al. 2014). In CKD patients, the inability to maintain Na+ balance 
can result in hypertension. Secretion of renin can worsen blood pressure related 
complications. Increased blood pressure further causes kidney damage and loss of kidney 
function (Quigley 2012).  
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1.7.2.2  Polycystic Kidney Disease 
Polycystic kidney disease (PKD) is a genetic disease which is characterized by the 
formation of fluid-filled pouch-like structures, called cysts. These cysts tend to grow larger 
over the years causing reduction of kidney function and finally lead to kidney failure 
(Deane and Ricardo 2007).  Thus, PKD falls under the category of chronic kidney diseases. 
In PKD, mutations occur in the PKD1 and PKD2 genes encoding PC1 and PC2 proteins 
respectively. Although the genetic cause of PKD is known, the factors which are 
responsible for the cyst expansion and disease progression are not clearly understood 
(Cowley 2004).   
One in every 1000 persons becomes affected by autosomal dominant PKD 
(ADPKD) (Gabow 1993), whereas autosomal recessive PKD (ARPKD) occurs around one 
in 20,000 live births (Zerres, Rudnik-Schöneborn et al. 1998). Around 50% of ADPKD 
patients face end-stage renal disease (ESRD) by the age around 60 years, and most of the 
infants with ARPKD who are able to survive the prenatal period encounter chronic kidney 
failure when they reach adolescence (Rohatgi, Greenberg et al. 2003). Mutations of PKD1 
and defective PC1 cause 85-90% of ADPKD, and the remaining ADPKD is caused due to 
the mutations of PKD2 (Wilson 2004). In ADPKD, the cysts become separated from the 
nephron and do not communicate with the tubules from which they were formed (Wilson 
and Falkenstein 1995). On the other hand, in case of ARPKD, the cysts still remain 
connected as the expanded forms of the collecting duct and allow fluid to flow through 
them (Osathanondh and Potter 1964). In both ARPKD and ADPKD, kidney cysts expand 
over years and cause malfunction of the rest of the functional epithelia and finally lead to 
renal failure (Grantham 1996). 
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i. Role of Primary Cilia and Cell Signaling Pathways in PKD 
Renal epithelia have primary cilia which may sense fluid flow using PC1 and PC2 
proteins and allow influx of Ca2+ in the renal epithelial cells. This Ca2+ influx effect is 
amplified due to the release of intracellular Ca2+ stores by epithelial cells (Pazour, San 
Agustin et al. 2002; Deane and Ricardo 2007).  Increased levels of Ca2+ inside cells 
stimulate cell signaling (eg., B-Raf/MEK/ERK pathway) events that may help in 
maintaining renal epithelial phenotype (Simons and Walz 2006; Deane and Ricardo 2007). 
When ciliary signaling is absent, renal epithelial cells may undergo dedifferentiation which 
can lead to cyst formation and expansion, and during this process the level of cAMP is 
found to be increased (Belibi, Reif et al. 2004). Increments of extracellular concentration 
of Ca2+ were shown to reverse phenotypic abnormalities seen in the cystic epithelial cells 
of PKD (Yamaguchi, Hempson et al. 2006) indicating the importance of ciliary flow 
sensing. Decreased levels of PC1 protein were shown to result PKD in mice models 
(Leeuwen, Dauwerse et al. 2004); whereas decreased levels of PC2 may show early signs 
of cystogenesis since reduced PC2 protein levels were found to cause the proliferation of 
kidney tubular cells and the fibrosis of the interstitium (Chang, Parker et al. 2006).  
In PKD, proteins (such as polycystins (e.g., PC1 and PC2), nephrocystins, 
fibrocystin, Wnt signaling proteins, and planar cell polarity (PCP) proteins) were found to 
be localized inside the cilium or basal body of the cilium, having altered functions (Pazour, 
San Agustin et al. 2002; Yoder, Hou et al. 2002; Veland, Awan et al. 2009). It has been 
hypothesized that epithelial cells in the nephron can undergo dedifferentiation and 
proliferation, and they are followed by redifferentiation in response to an injury to nephrons 
as an attempt to restore tissue function (Bonventre 2003; Guo and Cantley 2010). Renal 
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injury repair shares similar cell signaling pathways as PKD (Weimbs 2006; Weimbs 2007).  
In the Oak Ridge polycystic kidney mouse model,  renal cilia were found to be much 
shorter as compared to a normal mouse renal cilia (Pazour, Dickert et al. 2000; Yoder, 
Tousson et al. 2002), possibly implying a relationship between flow sensing and PKD.  In 
mouse models, kidney specific inhibition of ciliogenesis, i.e., the formation of cilia, was 
found to result in a PKD-like phenotype (Lin, Hiesberger et al. 2003).  Ciliary flow sensing 
was found to affect active Na+ transport in the normal mouse kidney cortical collecting 
duct epithelial monolayers (Resnick and Hopfer 2007; Resnick 2011). These findings 
suggested the importance of primary cilia and their flow sensing function in the context of 
PKD.  
In PKD, mammalian target of rapamycin (mTOR) and signal transducer and 
activator of transcription 6 (STAT6) signaling pathways remain activated even under 
normal conditions (Low, Vasanth et al. 2006; Becker, Saez et al. 2010).  In normal renal 
epithelial cell cultures, fluid flow induced by mild shaking retained the STAT6 in the 
cilium, and it prevented the translocation of STAT6 to cellular nucleus (Low, Vasanth et 
al. 2006). Thus, flow sensing of cilia can control cell division in kidney tubules (Singla and 
Reiter 2006), and in PKD this mechanism may be impaired. Fluid flow is also known to 
maintain differentiation of renal epithelial cells by blocking canonical Wnt signaling due 
to the elevated levels of inversin, a ciliary protein (Simons, Gloy et al. 2005; Deane and 
Ricardo 2007).  Fluid flow is known to cleave the C-terminal domain of the PC1 protein, 
followed by the translocation into the cellular nucleus. This nuclear localization is thought 
to affect transcription of different genes (Chauvet, Tian et al. 2004; Deane and Ricardo 
2007). PC1 is known to control cell proliferation since PC1 regulates the mTOR cell 
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signaling pathway, and this signaling pathway can be abnormally activated in case of PKD 
(Shillingford, Murcia et al. 2006). Combined activities of PC1 and PC2 control the cell 
cycle by regulating the JAK-STAT pathway (Bhunia, Piontek et al. 2002). Thus, different 
cell signaling mechanisms directly or indirectly related to cilia and ciliary flow sensing are 
responsible for controlling renal epithelial phenotype and gene expression and may be 
associated with PKD (Deane and Ricardo 2007).  
ii. Alterations of Epithelial Transport in PKD 
As discussed previously under the epithelial transport section, the collecting duct 
of the nephron helps in fine-tuning salt concentration by reabsorbing salt and water. In the 
collecting duct epithelial cells, Na+ enter cells through ENaC, and with help of basolateral 
Na+/ K+-ATPase, these Na+ move to the basolateral side and K+ enter the cells (Wilson, 
Dillingham et al. 1985). Na+ are reabsorbed from urine to blood through this mechanism.  
In mouse disease models of ARPKD, Na+/ K+-ATPase was detected in the apical 
membrane of cystic epithelial cells (Avner, Sweeney et al. 1992) suggesting similar Na+ 
secretion can occur in case of ADPKD (Rohatgi, Greenberg et al. 2003).  In the cystic 
epithelial cells of ADPKD patients, Na+/ K+-ATPase expression was also found to be in 
the apical side (Wilson, Sherwood et al. 1991; Rohatgi, Greenberg et al. 2003). Thus, the 
mislocalization of Na+/ K+-ATPase can be seen in both ADPKD and ARPKD. 
Another study using immunohistochemistry reported that in human cystic kidney 
tissue and in mouse kidney cysts, Na+/ K+-ATPase α1 catalytic subunit expression levels 
were significantly reduced in intermediate and large cysts (Yu, Kanzawa et al. 2008). This 
finding suggested that active Na+ transport may be diminished in PKD. The fluid 
accumulation and cyst expansion involve transepithelial fluid and solute secretion inside 
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the cyst lumen as opposed to the absorptive function of normal renal epithelial cells (Yu, 
Kanzawa et al. 2008). In kidney cysts, Cl- are believed to be actively secreted using 
Na+/K+/2Cl– cotransporter, NKCC1 (Lebeau, Hanaoka et al. 2002; Thomson, Mentone et 
al. 2003) and apical c-AMP stimulated chloride channels, CFTR (Brill, Ross et al. 1996; 
Hanaoka, Devuyst et al. 1996). In the cyst lumen, Na+ are thought to be secreted 
paracellularly due to the electrochemical gradient created by the active Cl- transport. The 
accumulation of Na+ and Cl- results in the secretion of water in the cyst lumen by the 
process of osmosis involving water channels AQP1 and AQP2  (Devuyst, Burrow et al. 
1996; Yu, Kanzawa et al. 2008). Thus, the secretion and accumulation of salt and water 
within the cysts can promote cyst expansion.      
Experiments using microcysts formed by growing cells on collagen scaffolds 
showed that cells were capable of absorption as well as secretion similar to the epithelia 
from the intestine and trachea (Alton and Smith 1995; Greger, Bleich et al. 1997; Sullivan, 
Wallace et al. 1998). Chloride ions are secreted actively using Na+/K+/2Cl– cotransporter 
in the basolateral membrane and CFTR channel in the apical membrane as shown in figure 
10 (Sullivan, Wallace et al. 1998). Two separate studies showed that they were able to 
reduce equivalent current or apical to basolateral Na+ movement of kidney cysts by adding 
the sodium channel blocker, amiloride (Perrone 1985; Wilson, Sherwood et al. 1991). 
Thus, active Na+ transport may still be present in kidney cysts. However, according to 
another study using ADPKD monolayers, Ieq remained unaffected even at 10 times higher 
concentration of amiloride  or with other active sodium transport blocking agents, 
indicating the possible contribution of active chloride transport (Sullivan, Wallace et al. 
1998). Thus, the contribution of active Cl- transport in PKD may be debatable to some 
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extent. However, the application of a CFTR inhibitor, CFTRinh-172 (Ma, Thiagarajah et 
al. 2002) was found to slow the cyst expansion in the MDCK cell culture cyst model, whole 
embryonic kidney organ culture, and mouse ADPKD model (Li, Findlay et al. 2004; 
Magenheimer, John et al. 2006; Yang, Sonawane et al. 2008). These findings strongly 
support the role of active Cl- transport in the PKD progression. 
 
Figure 10: Epithelial Transport in PKD. Figure credit (Sullivan, Wallace et al. 1998). 
Chloride and water secretion seen in secretory epithelia (Liedrke 1989). The same secretory 
mechanism is believed to be involved in cystic epithelia of PKD (Sullivan, Wallace et al. 
1998).  
iii. Alterations of Epithelial Junctional Complex in PKD 
a) Abnormal Adherens Junctions in PKD 
Adherens junctions (AJ) keep cells attached by binding to actin filaments using 
cadherins and catenins. Spot-like adherens junctions, which allow cells stay attached to 
cellular extracellular matrix (ECM), are called the focal adhesions (FA).  In ADPKD cystic 
epithelial cells, lateral AJ and FA show abnormalities. At the FA of an ADPKD epithelium, 
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the phosphorylation of focal adhesion kinase (FAK) is diminished and results in altered 
protein composition of FA (Wilson, Geng et al. 1999; Wilson 2011). Impaired 
phosphorylation of FAK complex leads to alteration in the cell shape, adhesion, and 
migration as seen in both ADPKD and ARPKD (Wilson, Geng et al. 1999; Israeli, Amsler 
et al. 2010; Elliott, Zheleznova et al. 2011; Wilson 2011).  
In ADPKD, E-cadherin remains absent from the lateral membrane of AJ since E-
cadherin undergoes internalization (Charron, Nakamura et al. 2000) similar to as seen in 
the epithelial to mesenchymal transition (Thiery and Sleeman 2006). In normal kidney 
epithelial cells, PC1 protein helps in forming a complex at the adherens junction with E-
cadherin and β-catenins  in order to maintain cell adhesion or polarity (Huan and van 
Adelsberg 1999). Increased phosphorylation of PC1 is seen in ADPKD cells causing 
disruption PC-1/PC-2/E-cadherin/β-catenin complex (Roitbak, Ward et al. 2004). 
Moreover, in ADPKD, the disruption of  this complex is enhanced since the E-cadherin is 
internalized and replaced by embryonic isoform N-cadherin (Roitbak, Ward et al. 2004). 
E-cadherin plays a crucial role in maintaining adherens junction and thereby controls the 
junctional complex (Capaldo and Macara 2007). In ADPKD, the function of the adherens 
junctions is impaired mainly due to insufficient presence and stability of E-cadherin and 
can affect polarity of epithelial cells leading to cyst formation (Roitbak, Ward et al. 2004). 
The disruption of adherens junctions can alter the function of the epithelial tight junctions 
(Yu, Kanzawa et al. 2008). 
b) Alteration of Tight Junctions in PKD 
Cluadin-7 is known to be expressed in distal nephron and creates a transport barrier 
for both cations and anions (Alexandre, Lu et al. 2005; Yu, Kanzawa et al. 2008). 
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Overexpression of claudin-7 was shown to decrease Cl- permeability and increase Na+ 
permeability in porcine kidney epithelial cells (Alexandre, Lu et al. 2005).  These findings 
suggested claudin-7 acts as a barrier against Cl-, whereas forming pores that allow Na+ 
through the paracellular space (Alexandre, Lu et al. 2005). In kidney cysts from human 
ADPKD patients, as well as in mouse kidney cysts, claudin-7 was found to be present in 
abundance (Yu, Kanzawa et al. 2008). It can be inferred that claudin-7 in the tight junctions 
of the cysts acts as a barrier preventing paracellular back-leak of Cl- and allows Cl- to be 
secreted only through transcellular transport pathway. The transcellular Cl- movement can 
drive Na+ movement paracellularly and water through osmosis into the cyst lumen (Yu, 
Kanzawa et al. 2008). Thus, claudin-7 in the tight junctions may contribute to cyst 
expansion.  
iv. Abnormal Protein Sorting System and Cell Polarity in PKD 
In the mouse model, lack of MALS-3, a PDZ-protein which interacts with polarity 
complex, resulted in cyst and fibrous tissue formation in the kidney (Olsen, Funke et al. 
2007). As shown in figure 11, Na+/ K+-ATPase were found to be mislocalized in the apical 
membrane due to the apical mislocalization of  trafficking protein syntaxin-4, and the 
membrane stabilizing proteins, ankyrin and fodrin (Wilson, Sherwood et al. 1991; Torkko, 
Manninen et al. 2008). The activation of Erb2 by phosphorylation causes alterations in the 
apico-basal polarity, and the overexpression of activated Erb2 leads to kidney cyst 
formation (Aranda, Haire et al. 2006; Wilson 2011). Membrane proteins are formed in the 
endoplasmic reticulum and undergo processing in the Golgi apparatus, followed by sorting 
to be directed and delivered by apical or basolateral vesicles (Wilson 2011).  The 
trafficking of proteins in the right membrane domain is believed to be contributed by at 
62 
 
least partly by small G proteins belonging to Rab/sec family along with exocyst complex. 
Some Rab/sec family proteins (such as Rab 8, Rab 10, Rab 11, Rab 14, syntaxin-3) are 
known to control the delivery and transport of proteins onto the apical membrane whereas 
other Rab/sec family proteins, such as Rab6 and syntaxin-4, are known to cause 
localization and trafficking in the basolateral membrane (Wilson 2011). In ADPKD cells, 
abnormalities were found in Rab6/Rab8 trafficking proteins and syntaxin-4 proteins. These 
abnormalities in the kidney cystic epithelia affect the vesicle trafficking complex, known 
as the exocyst, and can cause defects in the mechanisms involving the apical docking and 
maintenance of membrane protein-tethering domain  (Wilson 2011).  
 
Figure 11: Polarized membrane associated proteins in normal kidney and cystic 
(ADPKD) kidney epithelial cells. Figure credit (Wilson 2011). In ADPKD, Na+/ K+-
ATPase α1/β2, ErbB1/2 rab6/8 syntaxin 4, and ankyrin/fodrin are mislocalized onto the 
apical membrane and MALS-3 is absent from apico-lateral polarity complex. In the lateral 
adherens junction (AJ) of ADPKD cells, E-cadherin is substituted by N-cadherin and the 
pFAK is also diminished from focal adhesions (FA) of ADPKD cells (Wilson 2011).  
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In ADPKD cells, various changes are also noticed in the cellular cytoskeleton such 
as actin microfilaments, microtubules, and cytokeratin scaffolds. These cytoskeletal 
structures are known be associated with the process of vesicle transport and trafficking and 
stability of the membrane domain. Therefore, the alterations of cellular cytoskeleton are in 
agreement with the abnormal protein sorting system as seen in ADPKD cells (Oriolo, Wald 
et al. 2007; Wilson 2011).  Thus, the renal epithelial polarity or functional phenotype can 
be impaired in PKD.   
1.8  Role of Hypoxia on Cellular Functions and Diseases 
 1.8.1  Hypoxia and Hypoxia Inducible Factors 
Oxygen (O2) is crucial for the survival and normal function of mammalian cells and 
tissues. The lack of adequate O2 supply creates a condition called hypoxia, which is known 
to be associated with various kidney pathologies such as AKI. Therefore, it is important to 
understand how cells adjust to hypoxic conditions.  Hypoxia inducible factors (HIF) 
regulate cellular and tissue responses in an environment lacking sufficient availability of 
O2 (Andringa and Agarwal 2014).  HIF-1 and HIF-2 transcription factors are heterodimeric 
helix-loop-helix Per-Arnt-Sim (PAS) domain proteins (Haase 2009). These transcription 
factors form dimers and bind to the DNA of the target gene resulting in the activation of 
transcription (Semenza 2000). The α subunit is the O2 sensitive and regulatory subunit, and 
β is the constitutively expressed subunit of HIF (Haase 2006). The binding of the HIF 
heterodimer to a hypoxia response element (HRE) on a regulatory region of a hypoxia 
responsive gene causes HIF-regulated transcription (Haase 2006). HIF-1 and HIF-2 have 
very little similarity in their functions (Haase 2006). HIF activation occurs when the α 
subunit is translocated into the nucleus and dimerizes with the β subunit and followed by 
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the binding of transcriptional cofactors, such as p300 (Haase 2006). Hypoxia was found to 
cause fast accumulation of HIF-1α protein without a significant rise in the HIF-1α mRNA 
levels (Huang, Arany et al. 1996). HIF-1α is known to be expressed almost in all types of 
tissues in humans, mice, other rodents, whereas the expression of HIF-2α is known to be 
more selective and is expressed primarily in the endothelium and interstitial cells of the 
kidney (Semenza 2000; Haase 2006). HIF is known to be involved in the regulation of 
different kidney function related processes, such as metabolism of glucose, angiogenesis, 
erythropoiesis, migration of cells, and cell-cell and cell-matrix interactions (Haase 2006). 
Various HIF target genes (> 100 genes) have been identified. These HIF-regulated genes 
include the genes that enhance O2 delivery by promoting angiogenesis, for example 
vascular endothelial growth factor (VEGF), VEGF receptor-1 (Flt-1), and endoglin 
(CD105), the genes that enhance systemic delivery of O2, such as erythropoietin (EPO), 
and the genes that favor anaerobic glucose metabolism, such as GLUT-1 (Haase 2006).  
Thus, HIF can control diverse cellular functions. 
  1.8.1.1  HIF Degradation by O2 Sensing 
During normoxia (i.e., normal O2 level), HIF-1α and HIF-2α proteins undergo 
ubiquitin and proteasome-mediated degradation, and therefore these proteins cannot 
accumulate. HIF-α proteins have an oxygen-dependent degradation domain (ODD), 
containing a sequence of 200 amino acids, which plays an important role in the O2 mediated 
degradation of HIF-α (Huang, Gu et al. 1998; O’Rourke, Tian et al. 1999).  In normoxic 
condition, the ubiquitination and degradation of HIF-α is controlled by the binding of the 
tumor suppressor protein: the von Hippel-Lindau protein (pVHL) to the ODD domain of 
HIF-α (Maxwell, Wiesener et al. 1999; Kamura, Sato et al. 2000). The pVHL- mediated 
HIF degradation mechanism requires hydroxylation of specific proline residues (e.g., 
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proline residue at the position 564) within the ODD, and thereby proline hydroxylation is 
important in determining HIF-α levels and the downstream hypoxia responsive gene 
transcription (Epstein, Gleadle et al. 2001; Ivan, Kondo et al. 2001; Jaakkola, Mole et al. 
2001; Masson, Willam et al. 2001; Yuan, Hilliard et al. 2003).  
  1.8.1.2  Cobalt Prevents HIF Degradation 
The metal cobalt (Co2+) can stabilize HIF by preventing HIF degradation 
irrespective of the O2 concentration. As shown in figure 12A, when a sufficient level of O2 
is present, HIF-specific hydroxylases cause hydroxylation of HIF-α and induce HIF-α 
degradation. Even during an adequate O2 level, Co
2+ can bind and block the iron binding 
sites on those proline hydroxylases (PHD), causing the inactivation of hydroxylase 
enzymatic function as shown in figure 12B  (Epstein, Gleadle et al. 2001; Yuan, Hilliard 
et al. 2003). Moreover, as suggested in the figure 12B, Co2+ can still prevent the 
degradation of HIF-α even if the HIFs are already hydroxylated.  Co2+ can directly bind to 
the hydroxylated HIF-α and inhibit the interaction between HIF-α with pVHL, and thereby 
block the ubiquitination and degradation of HIF-α (Yuan, Hilliard et al. 2003). Similar to 
Co2+,  dimethyloxallylglycine (DMOG) acts as the competitive inhibitor of PHD (Bruick 
and McKnight 2001), and iron chelator desferrioxamine (DFX) prevents the activity of 
PHD and thereby they can stabilize HIF by preventing its degradation (Hirsilä, Koivunen 
et al. 2005). Thus, using chemicals such as cobalt chloride (CoCl2) and DFX, HIF can be 
stabilized even in the presence of adequate O2, and the effects of HIF stabilization can be 
studied.  
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Figure 12:  Mechanisms of HIF-α degradation or stabilization. Image credit (Yuan, 
Hilliard et al. 2003). (A) Current model of HIF-α and O2 sensing. In the HIF-specific 
hydroxylase, iron acts as a cofactor. When adequate level of O2 is present, PHD causes 
hydroxylation of proline residue at 564 in the peptide sequence of HIF. Hydroxylated HIF 
undergoes pVHL-mediated ubiquitination and is followed by proteasome guided 
degradation. B. Co2+ can prevent HIF hydroxylation by conjugating with iron-binding site 
of HIF hydroxylase and making the enzyme inactive. Moreover, in case HIF-α is already 
hydroxylated, Co2+  can bind directly to the hydroxylated HIF and can block the interaction 
between HIF-α and pVHL, and thereby prevents the degradation of HIF-α (Yuan, Hilliard 
et al. 2003).  
1.8.2  O2 Utilization and the Effect of Hypoxia in Kidney 
Around 20 % of total cardiac output (CO) goes to the kidney, but still the O2 
tensions are found to be low in the kidney. For example, in the kidney medulla, O2 tension 
is only 5 mm Hg (Lübbers and Baumgärtl 1997). Most O2 in the kidney is used by the 
mitochondrial respiratory chain to produce ATPs which are mainly used in the function of 
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Na+/ K+-ATPase to drive reabsorption of Na+ and other transport processes such as the 
passage of glucose and amino acids across cellular membranes (Haase 2013). Hypoxia 
causes a severe energy depletion and critical changes of metabolism (Devarajan 2006). 
Hypoxia results in the disruption of cellular cytoskeleton, leading to mislocation of 
polarized proteins, such as integrins and Na+/ K+-ATPase in the kidney (Nangaku and 
Eckardt 2007). 
1.8.3  HIF Activation or Hypoxia in Kidney Diseases 
Kidney hypoxia is found in PKD, diabetic kidney, ageing kidney, kidney injuries, 
and others (Nangaku 2006; Tanaka, Kato et al. 2006; Rosenberger, Khamaisi et al. 2008; 
Palm and Nordquist 2011). HIF-α stabilization is seen in both acute and chronic kidney 
diseases (Haase 2006). In diabetic nephropathy, the degree of HIF-activation was found be 
in correlation with the level of kidney injury (Higgins, Kimura et al. 2007). 
Pharmacological activation of HIF shows a protective effect in AKI, whereas similar HIF-
activation can show reno-protective and pathological effects in CKD (Bernhardt, Wiesener 
et al. 2007; Haase 2013; Andringa and Agarwal 2014). Previous data showed that the 
timing of the pharmacologic activation of HIF is crucial in the renoprotective effects (Yu, 
Fang et al. 2012).  
  1.8.3.1  Hypoxia in CKD 
a) Causes of Hypoxia in CKD 
Chronic ischemia (i.e., obstructed or restricted blood flow) is seen in the 
tubulointerstitium. The damage to renal arterioles and arteries and the deformation and 
decrease in the number of capillaries can cause intense tubulointerstitial injury due to the 
ischemic-hypoxic condition (Choi, Chakraborty et al. 2000; Kairaitis, Wang et al. 2005; 
Nangaku 2006). 
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I. Role of Fibrosis in Hypoxia 
In CKD kidney fibrosis may cause reduced O2 supply due to the decreased blood 
supply by peritubular capillaries (Nangaku 2006). Moreover, the formation of kidney 
interstitial fibrotic tissue layer in between peritubular capillaries and tubular cells decreases 
the efficiency of O2 diffusion from the capillaries to the cells (Nangaku 2006).  
II. Role of Glomerulosclerosis in Hypoxia 
During early stages of CKD, glomerulosclerosis causes a decrease in the blood 
supply and stagnant blood inside peritubular capillaries. These events further induce the 
loss of the capillaries and localized hypoxic condition, promoting tubulointerstitial injuries 
(Nangaku 2006).  
III. Role of Vasoactive Substances in Hypoxia 
During early stages of CKD, with normal glomerular structure and function, the 
imbalance of vasoactive substances, such as angiotensin II, may result in an intrarenal 
vasoconstriction, leading to kidney-localized hypoxia (Nangaku 2006).  The activation of 
the renin-angiotensin system is known to cause the vasoconstriction of efferent arterioles, 
leading to a hypoxic condition in the tubulointerstitium. The administration of angiotensin 
II was found to reduce the numbers of peritubular capillaries in rats (Lombardi, Gordon et 
al. 1999; Nangaku 2006). In patients with type II diabetes and normalbuminuria, the 
reduced levels of peritubular capillary flow showed a correlation with the tubular 
dysfunction (Futrakul, Vongthavarawat et al. 2005). This finding suggested that the chronic 
hypoxia may lead to ESRD in CKD patients (Nangaku 2006).  
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IV. Role of Anemic Condition in Hypoxia 
The O2 delivery (DO2) in the kidney or other organs is calculated using the 
equation: DO2= CO × (% Sat × 1.39 × [Hb]) 
where, CO= cardiac output, % Sat= the percentage of hemoglobin saturated with O2, [Hb] 
= the concentration of hemoglobin with units of grams per liter, and 1.39= the value of the 
hemoglobin binding constant. The anemic conditions of CKD patients can cause decreased 
levels of DO2, and thereby can result in the kidney-localized hypoxia (Nangaku 2006).  
V. Role of Oxidative Stress in Hypoxia 
Angiotensin II is known to be elevated in kidney diseases and creates oxidative 
stress by stimulating the NADPH oxidase. Moreover, the level of EPO decreases in CKD.  
The presence of superoxide causes decrease in the nitric oxide (NO) level. The NO 
suppresses mitochondrial respiration and the lack of NO elevates mitochondrial respiration 
process and can contribute to hypoxia (Nangaku 2006).  Mitigation of oxidative stress was 
shown to prevent hypoxia by enhancing the delivery of O2 to renal tissue in a study using 
a diabetic nephropathy model (Palm, Cederberg et al. 2003).  
b) Effects of Hypoxia in CKD 
Tubular cells under hypoxia are known to induce epithelial-mesenchymal 
transdifferentiation and be transformed into myofibroblasts (Manotham, Tanaka et al. 
2004). Hypoxia is known to cause apoptosis of tubular cells as well as results in the ECM 
deposition and fibrosis due to the deficiency of matrix metalloproteinases (MMPs), other 
proteases and lysosomal enzymes (Tanaka, Hanafusa et al. 2003; Nangaku 2006) . Thus, 
hypoxia can cause renal necrosis and fibrosis, resulting in the loss of renal function.  
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  1.8.3.2  Hypoxia in Kidney Cysts 
Kidney cysts in ADPKD and ARPKD are known to expand over years and finally 
lead to kidney failure. The factors responsible for the cyst expansion and disease 
progression are not well understood (Cowley 2004). When kidney cysts grow, they can 
compress the adjacent blood vessels, decreasing the blood and O2 supply. Moreover, the 
fluid inside the cysts is stagnant. Therefore, kidney cysts can be hypoxic environments. 
Higher levels of serum EPO were detected in ADPKD as compared to other kidney 
diseases (Eckardt, Möllmann et al. 1989). Arteriovenous EPO levels and cystic fluid EPO 
levels were found to be higher than normal in kidney cysts (Eckardt, Möllmann et al. 1989).  
New blood vessel formation, i.e., angiogenesis, is seen in polycystic kidneys due to the 
higher expression level of VEGF and VEGF receptors. Angiogenesis can allow enough 
nutrient and O2 supply for cellular proliferation in order for cyst to expand (Bello-Reuss, 
Holubec et al. 2001; Wei, Popov et al. 2006). HIF-1α and HIF-2α proteins were found to 
show  strong expression levels in rat kidney cysts similar to a kidney from a normal rat 
under hypoxia  (Bernhardt, Wiesener et al. 2007). In cysts from human ADPKD patients, 
HIF-1α protein expression was detected in the cystic epithelial cells of renal medulla and 
HIF-2α protein was found to be expressed in the interstitial and endothelial cells.  
Consistent with the increased expression levels of HIF-1α, elevated levels of VEGF were 
found in the kidney cysts and collecting duct in PKD (Bernhardt, Wiesener et al. 2007). 
The mRNA levels of HIF effector molecules: heme oxygenase-1 (HO-1), Glut-1, and EPO 
were found to be higher in kidney cysts as compared to normal kidneys under normoxia 
and hypoxia (Bernhardt, Wiesener et al. 2007). In cystic kidney, HO-1 and Glut-1 protein 
levels were also found to be higher in the polycystic kidney than a kidney from a rat under 
systemic hypoxia (Bernhardt, Wiesener et al. 2007).  In the cystic kidney epithelial cells, 
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Glut-1 and VEGF proteins were detected. The angiogenic factor, endoglin is an indicator 
of new blood vessels and the protein expression levels of endoglin were consistent with 
HIF-2α expression levels in the cysts of a human kidney (Bernhardt, Wiesener et al. 2007).  
Thus, the kidney cysts were found to be hypoxic and the HIF pathway seemed to remain 
continuously upregulated in the cysts. The kidney-localized hypoxia in the cysts showed 
signs of a higher level of hypoxia (i.e., chronic hypoxic response) as compared to a normal 
kidney from an individual encountering systemic hypoxia.  
  1.8.3.3  Effect of HIF-1α on Kidney Cyst Growth and Ion Transport 
Forskolin is known to stimulate the growth of cysts having secretory functions 
(Magenheimer, John et al. 2006). In MDCK in vitro cyst models, the stabilization of HIF-
1α by PHD inhibitors increased the level of GLUT-1 and promoted the forskolin-stimulated 
cyst growth. The knock down of HIF-1α by short hairpin RNA (shRNA) against HIF1α or 
the application of HIF-1α inhibitor was found to prevent cyst growth and also inhibited the 
stimulation of cysts with forskolin (Buchholz, Schley et al. 2013). Similarly, in embryonic 
mouse kidneys, the stabilization of HIF-1α was shown to increase Glut-1 and promoted 
cyst growth, and the inhibition of HIF-1α decreased Glut-1 and resulted in the formation 
of smaller cysts (Buchholz, Schley et al. 2013).   In the rat kidney cyst models, the 
correlation between Glut-1 and cystic index supported the role of HIF-1α on the in vivo 
cyst growth. In the MDCK in vitro cystic model, even the treatment with selenium, insulin, 
dexamethasone, transferrin for two weeks could not regain the ENaC or active Na+ 
transport. The application of CFTR inhibitor, CFTRinh-172 was found to prevent in vitro 
cyst growth (Buchholz, Schley et al. 2013). The stimulation of cystic epithelial cells with 
extracellular ATP molecules is known to increase intracellular concentration of Ca2+ 
promoting cyst growth due to the stimulation of purinergic receptors (Paulmichl and Lang 
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1988). The HIF1α deficient in vitro cysts could not grow in response to ATP or PHD 
inhibitor. These results suggested that the stabilization of HIF-1α induces calcium-
activated chloride secretion, leading to cyst expansion. Ionomycin, which is an ionophore, 
is known to cause an increase in intracellular Ca2+ concentration for a relatively extended 
period of time. In the presence of ionomycin, the Isc was generated due to the luminal Cl
- 
secretion process in normal MDCK cells, and this Isc was abolished in cells in which HIF-
1α was knocked down (Buchholz, Schley et al. 2013). Thus, in the MDCK in vitro cyst 
model, active Cl- secretion seems to be the major active transport which is regulated by 
HIF-1α. 
 1.8.4  Effects of Hypoxia on Active Na+ Transport and Cellular Junctions 
  1.8.4.1  Effects of Hypoxia/ Ischemia or HIF-stabilization on Renal    
    Epithelial Cells 
The comparison of Isc values in the kidney collecting duct monolayers showed that 
as compared to an ambient O2 concentration of 20%, an O2 concentration of 40%, increased 
the ENaC activity by 50%. Similarly, when the ambient 20% O2 concentration was reduced 
to 8%, ENaC activity was found to decrease by 40%. As compared to 8% O2, 40% O2 
showed higher surface expressions as well as higher levels of matured forms of β and γ 
ENaC subunits (Husted, Lu et al. 2010). Thus, an O2 concentration can regulate the ENaC 
activity of renal epithelial cells (Husted, Lu et al. 2010). 
Actin organization of renal epithelial cells of the proximal tubule was found to be 
affected by ischemia (White, Doctor et al. 2000).  In renal epithelial monolayers, 
chemically induced hypoxia-mimetic condition created by ATP depletion resulted in the 
disruption of F-actin cytoskeleton organization and tight junctions and endocytosis of Na+/ 
K+-ATPase. Spectrin (called fordin in epithelial cells) network connects actin cytoskeletal 
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to the cellular surface membrane. The dissociation of fordin and ankyrin from actin 
cytoskeleton causes fordin and ankyrin to become dispersed throughout the cellular 
cytoplasm (Molitoris, Dahl et al. 1996). Similarly during ischemia, the disruption of the 
cellular cytoskeleton can lead to the dissociation of Na+/ K+-ATPase from fordin and 
cytoskeleton, and Na+/ K+-ATPase becomes free to be distributed to the apical membrane 
of the proximal tubule (Molitoris, Dahl et al. 1992). The reabsorption of ions and water by 
proximal tubule cells is normally maintained due to the lipid and protein polarity in the 
apical and basolateral membranes.  An ischemic injury decreases sodium reabsorption by 
kidney proximal tubular cells due to the apical redistribution of Na+/ K+-ATPase from the 
basolateral side. The loss of membrane polarity due to ischemia can cause disruption of the 
tight junctions and actin cytoskeleton (Molitoris 1991).  In vitro, apical redistribution of  
renal Na+/ K+-ATPase was found to transport Na+ ions from basolateral to apical side 
(Molitoris 1993).   
In the VHL deficient clear cell renal cell carcinoma (CCRCC) cell line, the 
expression of VHL which is known to promote HIF1α degradation, increased the 
expression of claudin-1, E-cadherin, and occludin proteins. Immunofluorescence for ZO1 
showed intact tight junctions when VHL was present. The application of small interfering 
RNAs (siRNAs) against HIF-1α was shown to promote ZO1, claudin-1, and occludin based 
junctional assembly in the VHL deficient renal epithelial cells. The in vivo kidney cysts 
formed due to VHL deficiency showed diminished levels of claudin-1 and occludin 
proteins. Inactivation of VHL in the kidney epithelium was shown to down-regulate cell– 
cell adhesion molecules involved in AJs and tight junctions. Similar to HIF-1α-SiRNAs, 
histone deacetylase inhibitor sodium butyrate, which is known to inhibit HIF activation,  
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was able to restore ZO1, claudin-1, occludin, and E-cadherin in these VHL- deficient renal 
epithelial cells (Harten, Shukla et al. 2009).  
Thus, HIF-1α or hypoxia can alter renal epithelial tight junctions and active Na+ 
transport.  
1.8.4.2  Effects of Hypoxia on Alveolar Epithelial Cells 
In the human and rat alveolar cells, the active Na+ transport was found to decrease 
in response to hypoxia (Mairbäurl, Wodopia et al. 1997; Mairbäurl, Mayer et al. 2002). 
The decreased numbers of membrane-bound ENaC under hypoxia can cause a decrease in 
the ENaC activity in alveolar epithelial cells (Wodopia, Ko et al. 2000; Jain and Sznajder 
2005). In the alveolar epithelial cells, short-term (1 hour) hypoxia was shown to decrease 
Na+/ K+-ATPase due to the endocytosis of Na+/ K+-ATPase. A prolonged hypoxia produces 
reactive oxygen species (ROS) activating PKC-ζ molecules which cause endocytosis of 
Na+/ K+-ATPase  by a process involving phosphorylation of the serine reside at the position 
18 of the N-terminus of Na+/ K+-ATPase (Dada, Chandel et al. 2003). During the severe 
hypoxia, not the intracellular  Na+/ K+-ATPase, but the Na+/ K+-ATPase in the plasma 
membrane of alveolar epithelial cells were found to decrease around 50%  within 2 hours 
in order to minimize oxygen consumption (Jain and Sznajder 2005).  Thus, hypoxia was 
shown affect the expression or activity of apical ENaC and basolateral Na+/ K+-ATPase, 
causing a decrease in the active Na+ transport and resulting in reduced ability of alveolar 
epithelium to clear alveolar edema fluid (Vivona, Matthay et al. 2001; Planès, Blot-
Chabaud et al. 2002; Dada, Chandel et al. 2003). 
Hypoxia was also found to decrease ZO1 and occludin protein levels, affect the 
organization of actin cytoskeleton, and cause mislocalization of occludin from tight 
junctions to the cell interior in alveolar epithelial cells. Consistent with the effects on 
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cellular junctions, hypoxia was found to increase transepithelial electrical conductance in 
the alveolar epithelial monolayers (Bouvry, Planes et al. 2006; Caraballo, Yshii et al. 
2011).  
Thus, in alveolar epithelial cellular monolayers, hypoxia affects the active Na+ 
transport and epithelial tight junctions.  
1.8.4.3  Effects of Hypoxia or HIF-stabilization on Endothelial Cells 
Hypoxia was shown to alter tight junctions and permeability of other cell types, 
such as brain microvessel endothelial cells and intestinal epithelial cells (Xu, Lu et al. 1999; 
Yamagata, Tagami et al. 2004; Engelhardt, Al‐Ahmad et al. 2014). The stabilization of 
HIF-1α by hypoxia or chemically using CoCl2, DFX or DMOG was shown to disrupt the 
barrier function of brain microvessel endothelial cells due to alterations of tight junctions 
caused by the delocalization and elevated levels of tyrosine phosphorylation of tight 
junction proteins. The application of a HIF-1α inhibitor was shown to restore the barrier 
function in endothelial cells under hypoxia. In the endothelial cells, under hypoxia with 
1% O2, ZO1 protein levels were found to decrease significantly after 48 hours (Engelhardt, 
Al‐Ahmad et al. 2014). HIF-1 is known to bind to a HRE in the 5’ flanking region of the 
VEGF gene and stimulates the transcription of VEGF (Forsythe, Jiang et al. 1996). The 
tight junction proteins ZO1 and occludin are known to be phosphorylated by VEGF in 
endothelial cells (Antonetti, Barber et al. 1999). The elevated level of VEGF was shown to 
decrease the expression of occludin and induce dissociation of ZO1 and occludin from tight 
junctions in the endothelial monolayers (Wang, Dentler et al. 2001). Thus, hypoxia or HIF 
stabilization can alter tight junctions of endothelial cells.  
In summary, HIF stabilization or hypoxia can affect tight junctions, and thereby 
may affect the paracellular transport in endothelial and epithelial cells. The active or 
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transcellular transport in renal and alveolar epithelia was also shown to be modified by 
hypoxia or HIF.  
1.9  Research Hypothesis and Significance 
As described above, hypoxia or HIF-stabilization can affect active transport of renal 
and alveolar epithelial cells and passive transport of epithelial and endothelial cells. Cyst 
expansion, stagnant fluid accumulation, and inadequate vascular supply can result in 
localized chronic ischemia-hypoxia in cysts and as well as in normal epithelia adjacent to 
a cyst as discussed previously. HIF-1α is known to be a major regulator of cellular response 
to hypoxia. Active Cl- secretion by kidney cystic epithelia was shown to be affected by 
HIF-1α as mentioned earlier. Normal epithelia near a cyst encounter the ischemic-hypoxic 
environment created by cysts, and we aim to understand whether this ischemic-hypoxic 
condition or HIF-stabilization may act as a major contributor in PKD progression by 
affecting the transport properties of normal renal epithelial cells (Nag and Resnick 2018). 
 We hypothesize that in normal renal epithelia near a cyst, the stabilization of HIF-
1α can alter active and passive transport of normal epithelia, transforming the normal 
absorptive epithelial phenotype to a secretory cyst-like and paracellularly leaky phenotype, 
and may contribute to cyst expansion (Nag and Resnick 2018).  
The findings of this study can be broadly applicable to other kidney diseases or 
pathologies related to ischemia-hypoxia, e.g., AKIs and CKDs.  
In addition, renal cilia are believed to have an important role in PKD progression 
and ciliary flow-sensing is known to regulate active Na+ transport in renal epithelial 
monolayers as discussed before. Renal ciliary lengths and biomechanical property were 
shown to be affected due to HIF-stabilization as mentioned earlier. In this current study, 
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we have not investigated the specific contribution of cilia to the effect of HIF-stabilization 
on renal transepithelial transport. Future studies, involving comparisons among 
transepithelial transports in ciliated and deciliated epithelial monolayers with or without 
HIF-stabilization, can help to understand the role of cilia and ciliary flow-sensing in this 
context. 
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CHAPTER II 
MATERIALS & METHODS 
2.1  Cell Culture 
Experiments were performed using two cell lines, a mouse cell line (Kolb, Woost 
et al. 2004) developed by microdissection from the cortical collecting duct (mCCD 1296 
(d)) of a heterozygous offspring  mouse carrying a transgene, temperature-sensitive SV40 
large T antigen under the control of an interferon-γ response element (Nag and Resnick 
2017), and another cell line, a commonly used MDCK epithelial cell line (ATCC CRL 
2935). Both cell types were grown onto collagen-coated and suspended membrane cell 
culture inserts. The cultures of mCCD cell line maintain the major phenotypic features, 
such as contact inhibition, tight junction formation, cell polarity, and directed salt and water 
transport, similar to the characteristics of primary cortical collecting duct cultures (Nag and 
Resnick 2017). Most of the experiments were performed using these mCCD cells. 
2.1.1  mCCD Cell Culture 
 mCCD cells were allowed to grow until confluence under the incubation conditions 
of 33°C and 5% CO2. The growth medium was formulated by adding the following media 
constituents at final concentrations: Dulbecco’s Modified Eagle Medium (DMEM) without    
glucose and Ham’s F12 at a ratio of 1:1, 5 mg/ml transferrin, 5 mg/ml insulin, 10 mg/ml
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epidermal growth factor (EGF), 4 mg/ml dexamethasone, 15 mM 4-(2-hydroxyethyl)- 1- 
piperazineethanesulfonic acid (HEPES), 0.06 w/v% NaHCO3, 2 mM L-glutamine, 10 
ng/ml mouse interferon-γ, 50 µM ascorbic acid 2- phosphate, 20 nM selenium, 1 nM 3,3′,5-
triiodo-L-thyronine (T3), and 5% fetal bovine serum (FBS). The fully grown cellular 
monolayers were incubated in an incubation condition of 39°C and 5% CO2 to promote 
differentiation.  For cells to differentiate, FBS and growth factors (insulin, EGF, and 
interferon-γ) were withdrawn from the apical differential media (APDM) and only growth 
factors were withdrawn from the basolateral differentiation media (BLDM) (Nag and 
Resnick 2017). Antibiotics, Penicillin-streptomycin (stock concentration of 10 mg/ml, 
100X) and gentamycin (stock concentration of 50 mg/ml, 1000X) were added to cell 
culture media with final concentrations of 1X.  
Cells were first grown onto collagen-coated suspended membrane cell culture 
inserts having 30 mm diameter (Millipore PICM03050, area= 4.71 cm2), inside a 6-well 
cell culture plate (Falcon# 35116).  When sufficient cellular numbers (> 80% confluence) 
were achieved, cells were then passaged at a dilution of 1:3 onto suspended membrane cell 
culture inserts having 12 mm diameter (Millipore PICM 01250, area= 1.13 cm2), within a 
24-well cell culture plate (Falcon# 353047). Next, the cells were grown to confluence and 
were allowed to differentiate resulting in a ciliated functional epithelial monolayer that 
maintained a directed salt and water transport (Nag and Resnick 2017).  
 2.1.2  MDCK Cell Culture 
MDCK epithelial cells were cultured in a growth medium containing DMEM and 
Ham’s F-12 in a 1:1 ratio, 15 mM HEPES, 0.06 w/v% NaHCO3, 2 mM L-glutamine, and 
10% FBS. Upon confluence, FBS was reduced to 1% to promote differentiation and 
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ciliogenesis. Penicillin-streptomycin and gentamycin were added to MDCK cell culture 
media as described previously. During both growth and differentiation, MDCK cells were 
maintained in an incubator at 37°C and 5% CO2. MDCK cells were first grown onto 60 mm 
tissue culture dishes (Celltreat# 229660) and after reaching confluence, cells were passaged 
onto collagen coated small cell culture inserts (area= 1.13 cm2) inside a 24-well plate as 
discussed above. These MDCK cells were first grown and then the monolayers were 
differentiated for at least 3 days prior to performing permeability studies. MDCK 
monolayers do not display directed salt and water transport as mCCD monolayers, but 
MDCK monolayers do express a functional cilium early, after 3 days of serum starvation 
(Resnick 2016). 
2.1.3  Cell Culture Experimental Designs 
Figures 13 and 14 show schematic timelines of the cell culture experiments. Day 0 
is defined as the starting point, when confluent monolayers are switched to differentiation 
conditions. Upon entering differentiation culture conditions, over time mCCD monolayers 
develop functional characteristics, such as the development of a directed Na+ transport and 
the emergence of functional primary cilia, after approximately 5 days. As shown in figure 
13, mCCD monolayers are considered fully differentiated after 7-10 days having stable 
electrophysiological properties and remain viable for an additional 24 days (Nag and 
Resnick 2017). By contrast, MDCK cells express primary cilia after 3 days in 
differentiation conditions and are only viable for an additional 7 days as shown in figure 
14. Throughout the experiment, the apical media volume was restricted (100 µl) so that the 
thin fluid layer could allow adequate diffusion of O2 and maintain a normoxic culture 
condition  (Resnick 2011; Nag and Resnick 2017). 
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Figure 13: mCCD cell culture time line (Nag and Resnick 2017). 
 
Figure 14: MDCK cell culture time line. 
2.1.4  Application of fluid flow 
The presence of fluid flow was shown to alter active Na+ transport in mCCD 
monolayers (Resnick and Hopfer 2007; Resnick 2011). Fluid flow in mCCD cell cultures 
was generated by placing the cell culture plates onto an orbital plate shaker (IKA MS3 
digital) and operating the shaker at 4.2 Hz (̴ 250 RPM) (Nag and Resnick 2017).   
2.2  CoCl2 Treatment 
CoCl2 hexahydrate (S93179 from Fisher Scientific) was dissolved in a sterile 1X 
Phosphate Buffer Saline (PBS) to prepare 100 mmol/L CoCl2 stock solution, which was 
diluted in APDM or BLDM or MDCK differentiation media to obtain the final desired 
concentration of 100 µmol/L. Experiments were carried out with CoCl2 added to APDM, 
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BLDM, or to both APDM and BLDM (Nag and Resnick 2017).  CoCl2 was used in order 
to stabilize or prevent degradation of HIF1α in mCCD and MDCK monolayers (Verghese, 
Zhuang et al. 2011) (Nag and Resnick 2017). 
 A preliminary experiment was performed to study the effect 30 µmol/L of HIF-1α 
inhibitor, methyl 3-[[2-[4-(2-adamantyl) phenoxy] acetyl] amino]-4-hydroxybenzoate 
from San Cruz Biotechnology (Catalog no. sc-205346) on FITC-dextran permeability in 
MDCK monolayers in which HIF1α was stabilized using CoCl2.  
2.3  Fluorescein isothiocyanate (FITC)-dextran Permeability Assay 
Anionic FITC-dextran molecules with two different molecular weights (3 kDa and 
70 kDa), D 3305 and D 1823 (Molecular Probes, Life Technologies) in Hanks’ Balanced 
Salt Solution (HBSS), 1X (21-023-CM, Cellgro, Mediatech) were used to measure the 
transepithelial permeability.  According to the manufacturer (Molecular Probes), the 
specific lots consist of 1 mole of FITC per mole of 3 kDa dextran (Lot# 1709577 and 
1485224) and 7 moles of FITC per mole of 70 kDa dextran (Lot # 1583589) (Nag and 
Resnick 2017). 
2.3.1  Generation of Calibration Graphs 
The stock concentration of 120 µmol/L of both 3 kDa and 70 kDa dextran was 
serially diluted in 1X HBSS buffer to formulate eight different concentrations, ranging 
from 120 µmol/L to (120 × 10-8) µmol/L to create a calibration graph of FITC-dextran 
concentrations versus fluorescence intensities. Each concentration was prepared in four 
replicates, and then 100 µL solutions of each replicate at different concentrations were 
added into a 96-well plate, and fluorescence values were detected using a fluorescence 
plate reader (Perker Elmer Life Sciences/ Wallac Victor Multilabel Counter and Wallac 
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1420 Manager software) at 490 nm excitation and 530 nm emission. These calibration 
graphs were used to determine the unknown FITC-dextran concentrations from the 
fluorescence intensity values in renal epithelial permeability experiments (Nag and 
Resnick 2017).   
2.3.2  Experimental Procedure and Sample Collection 
In the FITC-dextran permeability experiments, the cell culture inserts with cellular 
monolayers were first transferred into a 12-well plate for easier manipulation. These cell 
culture inserts were gently washed with an HBSS buffer (HyClone, Catalog No. 
SH30268.02) three times to remove any residual media. Then, as shown in figure 10, 100 
µl of FITC-dextran in the HBSS buffer was added to the apical side and 1 ml of the HBSS 
buffer was added to the basolateral side of the cell culture inserts. The 12-well plate with 
the cell culture inserts were placed inside a cell culture incubator maintained at 37°C and 
5% CO2. A volume of 100 µl of buffer sample was collected from the basolateral side every 
10 minutes, for a total of 70 minutes, to detect FITC-dextran transport from the apical to 
basolateral side as shown in figure 15. Each of the collected sample from the 12-well plate 
was deposited onto a 96-well plate. The fluorescence intensity value of the sample was 
measured using the plate reader with the same settings as described previously, and then 
the sample was added back to the basolateral side of the cell culture insert to maintain a 
constant fluid volume as shown in figure 15. After finishing up the transport experiment 
with 3 kDa FITC-dextran, the cell culture inserts were washed with HBSS buffer thrice, 
and the 70 kDa FITC-dextran transport was performed in the same way. In the beginning 
of each experiment, the concentration of initial stock solutions of 3 kDa and 70 kDa FITC-
dextran molecules were determined from the calibration graphs. Each replicate of the 
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sample was individually plotted to calculate the permeability value. The average 
permeability of 3-5 replicates was calculated and shown in the results (Nag and Resnick 
2017). 
 
Figure 15: Experimental procedure of FITC-dextran permeability assay. 
2.3.3  Quantification of Epithelial Monolayer Permeability 
There are various published methods that are used to determine transepithelial 
permeability (Siflinger‐Birnboim, del Vecchio et al. 1987; Artursson 1990; Abbott, Revest 
et al. 1997; Gaillard, Voorwinden et al. 2001; Matter and Balda 2003; Balda and Matter 
2007; Yuan and Rigor 2010). Our quantification of an epithelial monolayer permeability 
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is based on the relationship between the time-dependent changes in tracer particles, such 
as FITC-dextran, and the transepithelial permeability. The derivation used in the 
quantification is shown below. This derivation considers all the physiological parameters 
(such as the area of the cellular monolayer and apical and basolateral fluid volumes) 
relevant to the experimental setup. However, this derivation, like other methods, cannot 
distinguish between transcellular and paracellular pathways (Nag and Resnick 2017).  
Following Fick’s first law of diffusion (Fick 1855), the mass flux of a tracer from 
the apical compartment passing through a semipermeable surface (area = ‘A’) to the 
basolateral compartment can be expressed using the equation: 
dM𝑏𝑙
dt
= P A [C(t)𝑎𝑝 − C(t)𝑏𝑙] 
     
(1) 
Where ‘Mbl’ is the total mass of tracer particles in the basolateral side, ‘P’ is the 
permeability with units of length/time, ‘C(t)ap’ is the time-dependent concentration of 
tracer particles in the apical compartment, and ‘C(t)bl’ is the time-dependent concentration 
of tracer particles in the basolateral compartment (Nag and Resnick 2017). 
With our experimental design, we can assume that the fluid volumes in the apical 
and basolateral sides stayed constant, and any possible changes were negligible during the 
time of the experiment (̴ 80 minutes). Thus, as the apical and basolateral fluid volumes 
remain constant, dividing by the basolateral fluid volume ‘Vbl’ and using the equation of 
conservation of mass M0 = C(t)apVap + C(t)blVbl, we obtain 
dC𝑏𝑙
dt
=
P A
𝑉𝑏𝑙
 [
𝑀0
𝑉𝑎𝑝
− C(t)𝑏𝑙
𝑉𝑎𝑝 + 𝑉𝑏𝑙
𝑉𝑏𝑙
] 
     
(2) 
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In the beginning of the experiment, when the tracer (FITC-dextran) was just added 
to the apical side (i.e., at time t = 0 second), the basolateral concentration of the tracer was 
Cbl(0) = 0. Now, we can use this initial experimental condition to find the solution of this 
equation. 
C(t)𝑏𝑙 = C0  [1 − Exp [−𝑃𝐴 (
1
𝑉𝑏𝑙
+
1
𝑉𝑎𝑝
) 𝑡]] 
     
(3) 
 
where ‘C0’ is the initial tracer concentration and C0 = M0/(Vap+Vbl). For convenience, we 
combine all the constant parameters as a single constant and denote it as the constant B = 
A (1/Vbl + 1/Vap) and reorganize the equation to solve for the permeability: 
P t = −
𝑙𝑛(1 − 𝐶(𝑡)𝑏𝑙 𝐶0⁄ )
𝐵
 
     
(4) 
Thus, from the measurements of the basolateral concentrations of FITC-dextran 
‘C(t)bl’ as a function of elapsed time ‘t’ (unit: seconds), we calculate the permeability ‘P’ 
as the slope of a best-fit line. The values of the parameters used in the calculation of 
permeability values are shown in table 2 (Nag and Resnick 2017).  
Table II: FITC-dextran permeability calculation parameters. 
 
 
 
 
 
Parameter Value 
Initial FITC-dextran concentration= C0 Variable 
Area of semipermeable filter= A 1.13 cm2 
Volume of fluid in apical chamber= Vap 100 µL 
Volume of fluid in basolateral chamber= Vbl 1 mL 
‘B’ (see equation 4) = constant= A (1/Vbl + 1/Vap) 12.43 cm-1   
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2.4  Renal Epithelial Electrophysiology 
The measurements of transepithelial voltage and resistance values were carried out 
using Endohm chambers (ENDOHM-24SNAP or ENDOHM-12) from World Precision 
Instruments (WPI) connected to a Millicell-ERS voltmeter from Millipore or EVOM2 
epithelial voltmeter from WPI.  Both voltmeters were calibrated using a test resistor of 1 
kΩ from WPI to ensure accurate resistance read outs. The resistance values were recorded 
using the voltmeter in a current-clamp mode. The Endohm chamber was first cleaned with 
70% ethanol for 10 minutes, followed by rinsing in distilled water. The chamber was then 
exposed to UV within our laminar cell culture hood for an hour. A volume of basolateral 
differentiation media sufficient to connect both sets of Ag/AgCl electrodes was added to 
the chamber, and electrodes immersed in the media were allowed to equilibrate for at least 
three to eight hours, until the voltage readings became stabilized. 
As discussed previously, epithelial monolayers were created on permeable 
membrane cell culture inserts, and then the cells were differentiated so that the cells 
maintain primary cilia and show functional electrophysiological properties. Once the 
Endohm-voltmeter measurement system was equilibrated and ready to use, the cell culture 
inserts with differentiated epithelial monolayers were transferred one by one onto the 
Endohm chamber to record cellular electrophysiological properties. This Endohm chamber 
has two sets of concentric electrodes: one for voltage measurement and another for current 
as shown in figure 16. The electrodes are made of Ag/AgCl and are considered to be safe 
for biological applications since Ag is known to dissolve slowly and is known to be non-
toxic (Nadeau 2017).   
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The electrical read outs are acquired from the voltmeter as resistance and voltage 
values. The TER values are presented with a unit of Ω-cm2 or kΩ-cm2 by multiplying raw 
resistance values with the area (1.13 cm2) of the cell culture insert. The short circuit 
equivalent current (Ieq) was calculated from voltage and resistance read outs using Ohm’s 
law, I= V/R. Ieq values were expressed as µA/ cm
2 by dividing obtained Ieq values by the 
area (1.13 cm2) of the filter. The values of Ieq relative to the control group are presented. 
Greater than 95% of the Ieq in mCCD monolayers was inhibited by the apical application 
of 10 µmol/L amiloride. Thus, the Ieq value in mCCD monolayers is considered 
proportional to ENaC activity or active Na+ transport (Resnick and Hopfer 2007; Resnick 
2011; Nag and Resnick 2017). The monolayers of MDCK cells did not produce any 
detectable voltage values, and hence MDCK cells were not used to study Ieq or active ion 
transport. To exclude samples that lost confluence or may have otherwise been damaged, 
any mCCD culture possessing a TER value below a resistance threshold of 1000 Ω-cm2 
was discarded. Similarly, any MDCK culture with a TER value below a resistance 
threshold of 150 Ω-cm2 was also omitted from the studies. Before collecting 
electrophysiological read outs, 100 µl of APDM was gently added to cell culture inserts in 
addition to the 100 µl of APDM already present to ensure electrical contact between the 
upper electrodes and apical fluid (Nag and Resnick 2017). Thus, electrophysiological 
analyses were performed.  
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Figure: 16: Electrophysiological Endohm chamber was used in the measurement of 
transepithelial transport (Image credit: Dr. Andrew Resnick).  Ciliated epithelial 
monolayers were grown and differentiated onto permeable membrane and these 
monolayers were transferred to Endohm chamber to obtain Ieq and TER values.  
2.5  Western Blot 
2.5.1  Cell Lysate Preparation 
Whole cell lysates were prepared using RIPA 1X cell lysis buffer. The original 
stock of 10X RIPA buffer from Cell Signaling Technology (Product no. 9806) was first 
diluted in molecular biology grade protease-free water (Fisher Scientific, Product no. BP 
2819) to prepare 1X buffer. The Halt Protease Inhibitor Cocktail from Thermo Scientific 
(Product no. 78430) was added at a final concentration of 1X. The RIPA buffer cell lysis 
protocol from Cell Signaling Technology was followed to prepare whole cell lysates (Nag 
and Resnick 2017). The protein levels of EPO, ZO1, and Na+/ K+-ATPase α1 subunit were 
compared in the whole cell lysates. 
Nuclear extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction 
Reagents from Thermo Scientific (Product no. 78833). The cells were treated with trypsin 
to detach and then centrifuged to form cellular pellets and the pellets were washed with 
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PBS buffer twice. For a confluent mCCD monolayer on a large cell culture insert (area= 
4.71 cm2) 56 µL Cytoplasmic Extraction Reagent I (CER I), 3 µL Cytoplasmic Extraction 
Reagent II (CER II), and 28 µL Nuclear Extraction Reagent (NER) were used. The Halt 
Protease Inhibitor Cocktail was added to the CER I and NER as instructed by the 
manufacturer. The protocol from Thermo Scientific was followed to separate cytoplasmic 
components to obtain nuclear extracts. During the cell lysate or nuclear extract preparation, 
samples were maintained on ice or at 4°C to minimize any possible protein degradation. 
The HIF-1α protein levels were compared in the nuclear extracts.  
The protein concentration in each sample was determined using Bradford assay 
using Coomassie Plus Protein Assay Reagent from Thermo Scientific (Product No. 
1856210). Before loading the samples in the wells of the polyacrylamide gels, sample 
buffer was added and samples were heated for 6 minutes at 95°C (Nag and Resnick 2017).   
2.5.2  Sodium Dodecyl Sulfate (SDS) Polyacrylamide Gel Electrophoresis    
(SDS-PAGE) 
Twelve percent acrylamide-bisacrylamide gels and 4% stacking gels were used.  In 
each well of the gel, same amount (30 µg) of proteins were loaded. The samples were run 
in a 1X running buffer containing SDS, glycine, and Tris Base for 2.5 hours at 100 volts. 
The gels were put onto methanol preactivated polyvinylidene difluoride (PVDF) 
membranes. Using a wet transfer method, the transfer was performed for 2 hours at 100 
volts in a cold transfer buffer containing 20% methanol. The membrane was blocked for 
1-2 hours in 6% non-fat dry milk in 1X Tris-buffered Saline-Tween 20 (TBST) buffer at 
room temperature. The concentrations of primary and secondary antibodies were 
formulated in 6% non-fat dry milk in TBST.  The following antibody concentrations were 
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used: mouse monoclonal beta-actin (Novus Biologicals# NB600-501) at a concentration of 
1:10,000, mouse monoclonal HIF-1α (Santa Cruz Biotechnology# sc-13515) at a 
concentration of 1:200, mouse monoclonal EPO (Santa Cruz Biotechnology# sc-80995) at 
a concentration of 1:200, mouse monoclonal Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) (Santa Cruz Biotechnology# sc-166545) at a concentration of 1:1000, rat 
monoclonal ZO1 (Developmental Studies Hybridoma Bank at University of Iowa# 
R26.4C) at a concentration of 1:100, mouse monoclonal Na+/ K+-ATPase α1 subunit 
(Developmental Studies Hybridoma Bank at University of Iowa# a6F) at concentration of 
1:600. Secondary HRP-conjugated anti-mouse and anti-rat antibodies were used at a 
concentration of 1:2000. The membranes were kept in primary antibody at 4°C overnight 
on a shaker and after washing steps these membranes were incubated with secondary 
antibody for 2 hours at the room temperature on a shaker. After incubation in primary or 
secondary antibodies, the membranes were washed with 1X TBST buffer for every 10 
minutes for a total of 40 minutes and during the washing steps the membranes were kept 
on the shaker. A chemiluminescence detection kit (Amersham ECL Prime Western 
Blotting Detection Reagent) from GE Healthcare (Catalog no. RPN 2232) was used. The 
luminol and peroxide solutions were mixed in a ratio of 1:1 and the mixture was evenly 
spread onto the membrane. The membranes were read using an Odyssey FC Imaging 
System from LI-COR Biosciences using Image Studio Software version 2.1.  The 
following membrane exposure times were found to be optimum to detect different proteins: 
membranes probed for ZO1 and Na+/ K+-ATPase α1 subunit with 5 minutes’ exposure, the 
membranes probed for HIF-1α and EPO with 10 minutes’ exposure, membranes probed 
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for beta-actin with 1-minute exposure, and membranes probed for GAPDH with 2 minutes’ 
exposure.  
To compare beta-actin levels in the membrane which was first analyzed for EPO 
levels, a stripping buffer, Restore Plus Western Blot Stripping Buffer from Thermo 
scientific (Product no. 46430), was used. Antibodies were stripped from the membrane 
for 10 minutes, followed by washing with 1X TBS and 1X TBST buffers, and the 
membrane was blocked again before the addition of the primary antibody, i.e. 
monoclonal beta-actin antibody. As described above, the membrane was treated in the 
same way with a secondary antibody and the detection reagents to find beta-actin protein 
levels (Nag and Resnick 2017).  
2.5.3  Densiometric Analysis  
The LI-COR Image Studio Software was used to measure band intensities in order 
to perform densiometric analysis (Nag and Resnick 2017). In the same membrane, the ratio 
of the band intensity of protein of interest obtained from a sample and the band intensity 
of beta-actin or GAPDH of the same sample was first calculated for a control sample (i.e., 
the lysate prepared from cells without CoCl2 treatment). Similarly, the ratio was calculated 
for a CoCl2-treated sample. The fold increase or decrease of the treated sample ratio was 
calculated by dividing the treated sample ratio with the control sample ratio. The control 
sample ratio after dividing by the same sample ratio is assigned a value of 1, and the results 
as folds of increase or decrease of treated samples as compared to the control samples are 
shown. Average values of densitometric fold changes with standard errors for 3-6 replicates 
are presented.  
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2.6  Cellular Metabolic Activity Assay 
The yellow colored tetrazolium salt, 3-(4,5-dimethythiazol2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT), is known to be reduced by the mitochondrial succinate 
dehydrogenase enzyme of viable cells to produce purple colored formazan crystals 
(Mosmann 1983). A Cell Titer 96 Non-Radioactive Cell Proliferation Assay (MTT) G4000 
(Promega) kit was used to check if cellular metabolic activity was affected by the addition 
of CoCl2. In brief, BLDM was removed and APDM was replaced with 150 µl of fresh 
APDM to which 20 µl of MTT dye solution was added and the culture was incubated for 
four hours.  Next, 150 µl of MTT solubilization/stop (acidic isopropanol) solution was 
added to the apical compartment and the culture was incubated for an additional 4 hours. 
Vigorously pipetted formazan crystals, formed by viable cells, were dissolved into the 
solution, and 200 µl of the homogenized solution was then transferred into a 96-well plate.  
Sample absorbance values were detected at 570 nm using an absorbance plate reader 
(Perker Elmer Life Sciences/ Wallac Victor Multilabel Counter and Wallac 1420 Manager 
Software). The average absorbance of 4 replicates are shown in the graph. Using trypan 
blue dye and a hemocytometer, cell enumeration was performed and a calibration graph 
was generated from cell seeding densities and absorbance values (Nag and Resnick 2017). 
MTT assay compares cellular metabolic activities and can be an indirect indicator of 
cellular viability (Jover, Ponsoda et al. 1994).   
2.7  Statistical Analysis 
Microsoft Excel 2016 was used to calculate values of mean or average and standard 
deviation. Standard error of mean (SEM) was calculated from standard deviation (σ) as 
𝑆𝐸𝑀 =
σ
√𝑛
 where, n = number of replicates. Values of SEM are shown in all the graphs.  
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A type three (i.e., two-sample unequal variance and heteroscedastic) and a two-tailed 
Student’s t-test was performed using Microsoft Excel to compare level of any significant 
difference between two groups, and IBM-SPSS software was used to perform a One-way 
ANOVA with post-hoc Tukey to compare among more than two groups (Nag and Resnick 
2017). The Pearson’s linear correlation analysis was also carried out using the SPSS 
software. 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
CHAPTER 
III.  RESULTS & DISCUSSION 
3.1  Results 
3.1.1  CoCl2 Stabilizes HIF1α in the Nucleus of Renal Epithelial Cells 
Western blots were performed to show that the addition of 100 µmol/L CoCl2 to 
our culture media increased nuclear HIF-1α in mCCD cells (Figures 17A & 17B) and 
MDCK cells (Figures 18A and 18B). Nuclear stabilization of HIF1α was found to cause a 
slight increase of HIF-1α effector molecule EPO levels in the whole cell extracts prepared 
from mCCD cells (Figures 19A and 19B) (Nag and Resnick 2018) and MDCK cells 
(Figures 20A and 20B). These findings are in agreement with previous studies (FISHER 
and Langston 1967; Fandrey, Frede et al. 1997; Verghese, Zhuang et al. 2011). According 
to densiometric analysis we found a significant increase in HIF-1α in the nuclear extracts 
of both mCCD and MDCK cells (Figures 17B and 18B). However, the slight increase of 
EPO levels was not statistically significant in mCCD or MDCK cells (Figures 19B and 
20B). We did not notice any effect of fluid flow on EPO levels of mCCD cells along with 
CoCl2 (Figures 19A and 19B)
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GAPDH gene has a HRE and its level can be elevated by nuclear stabilization of 
HIF-1α (Graven, Yu et al. 1999; Lu, Gu et al. 2002). The beta-actin mRNA level was found 
to be elevated by hypoxia (Zhong and Simons 1999). Thus, increased level of HIF1α by 
CoCl2 may increase the protein levels of our loading controls: GAPDH and beta-actin, and 
the densitometric analysis of our western blots may underestimate the effect of the 
application of 100 µmol/L CoCl2 on HIF1α and EPO protein levels to some extent.  
3.1.1.1  CoCl2 Stabilizes HIF-1α in the Nucleus of mCCD Cells 
  
Figure 17: HIF-1α was stabilized in the nucleus of mCCD cells by 100 µmol/ L CoCl2. 
(A) Shows the western blots for HIF1α and GAPDH (loading control) in the nuclear 
extracts prepared from cells treated with CoCl2 or without CoCl2 (Control) for 4 hours. (B) 
Shows the densiometric analysis of the HIF-1α bands, Student’s t-test, P= 0.004, N= 3. 
 
 
 
 
 
 
 
 
B 
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  3.1.1.2  CoCl2 Stabilizes HIF-1α in the Nucleus of MDCK Cells 
     
 
Figure 18: HIF-1α was stabilized in the nucleus of MDCK cells by 100 µmol/ L CoCl2. 
(A) Shows the western blots for HIF-1α and beta-actin (loading control) in the nuclear 
extracts prepared from cells treated with CoCl2 or without CoCl2 (Control) for 4 hours. (B) 
Shows the densiometric analysis of the HIF1α bands, Student’s t-test, P = 0.01, N= 3.  
3.1.1.3  CoCl2 Slightly Increases EPO Production in mCCD Cells 
    
 
Figure 19: EPO protein level was slightly increased in mCCD cells by 100 µmol/ L 
CoCl2. (A) Shows the western blots for EPO and beta-actin (loading control) in the whole 
cell extracts prepared from cells treated without CoCl2 (Control), with CoCl2, and CoCl2 
with fluid flow for 24 hours. (B) Shows the densiometric analysis of the EPO bands, One-
way ANOVA, P > 0.05, N= 3.  
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  3.1.1.4  CoCl2 Slightly Increases EPO Production in MDCK Cells 
    
 
Figure 20: EPO protein level was slightly increased in MDCK cells by 100 µmol/ L 
CoCl2. (A) Shows the western blots for EPO and beta-actin (loading control) in the whole 
cell extracts prepared from cells treated without CoCl2 (Control), with CoCl2, and CoCl2 
with fluid flow for 24 hours. The lanes between the ladder and the bands are spliced out 
(following American Journal of Physiology Guidelines) to show the bands or samples of 
interest. (B) shows the densiometric analysis of the EPO bands, Student’s t-test, P > 0.05, 
N= 3.  
3.1.2  Cellular Metabolic Activity: MTT Assay 
  3.1.2.1  MTT Calibration Graphs 
Cells were seeded onto cell culture inserts with an area of 1.13 cm2 at different 
mCCD cell seeding densities ranging from 104 to 7 × 105 cells per insert. MTT assay was 
performed in mCCD cells in growth condition (figure 21A) and in mCCD cells in fully 
differentiated condition (figure 21B). The calibration graphs showed that MTT absorbance 
values increase with initial cell seeding density. A logarithmic trend line was used to fit the 
scatter plot of cell seeding density versus MTT absorbance values.  Our calibration graphs 
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show that we can detect changes in cellular metabolic activities and we may detect cellular 
cytotoxicity due to the addition of CoCl2. 
These mCCD cells express thermolabile the simian virus 40 (SV40) large tumor 
(T) antigen (TAg) under the control of major histocompatibility complex H-2Kb promoter, 
which is induced by interferon γ (IFN γ). In the permissive temperature of 33 °C and in a 
growth medium containing of IFN γ, cells continuously proliferate. Under non-permissive 
temperature around 39°C and in a differentiation medium without IFN γ, mCCD cells stop 
proliferating and start to differentiate (Jat, Noble et al. 1991; Whitehead, VanEeden et al. 
1993; Resnick and Hopfer 2007). At high cell seeding densities, we do not notice any 
difference of MTT absorbance values, most likely due to the equal level of cellular 
confluence achieved by high cell seeding densities. 
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Figure 21: Cell seeding number versus MTT absorbance calibrations, N= 3-4. (A) 
Shows mCCD cells with specific cell seeding numbers after 3 days in growth media (GM) 
(B) Shows mCCD cells with specific cell seeding numbers in 3 days in growth media and 
9 days in differentiation media (DM). 
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3.1.2.2  Effect of 100 µmol/L of CoCl2 on Cellular Metabolic Activity 
An MTT assay determines cellular metabolic activity and can indirectly reflect the 
number of viable cells present (Mosmann 1983; van Meerloo, Kaspers et al. 2011). MTT 
absorbance values showed that there were no significant differences between control and 
CoCl2 treatment groups both in the presence or absence of fluid flow after 3 days (figure 
22A). MTT results indicate that the addition of 100 µmol/L CoCl2 to our culture media did 
not have any effect on cellular metabolic activities and can indicate equivalent cellular 
viability (Nag and Resnick 2018) or no significant cytotoxic effect up to 4 days of treatment 
(figures 22A and 22B). After 9 days of CoCl2 treatment, cellular metabolic activity was 
found to decrease and indicated decrease in cellular viability or cytotoxic effects (figure 
22C). It is to be emphasized that all our epithelial transport analyses were performed within 
3 days of CoCl2 treatment and the cytotoxic effect of 9 days of CoCl2 treatment is not 
applicable to our study. 
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Figure 22: Effect of CoCl2 on cellular metabolic activity of mCCD cells. (A) and (B) 
show that MTT absorbance values do not significantly change with the addition of 100 
µmol/L CoCl2 up to 3-4 days, indicating cell viability may have remained unchanged 
during 4 days of treatment, either in the presence or absence of fluid flow, One-way 
ANOVA, P > 0.05, N= 3-5. (C) Shows that the treatment of cells with 100 µmol/L CoCl2 
for 9 days causes significant decrease in the MTT absorbance i.e., cellular metabolic 
activity. One-way ANOVA, P < 0.0001, N= 3-4. 
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3.1.3  FITC-dextran Permeability 
  3.1.3.1  Calibration Graphs and Permeability Calculation                  
Figures 23 and 24 show calibration graphs of fluorescence intensities versus 
different concentrations of 3 kDa and 70 kDa FITC-dextran molecules. As shown in figure 
23, fitting a power-law curve to the 3 kDa FITC-dextran data obtains the equation y = 
5.67*104 x0.767. Similarly, 70 kDa FITC-dextran data yields a power law fit y = 6.13*105 
x0.813 as shown in figure 24.  Power law curve fitting was chosen because at low 
concentrations, the proportional change of fluorescence intensity is related to the 
proportional change of FITC concentration (Ohannesian and Streeter 2001).    
To calculate permeability value for each sample, a graph was generated for that 
sample by plotting ln [1- (Ct- C0)] versus time t in seconds as shown in figure 25. Here, Ct 
represents FITC-dextran concentration at time t (0- 4200) seconds for measurements 
obtained at intervals of every 600 seconds. C0 is the initial concentration in the apical side. 
The concentration (C0 and Ct) values of 3 kDa FITC-dextran were obtained from the 
equation of figure 23. The permeability value was calculated for a specific sample using 
the specific graph. For example, as shown in figure 25, permeability value was calculated 
from slope of the linear trend line. The slope of the line is 4 × 10-7 sec-1 and dividing this 
slope by the constant B = 12.43 cm-1, we can calculate the permeability value for this 
specific sample. Thus, we obtain a 3 kDa FITC-dextran permeability value of 3.22 × 10-8 
cm/sec.  
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Figure 23: Concentration vs florescence intensity calibration graph of FITC-dextran, 
3 kDa (N= 4). Using the equation of this graph, we can determine FITC-dextran (3 kDa) 
concentration from a fluorescence intensity value. 
 
Figure 24: Concentration vs florescence intensity calibration graph of FITC-dextran, 
70 kDa (N= 4). Using the equation of this graph, we can determine FITC-dextran (70 kDa) 
concentration from a fluorescence intensity value. 
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Figure 25: 3 kDa FITC-dextran transepithelial permeability acquired from 
fluorescence intensity measurements. Slope= 4× 10-7 sec-1, corresponding to 
Permeability = 3.22 × 10-8 cm/sec.  
 3.1.3.2  FITC-dextran Permeability in mCCD and MDCK Epithelial        
   Monolayers 
 Using the approach shown in figure 25, the permeability of a cell-free collagen-
coated cell culture insert was found to be (1.21 ± 0.46) × 10-5 cm/s (3 kDa) and (1.01 ± 
0.40) × 10-6 cm/s (70 kDa) as shown in figure 26.  
 
Figure 26: Permeability of FITC-dextran through empty cell culture inserts without 
cells, Student’s t-test, P < 0.0001, N= 8. 
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As mCCD epithelial cells differentiate, they undergo ciliogenesis, and the cells start 
to form tight junctions and gain functional properties, such as directed transport of salt and 
water. Figure 27 presents the data on transepithelial permeability of mCCD monolayers 
during this differentiation phase. As per our expectation, 3 kDa FITC-dextran permeability 
at day 1 (i.e., 24 hours after the onset of differentiation) was found to be significantly higher 
(8 times) as compared to a fully differentiated mCCD monolayer after 10 days of 
differentiation as shown in figure 27A.  This finding provides some evidence that the 
principal path of 3 kDa FITC-dextran diffusion in mCCD monolayers is through 
paracellular pathway, as tight junctions may form early during the differentiation process 
(Koizumi, Kojima et al. 2007).  By contrast, the permeability of 70 kDa FITC-Dextran 
showed no changes during differentiation (Figure 27B) (Nag and Resnick 2017).   
  
Figure 27: Transepithelial permeability of FITC-dextran molecules in mCCD 
monolayers under differentiation. (A) Shows that 3 kDa FITC-dextran transepithelial 
permeability at the onset of differentiation (day 1) is significantly higher as compared to 
fully differentiated mCCD monolayers (day 10), One-way ANOVA, P < 0.05, N=3-6.  (B) 
Shows that the permeability of 70 kDa FITC-dextran does not change significantly during 
differentiation, One-way ANOVA, P > 0.05, N= 3-6. 
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Fully differentiated mCCD monolayers showed 3 kDa FITC-dextran permeability 
of (5.36 ± 1.67) × 10-9 cm/s and 70 kDa FITC-dextran permeability of (1.56 ± 0.89) × 10-9 
cm/s as shown in figure 28. Permeability values of 3 kDa and 70 kDa FITC-dextran 
molecules in the differentiated mCCD monolayers are significantly decreased when 
compared to the cell-free insert (figures 26 and 28), demonstrating the importance of 
cellular tight junctions in regulating the transport through paracellular pathways (Nag and 
Resnick 2017). The monolayer permeability values of differentiated mCCD cells remained 
stable. 
 
Figure 28: Transepithelial permeability of fully differentiated mCCD monolayers, 
Student’s t-test, p < 0.02, N= 8.  
As shown in figure 29, once cells are fully differentiated, MDCK monolayers 
showed 3 kDa permeability of (2.64 ± 1.11) × 10-8 cm/s and 70 kDa permeability of (5.75 
± 2.15) × 10-10 cm/s and these monolayer permeability values of MDCK cells remained 
stable.  
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Figure 29: Transepithelial permeability of fully differentiated MDCK monolayers, 
Student’s t-test, P < 0.001, N= 7-8. 
  3.1.3.3  HIF-stabilization by CoCl2 Increases Transepithelial            
    Permeability 
We studied the effect of HIF-stabilization by CoCl2 on monolayer permeability. 
CoCl2 was found to alter the transepithelial permeability of FITC-dextran molecules 
through fully differentiated mCCD monolayers. An addition of 100 µmol/L of CoCl2 for 
48 hours increased 3 kDa FITC-dextran permeability to (4.02 ± 3.15) × 10-7 cm/s and the 
addition of 100 µmol/L CoCl2 for 72 hours increased the transepithelial permeability 
further to (9.05 ± 8.13) ×10-7 cm/s as shown in figure 30A. The treatment of CoCl2 
increased the transepithelial permeability of 70 kDa FITC-dextran to (1.99 ± 2.13) ×10-8 
cm/s at 48 hours and (7.24 ± 6.47) ×10-8 cm/s at 72 hours as shown in figure 30B.  The 
treatment with CoCl2 increased 3 kDa FITC-dextran permeability more than 100-fold and 
70 kDa FITC-dextran nearly 40-fold after 72 hours. Thus, HIF-stabilization by CoCl2 
significantly affected permeability of 3 kDa and 70 kDa FITC-dextran molecules in 
differentiated mCCD monolayers (Nag and Resnick 2017). 
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Figure 30 A: Effect of CoCl2 on permeability of 3 kDa FITC-dextran in differentiated 
mCCD monolayers. CoCl2 was added on day 0. Data shows that CoCl2 treatment for 48 
hours (Day 2) and 72 hours (Day 3) increased the permeability of differentiated mCCD 
monolayers. CoCl2 treatment significantly (One-way ANOVA, P = 0.02, N= 4-5) increased 
monolayer permeability on day 3. No statistically significant difference was found between 
control groups. 
 
Figure 30 B: Effect of CoCl2 on permeability of 70 kDa FITC-dextran in 
differentiated mCCD monolayers. CoCl2 was added on day 0. Data shows that CoCl2 
treatment for 48 hours (Day 2) and 72 hours (Day 3) increased the permeability of 
differentiated mCCD monolayers. CoCl2 treatment significantly (One-way ANOVA, P = 
0.02, N= 4-5) increased monolayer permeability on day 3. No statistically significant 
difference was found between control groups. 
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Similarly, we investigated the effect of HIF-stabilization by 100 µmol/L CoCl2 in 
MDCK monolayers. Figure 31A shows 3 kDa FITC-dextran permeability increased for 
MDCK monolayers: (3.65 ± 0.96) × 10-8 cm/sec after 48 hours of incubation and (3.62 ± 
0.46) × 10-8 cm/sec after 72 hours of incubation. Treatment with CoCl2 for 72 hours 
significantly increased 70 kDa FITC-dextran permeability as well, to (1.61 ± 0.0) × 10-9 
cm/sec as shown in figure 31B. The treatment with CoCl2 increased the permeability of 3 
kDa and 70 kDa dextran molecules in MDCK monolayers around 2-3 folds. The effect of 
HIF-stabilization by CoCl2 on the transepithelial permeability of MDCK monolayer was 
statistically significant, but the fold changes were much less in MDCK monolayers as 
compared to mCCD monolayers.   
 
Figure 31 A: Effect of CoCl2 on permeability of 3 kDa FITC-dextran in differentiated 
MDCK monolayers. CoCl2 was added on day 0. Data shows that CoCl2 treatment for 48 
hours (Day 2) and 72 hours (Day 3) significantly (One-way ANOVA, P ˂ 0.0001, N= 4-
12) increased the permeability of differentiated MDCK monolayers. No statistically 
significant differences were found among control groups. 
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Figure 31 B: Effect of CoCl2 on permeability of 70 kDa FITC-dextran in 
differentiated MDCK monolayers. CoCl2 added on day 0. Data shows that CoCl2 
treatment for 72 hours (Day 3) significantly (One-way ANOVA, P ˂ 0.025, N= 3-4) 
increased the permeability of differentiated MDCK monolayers. No statistically significant 
difference was found between control groups. 
The table below summarizes our permeability measurements: 
Table III: Summary of 3 kDa and 70 kDa FITC-dextran permeability values. 
 3 kDa, P (cm/sec) 70 kDa, P (cm/sec) 
Cell-free insert (1.61 ± 0.61) × 10-5 (1.41 ± 0.94) × 10-6 
mCCD w/o CoCl2 (control) (8.53 ± 4.46) × 10-9 (1.93 ± 1.65) × 10-9 
mCCD w/ 48h CoCl2 (4.02 ± 3.15) ×10-7 (1.99 ± 2.13) ×10-8 
mCCD w/ 72h CoCl2 (9.05 ± 8.13) × 10-7 (7.24 ± 6.47) ×10-8 
MDCK w/o CoCl2 (control) (1.41 ± 0.40) × 10-8 (5.63 ± 0.21) × 10-10 
MDCK w/ 48h CoCl2 (3.65 ± 0.96) ×10-8 Did not measure 
MDCK w/ 72h CoCl2 (3.62 ± 0.46) ×10-8 (1.61 ± 0.0) × 10-9 
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  3.1.3.4  Effect of HIF-1α Inhibitor Along with CoCl2 
A preliminary experiment was performed in MDCK monolayers to see if an 
inhibitor of HIF-1α can affect the cellular permeability along with CoCl2. In this 
experiment, an HIF-1α inhibitor was applied at a concentration 30 µmol/L as suggested by 
the supplier (Santa Cruz Biotechnology). We would like to emphasize that the HIF-1α 
inhibitor was not sequentially added; rather the inhibitor was added at the same time when 
CoCl2 was added. The HIF-1α inhibitor alone did not show any significant effect in altering 
3 kDa and 70 kDa FITC-dextran permeability on day 3 as shown in figures 32A and 32B. 
HIF-1α is known to be degraded under normoxic conditions, and, therefore, an HIF-1α 
inhibitor under normoxia does not show any effects on transepithelial permeability as 
expected. However, we made an interesting observation that the permeability of 3 kDa 
FITC-dextran increased more than 40-fold when monolayers were incubated with CoCl2 
and HIF-1α inhibitor for 72 hours (figure 32A). The treatment with CoCl2 alone was found 
to increase 3 kDa FITC-dextran permeability only around 3-fold. Therefore, it is tempting 
to speculate that the application of an HIF-1α inhibitor along with the stabilization of 
HIF1α by CoCl2 creates a chaotic cellular condition which may drastically affect tight 
junctions and shows a drastic increase in 3 kDa FITC-dextran permeability. However, we 
did not notice such an effect with 70 kDa FITC-dextran permeability (figure 32B). 
Application of the HIF-1α inhibitor is further discussed under the section of future 
directions.  
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Figure 32 A: Effect of HIF-1α inhibitor along with CoCl2 on 3 kDa FITC-dextran 
permeability in differentiated MDCK monolayers. Treatment started on Day 0. 
Combined application of 100 µmol/L of CoCl2 and 30 µmol/L of HIF1α inhibitor for 72 
hours (Day 3) drastically increased (40 folds) 3 kDa FITC-dextran permeability and this 
increase was statistically significant (One-way ANOVA, P < 0.0001, N=3-4). The 
application of CoCl2 alone for 72 hours increased the permeability around 3 folds. The 
application of HIF-1α inhibitor alone did not have any significant effect. 
 
Figure 32 B: Effect of HIF-1α inhibitor along with CoCl2 on 70 kDa FITC-dextran 
permeability in differentiated MDCK monolayers. Treatment started on Day 0. 
Combined application of 100 µmol/L of CoCl2 and 30 µmol/L of HIF1α inhibitor for 72 
hours (Day 3) increased 70 kDa permeability around 2 folds and the application of CoCl2 
alone for 72 hours (Day 3) increased 70 kDa FITC-dextran permeability around 3 folds 
(One-way ANOVA, P < 0.0001, N= 3-4). The application of HIF-1α inhibitor alone did 
not have any significant effect. 
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3.1.4  HIF-stabilization by CoCl2 Decreases ZO1 Protein Level 
ZO1 protein is known to link tight junction strand proteins to the actin cytoskeleton, 
and thereby ZO1 maintains the integrity of tight junctions and controls transport through 
paracellular routes (Denker and Sabath 2011). In mCCD cells, HIF-stabilization by CoCl2 
decreased ZO1 protein levels as seen in the western blot (figure 33 A). The densiometric 
analysis demonstrates significant reductions in ZO1 protein levels due CoCl2 treatment as 
shown in figure 30B. Fluid flow along with CoCl2 did not seem to have any additional 
effect. Decreased level of ZO1 due to HIF-stabilization by CoCl2 is consistent with the 
increased permeability of FITC-dextran molecules through mCCD monolayers (Nag and 
Resnick 2017). 
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Figure 33: ZO1 protein level in mCCD cells was decreased due to treatment with 100 
µmol/ L CoCl2. (A) Shows the western blots for ZO1 and beta-actin (loading control) in 
the whole cell extracts prepared from cells treated without CoCl2 (Control), with CoCl2, 
and CoCl2 with fluid flow for 24 hours. (B) Shows the densiometric analysis of the ZO1 
bands, One-way ANOVA, P < 0.0001, N= 4.  
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3.1.5  Transepithelial Electrophysiology Results 
  3.1.5.1  TER Results 
I.  Development of TER During Cellular Growth 
As shown in figure 31, TER values start to develop from the growth phase in mCCD 
cells. Increases in the TER value corresponds to the increment of transcellular resistance 
due to increase in cellular numbers during the growth phase as well as contributed by the 
cellular junctions.  
Figure 34: Development of TER values in growth condition of mCCD cells, N= 3-48. 
II.  Effect of Fluid Flow on TER of mCCD Monolayers 
 Fluid flow was applied during differentiation of mCCD monolayers. As shown in 
Figure 35, the presence of fluid flow did not seem to have any permanent effect on 
differentiating (up to day 8 i.e., D8) and in differentiated mCCD monolayers (e.g., day 8 
or D8 and onwards). Figure 35 also shows the variability and possible range of TER 
values. 
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Figure 35: Effect of fluid flow on TER of differentiating or differentiated mCCD 
monolayers. Differentiation up to day 7-8 (D7 or D8) and differentiated on day 8 onwards, 
N= 7-46.  
III.  Effect of HIF-stabilization by CoCl2 on TER of Renal Epithelial Monolayers 
Due to the integrity of tight junctions, an untreated confluent and fully 
differentiated mCCD monolayer maintains a TER value around 3 kΩ-cm2.  As shown in 
figure 36A and 36B, extended application of CoCl2 results in a significant decrease in TER 
value at day 2 and 3. This decrease in TER value due to CoCl2 treatment is consistent with 
the decreased level of ZO1 and increased permeability of FITC-dextran molecules. HIF-
stabilization by CoCl2 in mCCD monolayers cultured without fluid flow (figure 36A) 
showed an average TER value reduction after 30 hours, whereas in HIF-stabilized 
monolayers cultured with fluid flow (figure 36B), the average TER value was found to 
decrease after 48 hours. The TER of mCCD monolayers was found to decrease 4-fold in 
the absence of fluid flow and 3-fold in the presence of fluid flow due to HIF-stabilization 
by CoCl2. Statistical analysis suggests that the effect of HIF-stabilization in lowering TER 
values was favored when fluid flow was absent (Nag and Resnick 2017). 
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Figure 36: Effect of CoCl2 on TER of differentiated mCCD monolayers. CoCl2 was 
added on day 0 in the absence (A) or presence (B) of chronic steady fluid flow, N= 4-
16, One-way ANOVA. * denotes significant change (p < 0.05) between a control and CoCl2 
treatment at a specific time-point. # denotes CoCl2 treatment causes significant change (p 
< 0.05) between CoCl2 treated sample at a specific time point with control or CoCl2 treated 
sample at a different time point. One-way ANOVA shows no significant (P > 0.05) TER 
changes among control groups in (A) or (B).  Data in (A) shows that application of 100 
µmol/L CoCl2 significantly decreased TER values of differentiated mCCD monolayers 
after 48 hours (2 days) and 72 hours (3 days) without fluid flow. In figure (B) with fluid 
flow, at a specific time points of Day 2 and Day 3, statistical significance (P > 0.05) was 
not detected between control and CoCl2. However, we noticed CoCl2 treatment group value 
was significantly (P < 0.05, denoted by #) decreased as compared to control value at a 
different time point. TER on Day 3 of CoCl2 treated group was significantly decreased as 
compared to Day 2 control. Similarly, TER on Day 2 of CoCl2 treated group was 
significantly decreased as compared to Day 1 control.  
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 In contrast to mCCD monolayers, a confluent and fully differentiated monolayer of 
MDCK cells has a TER value around 200-400 Ω-cm2.  Figure 37 demonstrates that the 
TER values of MDCK monolayers increase due to HIF-stabilization by CoCl2 treatment.  
 
Figure 37: Effect of CoCl2 on differentiated MDCK monolayers without fluid flow. 
CoCl2 was added on day 0 in the absence of fluid flow. TER values increased significantly 
at Day 2 and Day 3 of CoCl2 treatment (One-way ANOVA, P < 0.0001, N= 3-9). No 
statistically significant differences were found among control groups.  
 
The Table below summarizes our TER measurements:  
Table IV: Summary of TER values. 
 TER w/o flow 
[Ω-cm2] 
TER w/ flow 
[Ω-cm2] 
mCCD w/o CoCl2 5502 ± 2870 5699 ± 665 
mCCD w/ CoCl2, 72 h 1356 ± 202 1881 ± 506 
MDCK w/o CoCl2 208 ± 14 Did not measure 
MDCK w/ CoCl2, 72 h 410 ± 35 Did not measure 
 
HIF-stabilization in MDCK monolayers increased FITC-dextran permeability but 
also increased TER value instead of decreasing it. We further investigated this finding by 
statistical analysis. We combined all the data of 3 kDa FITC-dextran and 70 kDa FITC-
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dextran permeability and TER values of fully differentiated and untreated mCCD and 
MDCK monolayers. We analyzed the data to find correlation between TER and 
permeability.  The summary of the correlation shown in the table below:  
Table V: Pearson’s correlation between TER values and 3 kDa or 70 kDa FITC-
dextran permeability in mCCD and MDCK monolayers.  
Cell Type TER versus 3 
kDa Dextran 
Permeability: 
Pearson’s 
Linear 
Correlation 
Coefficient, r 
Statistical 
Significance of 
3 kDa Dextran 
vs TER 
Correlation 
TER versus 3 
kDa Dextran 
Permeability: 
Pearson’s 
Linear 
Correlation 
Coefficient, r 
Statistical 
Significance of 
70 kDa Dextran 
vs TER 
Correlation 
mCCD   -0.5 P < 0.0001,  
N = 56 
 -0.54 
 
P < 0.0001,  
N = 56 
MDCK  0.21 P = 0.32, 
N = 24 
 -0.36  
 
 P = 0.3,   
 N =13 
 
TER is known to maintain an inverse relation with permeability. In mCCD 
monolayers, Pearson’s correlation coefficient (r) values were -0.5 and -0.54 for 3 kDa and 
70 kDa dextran, respectively (table 5). These values suggest fair or moderate correlation 
between FITC-dextran permeability and TER values in mCCD monolayers. The 
permeability and TER correlation was statistically significant in mCCD cells. In the case 
of MDCK monolayers, the 3 kDa FITC-dextran and TER showed a positive r value, 
indicating that the inverse correlation was not maintained (table 5). TER and 70 kDa FITC-
dextran showed a weak correlation. Moreover, in the MDCK monolayer, the correlation 
was not statistically significant as shown in table 5. Thus, the TER values of mCCD 
monolayers can be an indicator of FITC-dextran permeability, but not for MDCK 
monolayers (Nag and Resnick 2018). 
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  3.1.5.2  Ieq Results 
I.  Effect of Fluid Flow on Ieq of mCCD Monolayers 
The presence of fluid flow was found to decrease Ieq values.  The effect of fluid 
flow in lowering Ieq values was consistent both in differentiating and differentiated mCCD 
cellular monolayers as shown in figure 38. This finding agrees with previous reports 
(Resnick and Hopfer 2007; Resnick 2011). Active Na+ transport is mainly responsible for 
Ieq in mCCD monolayers and active Na
+ transport can be regulated by functional cilia and 
fluid flow.  
 
 Differentiation up to day 7-8 (D7 or D8) and differentiated on day 8 onwards, 
N= 7-46.  
II.  HIF-stabilization by CoCl2 Alters Ieq of mCCD Monolayers 
The effect of HIF-stabilization by CoCl2 on Ieq was found to be more prominent in 
mCCD monolayers cultured in the absence fluid flow (Figure 39A) as compared to 
monolayers cultured in the presence of fluid flow (Figure 39B). Treatment with CoCl2 in 
the absence of fluid flow showed a significant decrease of normalized Ieq values after 30 
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hours or 1.2 days (Figure 39A). Due to CoCl2 treatment for 3 days in monolayers not 
exposed to fluid flow, Ieq values showed a significant change and, very interestingly, a 
positive mean Ieq value of 0.9
 µA/ cm2 was detected. Movement of positively charged Na+ 
from the apical to basolateral side results in a negative value of Ieq. Thus, a positive Ieq 
value suggests that the net active ion transport may be occurring in the opposite direction, 
and the monolayer may have become secretory. It is tempting to interpret this finding as a 
confirmation of our hypothesis that the stabilization of HIF-1α for an extended period can 
transform a normally absorptive renal epithelial monolayer into a secretory monolayer.  
Analysis of normalized Ieq values of mCCD monolayers cultured with chronic fluid 
flow showed that the normalized Ieq values were significantly reduced at day 2 in response 
to CoCl2 treatment as shown in figure 39B. Control samples had a mean Ieq value of -2.6 
µA/ cm2, whereas CoCl2 treated samples showed mean Ieq values of 0.1 µA/ cm
2 and 0.2 
µA/ cm2 after 2 and 3 days, respectively.  
When figures 39A and 39B are compared, it is to be noted that HIF-stabilization by 
CoCl2 significantly altered Ieq values in the monolayers without fluid flow after 30 hours, 
whereas in the monolayers cultured with fluid flow, significant changes occurred after 48 
hours. In monolayers without fluid flow, CoCl2 treatment for 72 hours showed a more 
prominent change. Therefore, it can be inferred that the lack of fluid flow may have 
intensified the effect of HIF-stabilization (Nag and Resnick 2017). However, with our EPO 
western blots, we were unable to find any direct contribution of fluid flow in HIF-
stabilization.  
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Figure 39: Effect of CoCl2 on Ieq of differentiated mCCD monolayers. (A) Without 
fluid flow. (B) With chronic steady fluid flow.  CoCl2 was added on day 0. Data shows 
that application of 100 µmol/L CoCl2 significantly decreased Ieq values of differentiated 
mCCD monolayers after 48 hours (2 days) in both (A) and (B).  Interestingly, after 3 days 
of treatment, Ieq value switched to the positive direction. Current values are plotted as 
normalized Ieq (i.e., relative to average control Ieq values) as discussed in methods, N = 4-
16, One-way ANOVA. * denotes significant change (P < 0.05) between a control and 
CoCl2 treatment at a specific time-point. # denotes significant change (P < 0.05) between 
a CoCl2 treated sample at a specific time point with a control or CoCl2 treated sample at a 
different time point. In figure (A) and (B), CoCl2 treatment shows a gradual decrease of 
negative Ieq. Some of these gradual decreases of Ieq are statistically significant (e.g., figure 
(A) Day 1 CoCl2 vs Day 1.2 CoCl2; figure (A) Day 1.2 CoCl2 vs Day 2 CoCl2; figure (B) 
Day 1 CoCl2 vs Day 2 CoCl2) and were denoted by #. In figure (B) Day 3 CoCl2 shows a 
statistically significant decrease as compared to Day 2 Control (denoted by #).  
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  3.1.5.3  CoCl2 Acts on Basolateral Side of mCCD Cells 
In our mCCD cells, the transporter responsible for Co2+ uptake has not been clearly 
identified.  In mammalian cells, the divalent metal cation transporters Slc11a1 and Sla11a2 
are believed to be responsible for Co2+ uptake (Gunshin, Mackenzie et al. 1997; Forbes and 
Gros 2003).  We found that mCCD monolayers cultured in the presence of fluid flow 
exposed to apical CoCl2 treatment showed an initial, transient, increase in TER values but 
no chronic change to TER values as shown in Figure 40A.  Apical treatment with CoCl2, 
did not have any effect on Ieq values of mCCD monolayers (figure 40B). However, when 
CoCl2 was withdrawn from the apical media and added to the basolateral media, we noted 
significant dose-dependent decreases in both TER and Ieq values, as shown in figure 41A 
and 41B. Basolateral treatment with 100 µmol/L CoCl2 showed significant decreases in 
TER and Ieq values after 2 days of treatment as shown in figure 41A and 41B. The effect 
of CoCl2 on cellular electrophysiology (TER and Ieq) when added to basolateral media was 
similar as the effect of CoCl2 when added to both apical and basolateral media. Thus, it is 
interesting to find that CoCl2 affects the electrophysiological properties of our monolayers 
only when it is added in the basolateral media, potentially identifying the site of Co2+ 
uptake (Nag and Resnick 2017).   
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Figure 40: Effect of CoCl2 added to apical media of differentiated mCCD monolayers 
cultured in the presence of chronic steady fluid flow. (A) TER and (B) Ieq 
measurements. Data shows that application of CoCl2 in apical media does not cause any 
chronic changes in TER values (A) or Ieq values (B) of differentiated mCCD monolayers, 
One-way ANOVA, N = 5-8. In the TER and Ieq data, One-way ANOVA shows no 
significant (P > 0.05) TER and Ieq changes among any control groups. In the TER plot (A), 
* denotes a significant change (P < 0.05) between 0 µmol/L CoCl2 and 100 µmol/L CoCl2 
treatment at Day 0.4 (6 hours). # denotes a significant difference (P < 0.05) between a 
CoCl2 treated sample at a specific time point and a CoCl2 treated or control (0 µmol/L 
CoCl2) sample at a different time point. # are marked onto any noticeable significant 
changes due to CoCl2 treatment.  There is no significant effect (P > 0.05) of apical 
application of 0, 50, or 100 µm CoCl2 on Ieq of mCCD monolayers. 
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Figure 41: Effect of CoCl2 when withdrawn from apical media and added to 
basolateral media of differentiated mCCD monolayers in the presence of chronic 
steady fluid flow. (A) TER and (B) Ieq measurements. Data shows that application of 
100 µmol/L of CoCl2 to basolateral media significantly decreased TER values (A) and Ieq 
values (B) of mCCD monolayers in a dose-dependent manner after 2 days of treatment (N 
= 5-6). In the TER and Ieq data, One-way ANOVA shows no significant (p > 0.05) TER 
and Ieq changes among control groups. * denotes significant change (p < 0.05) among 0, 
50, and 100 µmol/L CoCl2 treatment at a specific time-point. # denotes CoCl2 treatment 
causes significant change (p < 0.05) between CoCl2 treated sample at a specific time point 
and CoCl2 treated or control sample at a different time point. In figure (A) we do not see 
statistically significant decrease of TER, * (p < 0.05) on day 2 or day 3 by 50 or 100 µmol/L 
CoCl2 as compared to control (0 µmol/L CoCl2) on that specific day. However, we notice 
some significant decrease of TER as compared to control at a different time point. For 
example, on day 3, 100 µmol/L CoCl2 causes a significant decrease in the TER value when 
compared to 0 µM CoCl2 TER value on day 2, denoted by #. In figure (B) we notice 
significant loss of Ieq with 100 µmol/L CoCl2 treatment on day 2 and significant loss of Ieq 
with both 50 and 100 µM CoCl2 treatment on day 3. Any noticeable significant changes 
due to CoCl2 treatment are denoted by #.  
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3.1.6.  HIF-stabilization by CoCl2 Decreases Na+/ K+- ATPase α1 Subunit 
Protein Level  
The catalytic subunit α of Na+/ K+-ATPase is known to be mainly responsible for 
active transport of Na+. Using western blot, we notice that HIF-stabilization by CoCl2 
decreases Na+/ K+-ATPase α1 subunit level in our mCCD cells as shown in figure 42A. 
Densiometric analysis confirms the significant decrease of Na+/ K+-ATPase α1 due to HIF-
stabilization (figure 42B). The presence or absence of fluid flow along with HIF-
stabilization did not seem to have any additional effect on Na+/ K+-ATPase α1 level 
(figures 42A and 42B) (Nag and Resnick 2017). The decrease of Na+/ K+-ATPase α1 
subunit level due to HIF-stabilization is consistent with the loss of Ieq i.e., decreased active 
Na+ transport from apical to basolateral side in mCCD monolayers.  
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Figure 42: Na+/ K+-ATPase α1 subunit protein level in mCCD cells was decreased due 
to treatment with 100 µmol/ L CoCl2. (A) Shows the western blots for Na+/ K+-ATPase 
α1 subunit and beta-actin (loading control) in the whole cell extracts prepared from cells 
treated without CoCl2 (Control), with CoCl2, and CoCl2 with fluid flow for 24 hours. (B) 
Shows the densiometric analysis of the ZO1 bands, One-way ANOVA, P = 0.001, N= 3.  
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3.2  Discussion 
3.2.1  100 µmol/L CoCl2 Stabilizes HIF-1α without Any Detectable Cellular 
Cytotoxic Effects until 4 Days  
 In our mCCD and MDCK monolayers 100 µmol/L CoCl2 was found to stabilize 
HIF-1α in the nucleus and also resulted in a slightly increased production of EPO. We 
detected EPO by western blot in the cell lysates. We think that the EPO was mostly released 
in the cell culture media and since we did not analyze EPO levels in cell culture media, we 
may have underestimated the effect of HIF-stabilization by CoCl2 in increasing EPO 
production by mCCD and MDCK cells. A concentration of 100 µmol/L CoCl2 was 
previously reported to stabilize HIF-1α in the nucleus of MDCK cells (Verghese, Zhuang 
et al. 2011).  Other studies showed cobalt can increase EPO production (FISHER and 
Langston 1967; Fandrey, Frede et al. 1997). CoCl2 was previously shown to prevent 
cellular growth of mouse embryonic fibroblasts at a concentration of 100 µmol/L. 
However, MTT assay showed 100 µmol/L CoCl2 did not have any significant cytotoxic 
effect on fibroblasts after 72 hours (Vengellur and LaPres 2004).  Similarly, using an MTT 
assay we did not notice any effect on the cellular metabolic activity of mCCD cells by 100 
µmol/L CoCl2 up to 4 days of CoCl2 treatment. All our epithelial transport experiments 
were carried out within 3 days of CoCl2 treatment, and during this time CoCl2 did not seem 
to have any cytotoxic effect. MTT assay may show a delayed response to indicate cytotoxic 
effects or may be unable to detect small variation in cellular viability (Page, Bejaoui et al. 
1988; Sieuwerts, Klijn et al. 1995). In this context, it is important to point out that we 
ensured that all our mCCD monolayers maintained a threshold TER value of 1 kΩ- cm2 
during epithelial transport experiments. Any small gap due to loss of cells (0.4 % loss of 
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cellular coverage) would cause 80% decrease in TER value (ávan der Meer, JungáKim et 
al. 2015). We did not notice such a drastic change of TER values in our monolayers due to 
CoCl2 treatment up to 3 days, supporting our MTT assay results that CoCl2 treatment may 
not have affected number of viable cells at least up to 3-4 days.  
 As discussed previously, in kidney cystic epithelia of rats and humans, protein 
levels of HIF-1α and mRNA levels of HIF-α target genes, such as EPO, Glut-1, and VEGF 
were found to be elevated (Bernhardt, Wiesener et al. 2007). Using CoCl2, we prevented 
degradation of HIF-1α in monolayers of mCCD and MDCK epithelial cells to understand 
the role of hypoxia or HIF-stabilized environment as experienced by normal renal epithelial 
cells in a hypoxic environment created by cysts in PKD (Nag and Resnick 2017).  
In our study, we considered that the cell culture in a regular incubator with 5% CO2 
as cells under normoxia. The normal atmospheric O2 is around 20%. In a normal cell culture 
incubator, the percent of O2 is similarly around 20%. The alveolar cells normally encounter 
around 20% O2 and arterial blood has O2% around 10-13% and O2% is other organs is 
around 1-8%. In vivo kidney medulla was reported to encounter around 1% O2 (Lübbers 
and Baumgärtl 1997). Therefore, renal epithelial cell culture maintained in a CO2 incubator 
may experience a hyperoxic environment, rather than a normoxic environment (Wenger, 
Kurtcuoglu et al. 2015). Future work can address this limitation using an O2 controlling 
chamber or incubator. 
3.2.2  Effect of Fluid Flow with HIF-stabilization 
Chronic fluid flow alone did not seem to have any effect on TER values of mCCD 
monolayers, but the presence of flow showed consistently decreased Ieq value, i.e, 
decreased Na+ transport, and this finding is consistent with previous reports (Resnick and 
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Hopfer 2007; Resnick 2011). Our results of electrophysiological analysis suggest that the 
presence of chronic fluid flow may blunt HIF-stabilized altered transepithelial transport. 
TER and normalized Ieq values decreased more rapidly in the absence of fluid flow as 
compared to monolayers cultured in the presence of fluid flow. It is tempting to suggest 
that monolayers cultured in the absence of fluid flow may be hypoxic to some extent and 
may already have increased HIF-1α to some extent. However, we maintained a thin apical 
fluid thickness that ensures adequate O2 availability to the monolayer. Our western blots 
did not show any additional effect of the presence or absence of fluid flow along with CoCl2 
on protein levels of EPO, ZO1, and Na+/ K+-ATPase. Therefore, renal epithelial response 
to fluid flow seems to be independent of HIF-1α (Nag and Resnick 2017). 
3.2.3  HIF-stabilization by CoCl2 Alters Transcellular and Paracellular 
Transport 
We presented our method of quantification of FITC-dextran permeability and 
showed permeability as a stable function of mCCD and MDCK epithelial monolayers. In 
MDCK C-7 epithelial cell monolayers with TER value of around 4000 Ω-cm2, 4 kDa FITC-
dextran apparent permeability (Papp) value was reported to be around 2×10
-9 cm/sec (Gekle, 
Wünsch et al. 1994; Kaiser, Pereira et al. 2015). In our mCCD monolayers with TER value 
around 3000 Ω-cm2, 3 kDa permeability value was found to be (8.53 ± 4.46) × 10-9 cm/sec. 
Thus, our calculated permeability values agree with previous reports.  Using 3 kDa and 70 
kDa FITC-dextran molecules, we were able to identify that the size selectivity was 
maintained in both mCCD and MDCK epithelial monolayers. 3 kDa FITC-dextran can be 
transported through epithelial monolayers either by fluid-phase transcytosis or by 
paracellular transport, whereas large 70 kDa dextran molecules are known to be transported 
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only through the paracellular pathway (Matter and Balda 2003). Thus, changes in 70 kDa 
FITC-dextran transport through mCCD and MDCK monolayers due to HIF-stabilization 
represent changes in the paracellular pathway. Increased permeability of anionic FITC-
dextran from apical to basolateral side suggests increased paracellular transport which can 
also be indicative of increased water permeability.  
In the mammalian kidney, paracellular permeability is known to decrease from the 
proximal tubule to the collecting duct due to the expression of different claudins and higher 
levels of occludin and ZO1 proteins (Gonzalez-Mariscal, Namorado et al. 2000; Denker 
and Sabath 2011). Paracellular transport through epithelial tight junctions is known to be 
driven by the ion gradient created by transcellular active transport. Proximal tubule is a 
leaky epithelial monolayer with a high paracellular permeability and low TER. The 
proximal tubule is known to be more than 100 fold more permeable than the collecting duct 
(Denker and Sabath 2011). In our mCCD monolayers HIF-stabilization for 72 hours with 
CoCl2 resulted in a 100-fold increase of 3 kDa FITC-dextran permeability and 40-fold 
increase of 70 kDa FITC-dextran permeability. Therefore, HIF-stabilized collecting duct 
epithelial monolayers appear to behave as monolayers from a more permeable region of 
the kidney, such as proximal tubule.   
The cortical collecting duct is responsible for 0.5% salt reabsorption and helps in 
fine-tuning water and salt balance in the body. In mCCD monolayers, Ieq primarily shows 
the active Na+ transport through ENaC channels since more than 95% of Ieq is known to be 
blocked by 10 µmol/L of Na+ channel blocker amiloride (Resnick and Hopfer 2007; 
Resnick 2011). We noticed that HIF-stabilization by CoCl2 caused a loss of Ieq values after 
48 hours, indicating diminished active Na+ transport. The decreased protein level of Na+/ 
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K+-ATPase α1 subunit was consistent with the loss of active Na+ transport. Similar 
observations were previously reported in kidney collecting duct epithelial monolayers, in 
which hypoxia was shown to decrease ENaC activity and thereby decreased Ieq of the 
monolayers (Husted, Lu et al. 2010). Moreover, in the HIF-stabilized mCCD monolayers 
without fluid flow, we noticed a switch in the direction of the current after 72 hours, 
suggesting that the direction of net ion transport was opposite as compared to the normal. 
Thus, we noticed our absorptive mCCD monolayer transformed to a secretory monolayer 
due to HIF-stabilization.  
In renal epithelial monolayers, hypoxia mimetic condition, created by depletion of 
ATP, caused disruption of actin cytoskeleton organization and tight junctions and 
endocytosis of Na+/ K+-ATPase (Molitoris, Dahl et al. 1996).  Similarly, we found that the 
Na+/ K+-ATPase catalytic subunit α1 level decreased in our mCCD cells, supporting the 
loss of active Na+ transport as observed by the loss of negative Ieq value in our mCCD 
monolayers. We also noticed that permeability increased and ZO1 protein level decreased 
in our mCCD monolayers, indicating alteration of tight junctions. In renal carcinoma cells, 
HIF-1α was shown to regulate tight junctions by altering normal protein levels of claudin-
1 and occludin and normal localization of ZO1, claudin-1, and occludin (Harten, Shukla et 
al. 2009).   
Ischemic injury was shown to decrease sodium reabsorption by kidney proximal 
tubule due to apical redistribution of Na+/ K+-ATPase α-subunit from basolateral side 
(Molitoris 1991; Molitoris, Dahl et al. 1992).  In vitro apical redistribution of Na+/ K+-
ATPase was shown to be functional in switching Na+ transport from the basolateral to 
apical side (Molitoris 1993).  In our mCCD monolayers, HIF-α stabilization in the absence 
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of fluid flow showed a positive Ieq value which indicated that ions, most likely Na
+, are 
actively transported in the opposite direction.  This switch in the direction of active ion 
transport could be due to the similar redistribution of Na+/ K+-ATPase to the apical side in 
our mCCD cells.  
Previous studies in alveolar epithelial cells reported similar observations as our 
results in renal epithelial cells (Mairbäurl, Mayer et al. 2002). Hypoxia was shown to 
decrease active Na+ transport in rat alveolar epithelial monolayers and also decrease TER 
of monolayers, increasing monolayer permeability of 4 kDa FITC-dextran (Mairbäurl, 
Mayer et al. 2002; Bouvry, Planes et al. 2006). We noticed that HIF-stabilization by CoCl2 
increased permeability of 3 kDa and 70 kDa FITC-dextran permeability both in our mCCD 
and MDCK monolayers. We also noticed that TER values of mCCD monolayers also 
decreased due to HIF-stabilization. In contrast, in MDCK monolayers, TER and FITC-
dextran permeability both increased due to HIF stabilization. As mentioned previously, in 
MDCK monolayers, TER did not seem to be a good indicator of FITC-dextran permeability 
(Nag and Resnick 2018). MDCK monolayers were reported to show increased TER values 
as well as increased permeability of 3, 4 and 40 kDa FITC-dextran permeability in different 
studies (Balda, Whitney et al. 1996; McCarthy, Francis et al. 2000; Van Itallie, Fanning et 
al. 2009). 
Hypoxia was shown to affect the expression or activity of apical ENaC and 
basolateral Na+/ K+-ATPase causing decrease in active Na+ transport of alveolar epithelia 
(Vivona, Matthay et al. 2001; Planès, Blot-Chabaud et al. 2002; Dada, Chandel et al. 2003). 
Alveolar Na+/ K+-ATPase activity is known to be decreased in response to hypoxia by 
endocytosis, which involves phosphorylation and ubiquitination of α1 subunit (Dada, 
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Chandel et al. 2003). The phosphorylation of Na+/ K+-ATPase is known to be mainly driven 
by PKC (Feschenko, Stevenson et al. 2000; Dada, Welch et al. 2007).   
Hypoxia was also reported to alter tight junctions and thereby showed increased 
permeability of monolayers of brain microvessel endothelial cells and intestinal epithelial 
cells (Xu, Lu et al. 1999; Yamagata, Tagami et al. 2004; Engelhardt, Al‐Ahmad et al. 
2014), further supporting our findings that HIF-stabilization can decrease monolayer 
resistance and can increase FITC-dextran permeability.   
Hypoxia was found to decrease ZO1 protein levels in the monolayers of alveolar 
epithelial cells (Bouvry, Planes et al. 2006). ZO1 protein level was shown to decrease in 
brain microvascular endothelial cells through HIF-1α (Engelhardt, Al‐Ahmad et al. 2014). 
Similarly, we also noticed decreased level of ZO1 protein in our mCCD cells due to 
stabilization of HIF-1α. Hypoxia can affect the actin cytoskeleton organization and can 
result in occludin mislocalization from tight junctions to the cellular interior in alveolar 
epithelial cells (Bouvry, Planes et al. 2006). Stabilization of HIF-1α was shown to affect 
the integrity of tight junctions of brain microvascular endothelial cells due to the 
mislocalization and tyrosine phosphorylation of tight junction complex proteins, such as 
ZO1 and occludin (Engelhardt, Al‐Ahmad et al. 2014).  
Thus, our results demonstrating altered transepithelial permeability are relevant and 
are supported by other findings demonstrating that epithelial tight junction morphology is 
regulated by HIF, with claudins (Saeedi, Kao et al. 2015), occludins (Caraballo, Yshii et 
al. 2011), and ZO1 (Engelhardt, Al‐Ahmad et al. 2014) being specific targets.  Similarly, 
our electrophysiological results are in agreement with previous reports (Husted, Lu et al. 
2010; Caraballo, Yshii et al. 2011). 
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We think VEGF may be a key player in altering renal epithelial tight junctions due 
to HIF-stabilization as seen in alveolar epithelial cells (Song, Kim et al. 2017). VEGF is 
known to be expressed in the renal tubules. VEGF-A mRNA was detected in the epithelial 
cells of glomerulus, distal tubules, and collecting ducts of humans and rodents (Bacic, 
Edwards et al. 1995; Tufro, Norwood et al. 1999; Karihaloo, Karumanchi et al. 2005). 
VEGF has a HRE and is elevated in response to HIF (Forsythe, Jiang et al. 1996). Cystic 
epithelial cells were found to be hypoxic and showed higher protein levels of VEGF 
(Bernhardt, Wiesener et al. 2007). Occludin, ZO1, and claudins are known to maintain 
integrity of tight junctions. Hypoxia was shown to decrease levels of occludin in 
endothelial cells (Brown and Davis 2005) and ZO1 in alveolar epithelial cells (Bouvry, 
Planes et al. 2006) and endothelial cells (Engelhardt, Al‐Ahmad et al. 2014). VEGF is 
known to cause phosphorylation of multiple serine and threonine residues of occludin 
involving activation of PKC (Antonetti, Barber et al. 1999; Harhaj, Felinski et al. 2006). 
Such a phosphorylation of occludin is known to modulate ubiquitination of occludin 
(Murakami, Felinski et al. 2009). VEGF is also known to cause tyrosine phosphorylation 
of ZO1 (Antonetti, Barber et al. 1999).  Ischemia was shown to promote tyrosine 
phosphorylation of occludin in brain endothelial cells (Kago, Takagi et al. 2006). Tyrosine 
phosphorylation of occludin was shown to disrupt tight junctions due to the decreased 
interaction with ZO proteins  (Kale, Naren et al. 2003). Phosphorylation of ZO1 and 
occludin correlated to increased permeability of endothelial cells (Antonetti, Barber et al. 
1999). Therefore, we think that in our mCCD cells, HIF-stabilization may have increased 
VEGF level causing alterations of renal epithelial tight junctions and increasing 
paracellular permeability through similar mechanisms.  
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By introducing point mutations and replacing serine and threonine residues of 
occludin and tyrosine residues of ZO1 with alanine residues if we can block the effect of 
HIF-stabilization by CoCl2, we can investigate if the phosphorylation of tight junction 
proteins are directly involved in the effect of HIF-stabilization on altered epithelial 
transport. We suspect that the loss and mislocalization of tight junction proteins may cause 
mislocalization and apical distribution of Na+/ K+-ATPase to the apical membrane and may 
cause movement Na+ in the opposite direction. If by blocking the effect of HIF on tight 
junction proteins, the effect of HIF-stabilization on Na+/ K+-ATPase can be blocked, then 
we can confirm whether the HIF-stabilization affects Na+/ K+-ATPase directly or 
indirectly. By inhibiting the action of VEGF, if the effect of HIF-stabilization can be 
blocked, we can confirm the direct effect of HIF-stabilization on tight junction protein. We 
suspect that the decreased level and loss of Na+/ K+-ATPase is also directly contributed by 
phosphorylation and ubiquitination of Na+/ K+-ATPase α1 subunit.  By introducing point 
mutations of amino acid at the phosphorylation site of Na+/ K+-ATPase α1 subunit, if we 
can prevent the loss of Na+/ K+-ATPase due to HIF-stabilization by CoCl2, the direct effect 
of HIF-stabilization on Na
+/ K+-ATPase α1 subunit can be verified.  
3.3  Conclusion 
In summary, in mCCD monolayers, we noted that HIF-stabilization by CoCl2 
caused a loss of negative Ieq and showed a positive Ieq value in the absence of fluid flow, 
indicating that there was a switch in the direction of net Na+ movement through active 
transport. Thus, our absorptive mCCD epithelial monolayer may have transformed into a 
secretory monolayer. The loss of Ieq was consistent with decreased level of Na
+/ K+-
ATPase α1. We suspect that the apical redistribution of Na+/ K+-ATPase α1 may be 
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responsible for the switch in the direction of active ion transport. In mCCD monolayers, 
HIF-stabilization showed a significant decrease of the TER values and increase in 70 kDa 
paracellular permeability. Decreased level ZO1 was consistent with increased paracellular 
permeability and decreased TER in mCCD monolayers. In MDCK monolayers, HIF-
stabilization also showed significant increase of 70 kDa paracellular permeability.  Thus, 
HIF stabilization seems to affect both the transcellular and paracellular pathways of kidney 
epithelial monolayers. Increased FITC-dextran permeability through cellular monolayers 
of mCCD and MDCK indicated altered selective epithelial barrier function. Moreover, we 
identified that Co2+ uptake occurs via basolateral side of monolayers. In conclusion, we 
have provided evidence in support of our hypothesis that HIF-stabilization can reverse net 
sodium transport and increases permeability of renal epithelial monolayers. Thus, chronic 
stabilization of HIF, as experienced by normal epithelial cells near to a cyst, can transform 
normal absorptive phenotype of epithelial cells to a leaky and secretory cyst-like phenotype 
and may contribute to cyst expansion and PKD progression. 
3.4  Future Directions 
1. Using immunocytochemistry, possible Na+/ K+-ATPase redistribution from 
basolateral to apical side due to HIF-stabilization can be checked.  
2. If functional Na+/ K+-ATPase pumps are redistributed to the apical membrane, 
apical application of ouabain will be able to block the positive Ieq seen due to HIF-
stabilization.  
3. Occludin protein level can be decreased due to HIF-stabilization as known in the 
literature. This can be checked by western blots.  
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4. Under the discussion section, we pointed out that VEGF may be the key player in 
altering renal epithelial tight junctions due to HIF-stabilization. By checking VEGF 
level after HIF-stabilization can establish the direction connection between HIF-
stabilization and altered tight junctions. We suspect that the redistribution of Na+/ 
K+-ATPase occurs as an indirect response to the alteration of actin cytoskeleton and 
tight junctions by HIF-stabilization. The direct effect of VEGF on tight junctions 
and indirect on Na+/ K+-ATPase can be better understood by using an anti-VEGF 
antibody. 
5. By introducing point mutations of phosphorylation sites of ZO1 and Occludin, the 
effect of HIF-stabilization by CoCl2 through VEGF can be confirmed.  
6. By causing point mutations of amino acid at the phosphorylation site of Na+/ K+-
ATPase α1 subunit, the direct effect of HIF-stabilization by CoCl2 on the decreased 
level of Na+/ K+-ATPase can be investigated. 
7. Use of a chemical inhibitor against HIF-1α will help to strengthen the connection 
between HIF-stabilization and altered transepithelial transport. The cellular 
monolayers will be pretreated with the inhibitor, followed by the treatment with 
CoCl2. HIF1α inhibitor (Santa Cruz Biotechnology, sc-205346) used in a 
preliminary study can be used. Other, HIF-inhibitors such as chetomin and 
echinomycin, can be used depending on the effectiveness. 
8. Study using another HIF-stabilizer such as, iron chelator DFX may also further 
strengthen the connection between HIF-stabilization and altered transepithelial 
transport. 
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9. Use of a hypoxic chamber will help to understand the effect low O2 level on 
transepithelial transport in our mCCD monolayers. The expected findings of active 
epithelial transport in a hypoxic chamber may be similar to the study reported 
previously (Husted, Lu et al. 2010) and somewhat consistent with our current 
findings. 
10. Comparisons among transcellular and paracellular transports in ciliated and 
deciliated mCCD monolayers with or without HIF-stabilization will help us 
understand the role of ciliary flow-sensing on altered transepithelial transport due 
to HIF-stabilization. 
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